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Abstract 
Bone invasion is a common feature of oral squamous cell carcinoma (OSCC) and is 
associated with poor prognosis. In this study, we report a novel role for cancer associated 
fibroblasts (CAF) in OSCC bone invasion, and provide additional evidence that two 
subsets of CAF, myofibroblastic and senescent fibroblasts, can both promote bone 
destruction via a mechanism involving receptor activator of nuclear factor kappa-Β ligand 
(RANKL) and extracellular vesicles (EV).	
Our results show two populations of CAF, alpha smooth muscle actin (aSMA) 
myofibroblastic, and aSMA and p16INK4a positive senescent, are present and show 
increased expression of RANKL in ex vivo OSCC bone resections. To examine the 
mechanism underlying this observation, senescence was experimentally induced in 
normal oral fibroblasts (NOF) by culturing to replicative mitotic exhaustion (S-NOFRep), 
or exposure of proliferating cells to hydrogen peroxide (S-NOFH2O2) or cisplatin (S-
NOFCis).  Elevated expression of the molecular markers of senescence, p16INK4a 
and interleukin-6 (IL6), were seen; the latter is also a key component of the senescence-
associated secretory phenotype (SASP) and mediator of bone absorption. Increased 
expression and secretion of RANKL was also detected in these cell cultures.	
Osteoclastogenesis and pit formation on a synthetic bone substrate were significantly 
increased in response to primary CAF, myofibroblastic and senescent fibroblast-derived 
conditioned media. This mechanism was significantly attenuated by the senolytic drugs 
Alvespimycin (17-DMAG) and Navitoclax (ABT263). Moreover, to understand the 
mechanism by which OSCC and surrounding CAF communicate in the tumour 
microenvironment, EV were isolated from H357 oral cancer cell line, primary CAF from 
fresh OSCC tissue and experimentally induced senescent fibroblasts (S-NOF). EV from 
all cells contained RANKL, and significantly promoted osteoclastogenesis. 
Osteoprotegrin (OPG), a RANKL decoy receptor, antagonist and bone resorption 
regulator reduced osteoclastogenesis, providing further evidence of a role of RANKL in 
CAF-mediated bone destruction. 	
In conclusion, this work provides novel evidence that CAF play a functional role in bone 
invasion. The ability of senolytic drugs to reduce senescent CAF burden and inhibit 
osteoclastogenesis holds promise as a novel therapeutic approach in bone invasive 
OSCC.
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1.1 Introduction 
Cancer is a term used to describe uncontrolled proliferation of anaplastic cells, 
with invasion of proximal tissue and metastasis to regional sites and distant 
organs. Cancer is one of the leading causes of mortality worldwide, with an 
estimate of 8.2 million deaths recorded in 2012 (Cancer Research, UK, 2017). 	
Head and neck cancers are predominantly of epithelial origin. Oral squamous cell 
carcinoma (OSCC), comprises 95% of all neoplasia of the oral cavity, and 
approximately 30% of head and neck malignancies involving pharynx, nasal 
cavity, paranasal sinuses, oral cavity, and lips (Haddad and Shin, 2008). In 
reference to the State of Mouth Cancer UK Report 2018/2019, more than 8,300 
people are diagnosed with oral cancer each year. It is the fourteenth most 
common cancer, in which over 78% are over the age of 55 (dentalhealth.org, 
2019). Unfortunately, oral cancer has been on a rise to up to 33% in the last 
decade (Cancer Research UK, 2019).	
OSCC has diverse risk factors, such as excessive alcohol consumption, tobacco, 
diet and genetics either affecting independently or synergistically. Over the past 
two decades, OSCC incidence has been increasing in young patients and in 
developed countries particularly. This escalation has been partly attributed to 
tonsillar and oropharyngeal cancers related to human papillomavirus (HPV), but 
the particular causes and mechanism of this rapid increase remain rather 
speculative (Warnakulasuriya, 2010; Cleary et. al, 2016; Office of National 
Statistics, 2017).	
Oral cancer remains difficult to treat and one main reason is the lack of specific 
biomarkers and late detection of these lesions at an advanced stage. OSCC can 
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arise from histologically normal epithelium but usually develops within an existing 
potentially malignant lesion clinically presenting as erythroplakia or leukoplakia 
i.e. red or white lesions respectively (Colella et. al, 2008). Lesions can originate 
anywhere in the oral mucosa, but the gingiva, floor of mouth and tongue are 
considered the most frequent sites (Jimi et al., 2011). 	
Advanced OSCC is very aggressive, with a three-year survival rate of 40% often 
due to regional metastasis (National Cancer Intelligence Network (NCIN), 
2013).  As tumour cells proliferate and invade the connective tissue, the lesion 
expands in size and may lead to involvement of locoregional structures including 
the mandible, maxilla or facial bones. In fact, bone invasion is a hallmark of 
OSCC, upgrading the tumour stage and is seen in 12% to 56% of OSCCs (Chen 
et al., 2011). Maxillofacial bones (particularly maxilla and mandible) are closely 
associated with complex anatomical structures such as sinuses, nose, eyes, 
cranial nerves, and brain; therefore, OSCC infiltration can cause critical functional 
complications. Such cancers are difficult to treat and eradicate surgically due to 
the complex maxillofacial anatomy, difficult surgical access and attempt at 
preservation of functionality. The primary treatment modality for OSCC is surgery 
with adjuvant radio or chemotherapy. However, surgery can have associated 
morbidity with aesthetic and psychosocial impact on patients. Bone involvement 
is usually related to a poor prognosis, significantly deteriorating the patient’s 
quality of life and postoperative outcome. Therapy and rehabilitation could be 
challenging, as principal functions such as speech, mastication, and swallowing 
can be adversely influenced. Despite these significant issues related to bone 
invasion in OSCC, its precise mechanism remains under-investigated and poorly 
understood (Quan et al., 2012).	
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Surgical radical resection with a healthy margin is the treatment of choice for 
OSCC patients presenting with bone involvement (Shah and Gil, 2009). The 
American Joint Committee on Cancer Classification (AJCC), recommends 
upgrading OSCC with bone invasion to a clinical (and pathological) primary 
tumour stage T4 (irrespective of any other parameters) with an overall stage (IV); 
the latter associated with a poor prognosis (Frederick et al., 2002). Shah and 
Lydiatt (1999) recorded the 5-year survival rate of patients with stage IV OSCC 
as 39%, compared to 53, 68 and 70% for stages III, II and I respectively, indicating 
its significance as a clinical issue. A retrospective study reviewing cases with 
histopathologically confirmed bone invasion reported that cancellous bone 
invasion (rather than superficial cortical bone resorption) is the prime factor that 
has a prognostic implication on survival. (Ebrahimi et al., 2011).	
It has recently become increasingly evident that the stroma surrounding 
tumour (predominantly fibroblasts, inflammatory cells, and endothelial cells) 
plays a critical role in tumour advancement (De Wever et al., 2008). Marsh et al. 
(2011), amongst others, highlighted the importance of the tumour 
microenvironment in OSCC progression, showing that stromal features such as 
the presence of myofibroblast-like cells are more sensitive predictors of OSCC 
aggression, than other tumour features or TNM staging. Alpha smooth muscle 
actin (αSMA) expressing stromal myofibroblasts (cancer associated fibroblasts, 
peri-tumour fibroblasts or cancer activated fibroblasts) are apparent in numerous 
solid tumour microenvironments (Radisky et al., 2007). Xu et al. (2009) observed 
the transdifferentiation of myofibroblasts through TGFβ and postulated that 
cancer associated fibroblasts (CAF) could differentiate from epithelial cancer 
cells through epithelial mesenchymal transition (EMT). However, Marsh et al. 
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(2011) suggested that myofibroblasts are likely to originate from local 
mesenchymal cells and promote tumour progression by creating a 
microenvironment encouraging cancer growth and spread. 	
Nonetheless, the role of OSCC stroma in bone invasion remains largely 
unexplored. Ishikuro et al. (2008) reported the presence of intervening fibrous 
stroma at the OSCC and bone interface evident in mandibular bone invasion, in 
addition to expression of RANKL in cells surrounding osteoclasts in OSCC bone 
sections. Moreover, they co-cultured human OSCC cell lines with murine 
osteoblasts, reporting an amplification of RANKL and RANK mRNA expression. 
However, the outcome from this study is inconclusive to some extent, as stromal 
activation markers were not examined, nor did they study the effect of human 
osteoblasts co-cultured with CAF.	
Bone invasion in oral cancer may be associated with an elevation in both 
osteoblastic and osteoclastic activity. Totsuka et al. (1991) reported two patterns 
of bone invasion in OSCC. In the expansile pattern, the tumour invades with a 
broad pushing invasive front, surrounded by fibrous stromal tissue. Alternatively, 
the infiltrative pattern of bone invasion is recognised as strands and nests of 
extensive discohesive infiltrating tumour cells (Müller and Slootweg, 1990). 
Cases with intermixed patterns are referred to as showing a mixed pattern of 





 Chapter 1 Introduction and Literature Review 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 6 
1.2 Bone physiology 
1.2.1 Bone tissue  
Osseous (bone) tissue is a rigid but dynamic structure. It has both organic and 
inorganic constituents. In order to maintain tissue integrity, homeostasis must be 
achieved; hence conserving cellular equilibrium and bone structure. Numerous 
cell types regulate bone deposition, resorption, and architectural integrity. The 
basic unit modulating this mechanism are osteoclasts, which actively resorb 
osseous tissue, while osteogenic or osteoblast lineage cells (bone lining cells, 
pre-osteoblasts, osteoblasts, and osteocytes) are responsible for structural 
preservation (Kular et. al, 2012; Nanci, 2017).	
Osteoblasts are derived from mesenchymal stem cells and are the sole cells 
accountable for bone matrix deposition. Upon stimulation, osteoblasts have the 
ability to differentiate through four different stages, starting as preosteoblasts and 
gradually maturing from osteoblast finally presenting as bone lining cells. Mature 
osteoblasts are mononuclear cuboidal cells that mainly secrete type 1 collagen, 
osteocalcin, and alkaline phosphatase, jointly responsible for bone foundation. 
On maturation, osteoblasts become surrounded by their secreted matrix or 
osteoid, and are referred to as osteocytes (Clarke, 2008).	
Osteocytes are terminally differentiated bone cells embedded within mineralised 
bone. These cells are connected to other cells in bone matrix and surface and 
form signalling networks through their processes (Prideaux et al., 2016). 
Osteocytes predominantly function as mechanical receptors, resulting in initiation 
of bone remodelling by modulating osteoblasts and osteoclasts, however when 
generating osteoclasts in culture, the presence of these cells are not necessary 
(Marino et al., 2014). 	
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Osteoclasts are large multinucleated tartrate resistant acid phosphatase (TRAP) 
staining cells, derived from fusion of haematopoietic monocytes, in a process 
termed osteoclastogenesis. Several factors are required to regulate 
osteoclastogenesis. Macrophage colony-stimulating factor (M-CSF), receptor for 
activation of nuclear factor kappa B (NF-κB) ligand (RANKL) expressed both by 
osteoblasts and stromal cells, and its receptor RANK present on osteoclast cell 
membranes, are necessary to promote osteoclast formation (Kular et al., 2012). 
Binding of RANK ligand to its receptor activates a signalling cascade resulting in 
osteoclastic differentiation of progenitor bone cells. However, RANKL can 
actively be antagonised in the presence of osteoprotegerin (OPG), which acts as 
a decoy receptor competing with RANKL binding to RANK, consequently 
inhibiting osteoclastogenesis (Jimi et al., 2013; Nanci, 2017). 	
1.2.2 The dynamic mechanism of bone remodelling 
Remodelling is a complex synchronised process involving the coordinated 
functioning of two main cell types; the osteoblast, responsible for bone matrix 
synthesis as well as remineralisation; and osteoclasts, the principal cells in bone 
mass regulation and resorption. 	
The remodelling cycle initially commences with osteoclast recruitment to the bone 
surface, allowing activation and conservation of demineralisation, and resorption 
of bone matrix through secretion of enzymes, acid phosphatase and cathepsin B 
(Nanci, 2017). Osteoclast stimulation is activated by RANKL binding to its 
designated receptor in the presence of parathyroid hormone related protein 
(PTHrP), interleukin-11 (IL11), sclerostin, and prostaglandin (PG2) (Theill et al., 
2002; Boyle et al., 2003; Wada et al., 2006). Following RANK attachment to its 
ligand, osteoclasts further release fusion proteins Atp6v0d2 (an ATPase) (Lee et 
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al., 2006), FcRy (Fc receptor-related protein Y), and DC-STAMP (dendritic cell-
specific transmembrane protein) (Kukita et al., 2004). Moreover, osteoclast 
proliferation is escalated by osteoblast secretion of M-CSF, further triggering 
RANK activity.	
Following attachment of osteoclasts to the bone surface, lysosomes are released 
to the binding sites, actively disintegrating bone matrix (Sims and Gooi, 2008). 
Throughout bone demineralisation and resorption, osteoclasts may disseminate 
bone forming proteins and growth factors TGFβ (Centrella et al., 1991), BMP 
(Harris et al., 1994), and IGF (Schmid et al., 1992), which upon activation 
stimulates osteoblast recruitment; facilitating bone formation (Mohan and Baylink, 
1991) (Figure 1.1). 
 
Figure 1.1: Bone remodelling.  Bone remodelling is a continuous process that 
maintains the tissue integrity. In this mechanism, bone is resorbed by osteoclasts 
differentiated from haematopoietic cells in the presence of M-CSF and RANKL 
(preosteoclasts). OPG/OCIF released by osteoblasts blocks osteoclast generation and 
bone resorption, allowing osteoblasts to deposit new bone in resorptive areas. 
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(Illustration generated using PowerPoint software). 
A reverse interval of resorption follows, as the active osteoclastic bone 
degradation is halted, and osteoclasts undergo apoptosis, while osteoblast 
lineage cells proliferate and undergo differentiation. This stage is considered a 
transition from predominant osteoclast to osteoblast influence (Kular et al., 2012). 
Bone deposition proceeds primarily through osteoclast-osteoblast 
communication through ephrinB2 and its corresponding receptor EphB4 on 
osteoblasts, thus promoting osteoblast maturation (Zhao et al., 2006). However, 
this interaction could be impeded in the presence of PTH, hence depleting bone 
mineralisation due to an increase in unbound ephrinB2 (Allan et al., 2008). An 
equivalent pathway has been described which blocks both osteoblast and 
osteoclast differentiation in the presence of osteoclast inhibitory factor (OCIF) 
(Zhou et al., 2001).	
In the termination stage, remodelling is halted as osteoblasts reverse differentiate 
into bone lining cells, and either remain on the bone surface or become entrapped 
in mineralised bone matrix as osteocytes. Sutherland et al. (2006), noted that 
osteocyte expression of sclerostin acts as a negative regulator of bone formation 
by diminishing osteoblast proliferation, decreasing matrix mineralisation, and 
promoting osteoblast apoptosis. It has recently been shown that neutralisation of 
sclerostin with a specific antibody elevates bone mass (McClung et al., 2014; 
Recker et al., 2015). Finally, following bone deposition fulfilment, osteoblasts 
migrate back to the bone surface, and matrix mineralisation progresses until a 
sufficient level is attained.	
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1.3 Cellular and molecular mechanisms in bone 
invasion by tumours 
Previous literature has demonstrated the critical role osteoclasts play in bone 
invasion; however, the process by which neoplastic tumour cells and 
corresponding myofibroblastic stromal tissue destroys and penetrates osseous 
tissue still remains obscure. Quan et al. (2012) described three integrated stages 
in OSCC bone invasion.	
Initially, tumour cells secrete proteolytic enzymes, proteases, disintegrating the 
extracellular matrix (ECM), and facilitating tumour cell infiltration. In addition, 
these enzymes trigger the differentiation of progenitor bone cells - osteoclast 
recruitment - further amplifying bone destruction. Collagen, elastin, and 
proteoglycans act as physical barriers in bone matrix. To enhance tumour 
migration and progression, tumour cell expression of zinc metalloenzymes, 
matrix metalloproteinases (MMP) has been shown to disrupt these barriers 
(Krane and Inada, 2008; Kessenbrock et al., 2010). A previous study co-cultured 
OSCC cells with osteoblasts and noticed amplification in MMP-2 expression by 
tumour cells, and increased MMP-9 expression in osteoblasts (Quan et. al, 2012). 
These findings are in agreement with similar research conducted earlier 
identifying the role of these proteolytic enzymes in OSCC invasion and distant 
metastasis (Krane and Inada, 2008).	
Sinevici and O’Sullivan (2016) recently reviewed various oral cancer biomarkers 
and reported that the increase in MMP expression correlates with tumour 
behaviour and prognosis. Collagenase (MMP-1 and MMP-13), stromelysin 
(MMP-3, MMP-10, and MMP-11), and gelatinase (MMP-2 and MMP-9) have been 
shown to contribute to bone invasion. Primarily, gelatinase secretion disrupts 
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epithelial stability by triggering the destruction of the basement membrane and 
activation of growth factors TGF-β1, initiating EMT through SNAIL-regulated 
pathways. During EMT, keratinocytes exhibit morphological changes, and a loss 
in extra- and intracellular adhesions, featuring an increase in N-cadherin and a 
decline in E-cadherin adhesion molecules. Ex vivo expression of stromelysin 
(MMP-3) was detected in tumour boundaries of OSCC biopsies, further linking 
this biomarker to tumour progression, whereas MMP-10 and MMP-11 were 
associated with OSCC differentiation and direct invasion. 	
In the resorptive stage, bone deposition and destruction are regulated by tumour 
necrosis factor (TNF) related proteins, triad nuclear factor kappa B (NK-kB) 
activator receptor RANK binding to its ligand RANKL triggering 
osteoclastogenesis, or its decoy OPG promoting bone preservation. Preliminary 
studies have claimed to examine the role of stroma in bone invasive OSCC. In a 
previous study, RANKL positive fibroblasts were noticed surrounding tumour 
body in close proximity to bone, in addition to mRNA expression of RANKL in co-
cultures of murine osteoblasts with a human OSCC cell line (Ishikuro et al., 2008). 
Unfortunately, this research did not investigate the role of human CAF in bone 
invasive OSCC.	
Several cytokines have been noted to mediate bone destruction, of these 
interleukin-1β (IL1β) (Dewhirst et al., 1985; Cheng et al., 2014), IL6, IL11, and 
IL15 (Walsh et al., 2006; Brailo et al., 2012) being the most prevalent. Glenn 
(2004) noted that neoplastic lesions have the ability to react to growth stimulating 
cytokines, hindering tumour cell apoptosis and promoting invasion and 
metastasis. Another group reported IL6 and IL11 amplification in bone invasive 
OSCC as opposed to non-invasive OSCC (Shibahara et al., 2005). Furthermore, 
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significant amplification of IL6 on a protein and mRNA transcript level in human 
OSCC cell lines was reported to play a role in osteoclast generation (Tang et al., 
2008; Hwang et al., 2012). 	
Bone is a rich reservoir of growth factors and upon OSCC induced destruction 
releases epidermal growth factor (EGF), connective tissue growth factor (CTGF) 
or transforming growth factor (TGF). These growth factors regulate osteoblasts 
and osteoclast recruitment in tumour progression and bone destruction (Matsuo 
and Irie, 2008; Quan et al., 2012). Huang et al. (2002) reported a decline in OSCC 
proliferation and invasion due to the obstruction of anti-EGF receptor (EGFR). 
The role of CTGF in neoplastic keratinocytes and osteoclasts of bone invasive 
OSCC was verified by the genesis of TRAP staining cells stimulated by 
recombinant (rh) CTGF in vitro (Shimo et al., 2008), further clarifying their 
previously published work (Shimo et al., 2004) on CTGF as a diagnostic 
biomarker in osteolytic conditions. However, more research is necessary to 
establish the significance of these growth factors in bone invasive OSCC.	
1.4 Role of tumour microenvironment in cancer 
Rudolph Virchow (1863) first suggested the importance of microenvironment in 
cancer progression. The study identified leukocytes surrounding solid tumour 
mass, and further hypothesised that cancer originated from chronic inflammation. 
However, this study focused on inflammation and didn’t examine other 
components of the tumour microenvironment. Although when Paget (1889) 
suggested the ‘seed and soil’ phenomenon years later all the components were 
considered.  Moreover, in 1982, Bissell et al. reported that tumour 
microenvironment (TME) was as crucial as genetic predisposition in the 
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development and progression of cancers. Understanding the TME is essential in 
establishing modern prognostic markers, and new generation therapeutics.	
1.4.1 Components of tumour microenvironment 
The TME in OSCC comprises diverse non-malignant cells integrated in a complex 
extracellular matrix (ECM). Collectively, these cells embedded in a matrix 
comprise the tumour stroma. The cross talk between neoplastic cells and 
surrounding stroma is constantly maintained, enabling tumour cell stimulation of 
the microenvironment, which as a result actively transmits paracrine signals 
increasing tumour cell proliferation and invasion (Figure 1.2).	
 
Figure 1.2: Tumour microenvironment. Tumorigenesis involves the co-existence of 
neoplastic cells, immune, stromal and endothelial cells embedded in an extracellular 
matrix. The tumour niche is a dynamic structure with access to various growth factors, 
and vascular supply. (Illustration generated using Photoshop software). 
 
The main cellular components of the TME are fibroblasts, inflammatory cells, 
mesenchymal stem cells, pericytes, bone marrow derived cells, hematopoietic 
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and vascular endothelial cells, nerves and lipocytes (Joyce and Pollard, 2009). 
Weinberg (2013) estimated that these non-neoplastic cells could make up 90% 
of the tumour mass. Although these cells usually have a protective role in 
confining tumour progression, there is increasing evidence that the cells of the 
TME play an active role in tumour dissemination. Allen and Jones (2011) in a 
recent review, highlighted that tumour cells can initiate stromal activation through 
the expression of cytokines (growth factors and chemokines) and extracellular 
proteases, enhancing angiogenesis, and increasing malignancy progression.	
1.4.1.1 Extracellular matrix	
The cells of the TME are embedded in a complex mesh of proteins termed the 
extracellular matrix. The ECM is a network of proteoglycans, elastin, collagen, 
laminin and fibronectin that provide support for cells to adhere to (Boy, 2002). 
Stromal fibroblasts mainly synthesise and regulate this matrix. The ECM is a 
regulator of cellular morphology, by altering cell cytoskeleton, function and 
signalling (Kim et al., 2011). In addition, the mechanical properties of ECM have 
an impact on modulating tumour cell growth, differentiation and migration. A 
decline in ECM tensile strength has been reported to suppress malignant 
behaviour in breast cancer (Pazek et al., 2005). Lysyl oxidase (LOX), an enzyme 
secreted particularly by fibroblasts, has been shown to modulate tensile strength 
of the ECM by facilitating collagen and elastin cross-linkage, and elevating rigidity 
(Kagan and Li, 2003). This alters tumour behaviour, promoting invasiveness 
(Levental et al., 2009), and giving rise to the hypothesis and subsequent evidence 
that an increase in breast tissue densities, detected by mammography, is related 
to a higher risk of breast cancer (Martin and Boyd, 2008).	
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Significant modulation and remodelling of the ECM occur during tumour 
advancement, which can be regulated by different growth factors, such as PDGF, 
EGF, and TGFβ1 (Matrisian and Hogan, 1990), but is principally regulated by 
stromal fibroblast expression of proteases, particularly MMP (Kessenbrock et al., 
2010). MMP degrade the ECM, contributing to tumourigenesis and metastasis 
through several pathways. Initially, MMP and other proteases trigger ECM 
degradation, facilitating a pathway for cellular dissemination and mobility, by 
releasing growth factors, PDGF, HB-EGF, and TGFβ1 (Joyce and Pollard, 2009). 
Moreover, proteases trigger proteolytic cleavage of dormant growth factors and 
MMP allowing their activation (Kessenbrock et al., 2010). Latent TGFβ1 is 
reportedly activated by MMP expression by stromal fibroblasts, stimulating EMT 
and tumour progression (Biere and Moses, 2006). However, MMP have also 
been reported to act as tumour obstructers rather than promoters (Gutierrez-
Fernandez et al., 2008). By regulating angiogenesis, protease cleavage of 
plasminogen is reported to generate angiostatin, inhibiting angiogenesis, and 
suppressing tumour development (Houghton et al., 2006).	
1.4.1.2 Angiogenesis and hypoxia	
Angiogenesis is an essential factor for tumour genesis and survival (Carmeliet 
and Jain, 2000). Tumour and surrounding microenvironment express endothelial 
growth factors, mainly vascular endothelial growth factor (VEGF), which 
regulates neoangiogenesis (Carmeliet et al., 1996; Fukumura et al., 2001; Lin et 
at., 2017). Similarly, neoplastic tissue requires nutrient supply and waste removal 
more so than normal tissue (Papetti and Herman, 2002; Lin et at., 2017). During 
tumour development, due to the increase in proliferation of malignant cells, areas 
of hypoxia develop because of insufficient vascular supply. Although hypoxia is 
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sometimes considered a restraining factor for tumour development, several 
studies have shown otherwise (Zhu et al., 2017). Hypoxia-inducible family (HIF) 
proteins, expression in hypoxic tumour regions, have been noted to modulate 
cellular metabolism (Chen et al., 2010), proliferation, apoptosis (Carmeliet et al., 
1998) and remodelling (Canning et al., 2001). In addition, Esteban et al. (2006), 
reported an up regulation of EMT, following a decline in epithelial E-cadherin 
expression. 	
1.4.1.3 Inflammation in tumour microenvironment 	
A state of inflammation increases the risk of malignancy. Colotta et al. (2009) 
reported that inflammation associated with cancers influenced genetic instability 
in cancer cells. The inflammatory milieu is composed of numerous immune cells, 
which secrete growth factors, cytokines, and proteolytic enzymes (TNF-alpha, 
TGFB, VEGF, Interleukins, MMP, cyclooxygenase 2 (COX-2), and CXC motif 
ligand 8 (CXCL8), further recruiting inflammatory cells, and altering the stromal 
phenotype (Murdoch et al., 2008). In particular, bone derived macrophages 
assemble in the TME through chemotactic signalling of VEGF, macrophage 
colony stimulating factor-1 (MCSF-1), and monocyte chemotactic protein-1 
(MCP-1) (Bingle et al., 2002). This leads to an increased number of tumour-
associated macrophages (TAM) (Hsu et al., 2010 and Ojalvo et al., 2010), which 
correlates with an unfavourable prognosis in a range of malignancies (Mantovani 
et al., 2017; Tan et al., 2016; Joyce and Pollard, 2009; Bingle et al., 2002).	
TAM exhibit a characteristic phenotype and have been shown to express tumour-
promoting factors VEGF (O’Sullivan et al., 1993), and EGF (Lewis et al., 2000), 
induce neoangiogenesis, while subsequently stimulating invasion and metastasis 
(Lewis and Pollard, 2006; Mantovani et al., 2006).	
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Briefly, macrophages can be classified according to their activity, as classically 
(M1) or alternatively activated (M2) (Kaneda et al., 2004). In conventional 
immunological reactions, M1 macrophages are recruited through T-helper cells 
(Th1), and cytokine, interferon gamma (IFN-γ) and lipopolysaccharide (LPS) in 
response to the presence of pathogens. M1 macrophages are characterised by 
highly expression of IL12, major histocompatibility class II (MHCII) and TNF-α. 
Contrastingly, during tissue wound occurrence, humoral, or in a pro-tumourigenic 
response, M2 differentiation is induced through Th2 cytokines IL4 and IL13, 
promoting angiogenesis by expressing amplified levels of IL10, and distinctive 
low levels of MHCII and IL12 (Mantovani et al., 2004; Mosser and Edwards, 2008; 
Joyce and Pollard, 2009; Laoui et al., 2011).	
1.4.2 Fibroblasts 
Decades ago, Tarin and Croft (1969), first reported fibroblasts as abundant cells 
located in mesenchymal connective tissue embedded in an extracellular matrix 
comprising fibronectin, and collagen type I. Fibroblasts, the predominant cells in 
the TME in most malignancies, contribute to tumour cell proliferation and spread, 
and are associated with ECM desmoplastic attachment, resulting in an increase 
in tensile strength or “stiffening” of the tissue (Cardone et al., 1997).	
Several markers have been utilised to identify fibroblasts including vimentin, 
alpha smooth muscle actin (αSMA), fibroblast specific protein 1 (FSP1) and 
fibroblast activation protein (FAP). Unfortunately, due to the vast genetic diversity 
of fibroblasts, these markers are not considered as strong indicators, since no 
specific marker is exclusive for all fibroblast derivatives or subtypes (Kalluri and 
Zeisberg, 2006). However, αSMA is reliable and most commonly used (Shiga et 
al., 2015). 	
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In addition, fibroblasts regulate matrix deposition, remodelling and progression, 
through expression of heterogeneous proteins, primarily collagen type I, III, IV 
and V (Hinz et al., 2007), fibronectin-1, and MMP (Kalluri and Zeisberg, 2006; 
Dewever er al., 2008; Kessenbrock et al., 2010).  	
1.4.3 Myofibroblasts 
Cancer associated fibroblasts (CAF) share similar phenotypic characteristics to 
myofibroblasts found in granulation tissue during fibrosis, and wound contraction 
during healing (Gabbiani et al., 1994; Kalluri and Zeisberg, 2006; Hinz et al., 
2007). Myofibroblasts are histologically defined as elongated spindled cells with 
elevated expression of alpha smooth muscle actin (αSMA) (Desmouliere et al., 
2004; Hinz et al., 2007) and show increased secretion of MMP2, MMP3 and 
MMP9, enhanced proliferation (Rodemann and Muller, 1991), and amplification 
in cytokine and growth factor production (Bhowmick et al., 2004). However, it is 
important to note that pericytes, endothelial cells, myoepithelium, smooth muscle 
cells and myofibroblasts are also αSMA positive (Gabbiani et al., 1994; 
Desmouliere et al., 2004). Regardless, myofibroblasts are still referred to as 
αSMA positive cells, without conducting further characterisation assays based on 
location and morphology. Additionally, myofibroblasts comprise contractile 
microfilaments, which allow these cells to adhere to each other and the 
surrounding ECM (Hinz et al., 2007). 	
Myofibroblasts have been reported to differentiate from fibrocytes, pericytes, 
smooth muscle cells, mesenchymal cells and epithelial cells through EMT (Hinz 
et al., 2007; McAnulty et al., 2007; Mueller et al., 2007). Myofibroblastic 
differentiation can be triggered as a result of inflammation or neoplasia (Werner 
and Grose, 2003).	
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It has previously been shown that squamous carcinomas may directly enhance 
the myofibroblastic phenotype, through the expression of TGFβ (Lewis et al., 
2004; Rønnov-Jessen and Bissell, 2009). In OSCC, myofibroblastic 
differentiation of normal oral fibroblasts (NOF) is induced through TGFβ 
dependent pathways, which has been shown to be amplified in the presence of 
IL1β (Lygoe et al., 2007; Anderberg and Pietras, 2009). Furthermore, carcinomas 
secrete chemotactic factors; platelet-derived growth factor A (PDGF-A), and 
fibroblast activation factor that are suggested to contribute to the accumulation of 
CAF in stroma (Tejada et al., 2006; Xouri and Christian, 2010). The close 
proximity and spatial arrangement of myofibroblasts in neovascularised areas, 
and tumour invasive fronts, implies the role of these fibroblasts in tumour invasion 
(Thode et al., 2011).	
Santos et al. (2009), claimed that CAF may be a promising target in treating 
cancer due to their genetic stability, and phenotypic similarities of stromal 
fibroblasts across various cancers. Therefore, targeting stromal fibroblasts may 
hinder the progression of cancerous cells. 	
1.4.4 Myofibroblasts in oral cancer 
Several previous studies on oral mucosa have reported that essential factors 
released by both keratinocytes and fibroblasts are paramount in epithelial 
differentiation and morphogenesis (Hill et al., 1984; Mackenzie and Dabelsteen, 
1987). Costea et al. (2006) isolated premalignant human oral keratinocytes from 
dysplastic oral lesions and reported that in vitro invasion was only seen in the 
presence of fibroblasts. Their findings also showed that conditioned media from 
co-cultured fibroblasts and potentially malignant keratinocytes can yield this 
effect as spent media from mono-cultured fibroblasts was unable to produce this 
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outcome indicating a paracrine interrelation between tumour cells and associated 
fibroblasts. Interestingly, Gaggioli et al. (2007), reported a mechanical role of 
tumour associated fibroblasts in invasion. Co-cultures of squamous cell 
carcinoma keratinocytes and fibroblasts grown on collagen matrix showed 
fibroblast-led invasion, followed by tumour cells advancing in the ECM paths 
initially generated from cultured fibroblasts.	
Two definite patterns of myofibroblasts associated with tumour stroma have been 
identified in published literature i.e. the ‘spindle’ and ‘network’ pattern. The former 
is characterised by spindle shaped morphology surrounding the tumour mass, to 
a maximum of three layers, while the latter is abundant throughout the whole 
depth of stroma (Kellermann et al., 2007; Vered et al., 2009).	
Several recent studies have reported the correlation between αSMA positive 
myofibroblasts and cancer progression and invasion in TME (Rodrigues et al., 
2015; Elmusrati et al., 2017; Smitha et al., 2019). Abundance of myofibroblasts 
have been associated with OSCC prognosis in various semi-quantitative 
histological studies (Kellermann et al., 2007; Vered et al., 2010). Kellermann et 
al., (2007) noted the correlation of αSMA positive myofibroblasts with tumour 
invasive front. Furthermore, Vered et al. (2010) reported that weak or negative 
αSMA expression in myofibroblasts was related with a significantly better disease 
free 5-year survival as opposed to OSCC patients with strong αSMA staining. 
The invasive front of OSCC, indicated by the band of tissue located between 
cancerous growth and normal tissue has been suggested to reflect tumour 
aggressiveness (Bryne et al. 1989; Bryne et al. 1991). This has led to the 
hypothesis of tumour-associated myofibroblasts being generated from neoplastic 
keratinocytes through EMT, following numerous studies involving 
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immunohistochemical analysis of antigen surface markers (Kellermann et al., 
2007; Turley et al., 2008; Vered et al., 2010). 	
1.4.5 Origin of cancer associated fibroblasts 
CAF configuration derives from heterogeneous aberrations presumably due to 
their diverse origin, but the process by which CAF arise still remain obscure 
(Kalluri and Zeisberg, 2006; Augsten 2014). Whilst the main source of CAF is 
commonly thought to be the activation of regional stromal fibroblasts (Kalluri and 
Zeisberg, 2006), alternative experimental models have demonstrated the lineage 
of CAF from genetically marked bone marrow originated cells (Direkze et al, 
2006). Radisky and Radisky (2007), also suggested that normal or malignant 
epithelial cells undergoing EMT may be a source of myofibroblasts. However, it 
is still argued that CAF originate from transdifferentiation of fibrocytes, pericytes, 
smooth muscle, and mesenchymal stem cells. 
 
1.4.6 Significance of CAF in tumour microenvironment  
Barth et al. (2004), were amongst the first to report the presence of CAF in OSCC 
stroma, and later studies have further emphasised their significance. The 
presence of CAF in OSCC appears to be strongly correlated with tumour 
progression, invasion, recurrence, and poor patient outcome (Kawashiri et al., 
2009; Vered et al., 2010). It has also been shown that activated fibroblasts are 
more sensitive and accurate predictors of OSCC recurrence and patient mortality 
compared to conventional parameters such as TNM staging (Marsh et al., 2011).	
Most recently, Cirillo et al. (2016) conducted in vitro studies on OSCC by using 
CAF derived from genetically unstable OSCC cells (GU-OSCC), and genetically 
stable OSCC (GS-OSCC). The former was characterised by an abundant loss of 
heterozygosity, p16INK4a and TP53 genes, while the latter expressed wild type 
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p16INK4a and TP53 with minimum loss of heterozygosity. Their findings showed 
a correlation between increased expression of TGFβ1 & TGFβ2 in CAF from GU-
OSCC, but not in CAF from GS-OSCC or normal fibroblasts suggesting that the 
sequential EMT and reduction in expression of cell adhesion molecules E-
cadherin and vimentin results in epithelial dis-cohesion and invasion regulated 
through a TGFβ dependent signalling. Bhowmick et al. (2004) showed that 
mouse models with inactive TGFβ RII receptor inhibit tumour and surrounding 
stroma proliferation in vivo. 	
1.4.7 Senescence in fibroblasts 
Hayflick (1965) reported that human extracted fibroblasts, despite being vital and 
metabolically functional, do not have the ability to proliferate indefinitely, and fail 
to propagate following considerable cell splitting. The irreversible state of growth 
arrest (at G1 phase) is termed senescence, unlike quiescence, which is 
characterised by amplification in p16INK4a (Prime et al., 2016). Senescent 
fibroblasts are also distinctive to myofibroblasts, as they express up-regulated 
levels of p16INK4a and p21.  	
Senescent CAF have been identified in tumour microenvironment (Hassona et 
al., 2013; Kabir et al., 2016), and premalignant lesions (Costea et al., 2013; 
Procopio et al., 2015). Several factors are responsible for fibroblasts undergoing 
senescence including exhaustive mitotic activity, permanent DNA damage 
induced as a result of oxidative stress from mitochondrial malfunction and 
uncontrolled cell division due to amplification of oncogene expression promoting 
genome replication (Di Micco et al., 2006), in addition to chemo and radiotherapy. 
Senescence can be induced in vitro by exposure to radiation, damaging DNA or 
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through treatment with hydrogen peroxide or anticancer therapeutic drugs such 
as cisplatin (Rodier and Campisi, 2011; Kabir et al., 2016).	
In carcinomas, irreversible damage in cell recovery, or over exhausted DNA, 
results in senescence, which acts as an effective tumour suppressor. However, 
in contrast, senescence occurring in tumour-associated fibroblasts is a 
considered a key tumour promoter (Parkinson, 2010). Senescent fibroblasts 
express a vast range of pro-tumourigenic secretory proteins, which are jointly 
termed senescence associated secretory phenotype (SASP) (Kuilman and 
Peeper, 2009; Laberge et al., 2015). The SASP collectively comprises 
chemokines, inflammatory factors, osteopontin, growth factors (VEGF), 
proteases (MMP), extracellular proteins (collagen, laminin and fibronectin), 
reactive oxygen species (ROS), and interleukins (IL6 and IL8) (Coppe et al., 
2008; Pazolli et al., 2009). Senescent cells promote tumours through 
enhancement of neoplastic proliferation, invasion, metastasis and therapeutic 
resistance (Prime et al., 2016; Kabir et al., 2016). During cancer therapy, cisplatin 
promotes apoptosis or induces senescence to suppress tumour growth (te Poele 
et al., 2002; Banito and Lowe, 2013). 	
Kabir et al. (2016) investigated the mechanism underlying SASP development in 
OSCC and reported that microRNA (miR-335) amplified in primary human CAF 
and experimentally induced senescent oral fibroblasts were able to regulate 
SASP expression and further promote OSCC cell migration following co-culture 
experiments. Moreover, on blocking miR-335 with celecoxib (an inhibitor of cyclo-
oxygenase inhibitor 2, COX-2) the secretion of SASP factors decreased, reducing 
pro tumorigenic effects (Kabir et al., 2016). 	
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Interestingly, several recent studies have shown the role of TGFβ as a regulator 
in tumour-senescence fibroblast crosstalk (Hassona et al., 2013; Hassona et al., 
2014; Calon et al., 2014). In conjunction with reactive oxygen species (ROS), 
TGFβ induces fibroblast senescence and activation. Fibroblasts associated with 
genetically unstable OSCC (GU-OSSC) were noted to be senescent, due to the 
detection of amplified levels of ROS, TGFβ1, and TGFβ2, resulting in oxidative 
DNA damage (Hassona et al., 2013). Following senescence, CAF secrete 
increased levels of TGFβ and MMP2, which initiates EMT of neoplastic 
keratinocytes, leading to loss of cellular adhesion and promoting invasion (Prime 
et al., 2016).	
The mechanisms of fibroblast activation and senescence have been suggested 
to be closely related. Hassona et al. (2013) claimed that these may be different 
phases of indistinguishable pathways. This was further verified as fibroblast 
senescence was demonstrated following TGFβ fibroblastic activation. 
Furthermore, both fibroblast phenotypes are SMA positive, and their tumour-
promoting capabilities are mediated through similar pathways (Demehri et al., 
2009; Alspach et al., 2014; Procopio et al., 2015).	
 
1.5 Extracellular vesicles: cellular messengers in 
tumour microenvironment  
Extracellular vesicles (EV) are microscopic plasma membrane-derived 
structures, made up of a lipid bilayer membrane and released extracellularly by 
a vast number of cells (Théry et al., 2002; Raposo and Stoorvogel, 2013; 
Andaloussi et al., 2013). Recently, EV have been gaining interest as a novel 
mode of cellular communication in biomedical research. EV are capable of 
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shuttling bioactive particles comprising nucleic acid as microRNA, mRNA, DNA, 
and proteins or lipids from one cell to another, leading to an interchange of 
genetic material and reprogramming of target cells. There is increasing evidence 
that EV expression is amplified in tumorigenesis, which has an impact on tumour 
progression, metastasis and chemotherapeutic drug resistance (Kahlert and 
Kalluri, 2013; Vader et al., 2014; Minciacchi et al., 2015; Becker et al., 2016). In 
addition, EV transfer their cargo from tumour cells to surrounding tumour 
microenvironment, disseminating growth factors and other mediators to altering 
extracellular milieu contributing to a more aggressive tumour pattern (Webber et 
al., 2010; Kahert and Kalluri, 2013; Becker et al., 2016).	
1.5.1 Classification biogenesis, and contents of EV  
Extracellular vesicle nomenclature has been conflicting and inconsistent over the 
past years. Based on their origin or biological role, the terms cardiosome 
(Waldenström et al., 2012), ectosome (Stein and Luzio, 1991), oncosome 
(Morello et al., 2013), argosome (Greco et al., 2001), and deteriosome (Yao et 
al., 1993) have been used. Currently, EV are widely classified in accordance to 
their mechanism of biogenesis to apoptotic bodies (1-5 μm) released by cells 
undergoing apoptosis, microvesicles/microparticles (100-1000 nm) formed by 
outward budding of the plasma membrane, and exosomes (30-100 nm) produced 
when multivesicular bodies fuse with the plasma membrane, releasing the 
intraluminal vesicles they carry out of the cell (Figure 1.3). However, these 
dimensions overlap making the separation of distinct subgroups challenging.   
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Figure 1.3: Biogenesis of extracellular vesicles. EV are widely classified in 
accordance to their mechanism of biogenesis to apoptotic bodies (1000-5000 nm) 
released by cells undergoing apoptosis, microvesicles (100-1000 nm) formed by outward 
budding of the plasma membrane, and exosomes (30-120 nm) produced when 
multivesicular bodies fuse with the plasma membrane, releasing the intraluminal vesicles 
they carry out of the cell. (Illustration generated using Photoshop software). 
 
The exact mechanism behind the programmed sorting of cargo is still unclear. 
The endosomal sorting complex required for transport (ESCRT)-dependent and 
ESCRT independent messages have been proposed to control the sorting of EV 
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components (Trajkovic et al., 2008; Colombo et al., 2013). In addition, syndecan 
heparan sulfate proteoglycans has been reported to regulate EV biogenesis 
(Baietti et al., 2012; Kowal et al., 2014). EV secretion on the other hand, has been 
described to be regulated by Rab guanosine triphosphates (GTPases) (Hsu et 
al., 2010; Kowal et al., 2014), and by accumulation of calcium ions (Savina et al., 
2003; Emmanouilidou et al., 2010). In cancer, the pH of the TME has been 
described to inversely modulate EV expression; at a low pH EV secretion from 
donor cell and uptake by recipient cell is amplified (Parolini et al., 2009). 
Furthermore, tumour suppressors and oncogenes have been reported to regulate 
EV secretion, influencing tumorigenesis and progression of cancer (Yu et al., 
2005).	
EV act as envelopes that shelter their cargo (RNA, DNA, proteins and lipids) from 
degradation in the ECM (Lässer et al., 2011). They interact with target cells via 
surface receptors, directly merge to cell membrane or are ingested by 
endocytosis, proceeding to the relocation of their contents to the recipient cell 
(Mulcahy et al., 2014). Various techniques for EV isolation have been described. 
Most commonly, ultracentrifugation solely or combined with size exclusion 
chromatography (SEC), and magnetic sorting or immune bead isolation have 
been used. Characterisation of the protein composition of tumour cell-derived EV 
has also been well defined using various proteomic methods. ExoCarta 
(www.exocarta.org) is a well-recognised tool, which identifies the most common 
miRNA, mRNA, and proteins found in EV.	
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1.5.2 Extracellular vesicles in bone 
Bone is in continual dynamic equilibrium of resorption and deposition harmonised 
by a mineral metabolic process. Bone homeostasis involves several cell types 
comprising osteocytes, osteoblasts, osteoclasts and their 
precursors.  Intercellular communication between these cells is mandatory to 
carry information from one cell to another, further regulating this process.	
Primarily, bone forming cells or osteoblast derived EV play essential roles in 
intercellular communication in bone. Deng et al. (2015), reported that osteoblast 
EV expressed RANKL, and can promote RANK-RANKL interaction, initiating 
osteoclastogenesis. In addition, targeting osteoblast derived microvesicles can 
diminish bone loss (Deng et al., 2017). These results suggest that osteoblasts 
can initiate and activate osteoclast generation through secretion of EV without 
immediate cell to cell contact. Furthermore, Ge et al. (2015), revealed the 
proteomic analysis of osteoblast derived EV isolated from mouse MC3T3 
osteoblasts, and reported the expression of an abundant amount of 
osteogenesis-related localised proteins, including eukaryotic initiation factor 2 
(EIF2) signalling, which takes part in BMP induced osteoblast differentiation.	
Secondarily, preosteoclasts and osteoclast derived EV play a key role in 
mineralisation metabolism in bone. Recently, Huynh et al. (2016) described that 
osteoclast EV express surface RANK, targeting osteoblasts through 
RANKL/RANK interaction, consequentially leading to RANKL expressing 
osteoblast EV promoting osteoclast generation in return. In addition, osteoclast 
EV expressing RANK, may impede osteoclastogenesis by binding to RANKL 
expressing osteoblast EV. Interestingly, Huynh et al. (2016) reported RANK in 
osteoclast derived EV but not in preosteoclasts. Preosteoclast EV can promote 
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osteoclast formation, and osteoclasts EV can block osteoclast generation, 
suggesting that preosteoclasts are functionally different and can be responsible 
for stabilisation of bone mineralisation. 	
Sato et al. (2017) found that osteocyte derived EV may transfer miRNA to the 
target cell via blood circulation, suggesting how osteocytes might be regulated 
regionally and systemically. Most recently, Qin et al. (2017) showed that 
osteocyte EV contained miRNA-218 inhibited sclerostin and promoted the 
differentiation of osteoblasts. Sclerostin and RANKL are the main molecules 
expressed by osteocytes, but unfortunately there is no evidence that they are 
found in osteocyte derived EV.	
1.5.3 Roles of extracellular vesicles in cancer and 
microenvironment 
Increasing evidence shows that EV play important roles in cancer. EV transport 
oncogenic nucleic acids and proteins to recipient cells, playing vital roles in 
tumour growth, progression, metastasis and therapeutic resistance. EV derived 
from malignant cells are capable of inducing dysplastic transformation in normal 
cells. Abd Elmageed et al. (2014), found that adipose-derived stem cells had a 
potential oncogenic transformation when exposed to EV isolated from prostate 
cancer. Similar results have also been reported in breast cancer, where miRNA 
containing EV silenced mRNA in non-neoplastic cells, resulting in transcriptome 
reprogramming and malignant transformation (Melo et al., 2014).	
Tumours are composed of a heterogeneous population of neoplastic and non-
neoplastic cells such as mesenchymal, immune cells and acellular ECM. 
Recently, tumour complexity has been further highlighted by the emergence of 
EV in tumour microenvironment. Cancer cell EV have the potential to 
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communicate with the surrounding host stroma, stimulating or restricting tumour 
progression.	
Cancer derived EV have a significant impact on the tumour microenvironment by 
encouraging tumour angiogenesis, immune cell infiltration, and activation of 
resting fibroblasts to CAF, advancing tumour progression. Webber et al. (2010), 
reported that prostate cancer EV expressed TGFβ, and actively triggered 
myofibroblastic differentiation of normal fibroblast in tumour microenvironment, 
which promoted tumour growth. These results are in further agreement with Gu 
et al. (2012), where gastric cancer EV stimulated the differentiation of 
mesenchymal cells to CAF. Moreover, these findings were also observed in 
breast cancer (Cho et al., 2012). Interestingly, CAF communication with cancer 
cells favours tumour progression, affecting radiation and chemotherapy 
resistance. Boelens et al. (2014) demonstrated that EV expressed by CAF 
communicated with breast neoplastic cells initiating the NOTCH3 pathway to 
increase therapy resistance. Stromal derived EV have also been suggested to 
promote invasion and metastasis in breast cancer through Wnt-planar cell 
polarity signalling (Luga et al., 2012). Hence, EV communication between cancer 
and surrounding stromal fibroblasts adds another dimension to the complexity of 
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1.5.4 EV and cancer biomarkers and potential therapeutics 
EV have been isolated from numerous biological fluids, including saliva, blood, 
tears, bile, urine, cerebrospinal fluid and breast milk. (Lässer et al., 2011; Raposo 
and Stoorvogel, 2013; De Toro et al., 2015). Cancer derived EV have been 
reported to be systemically elevated in circulation and may serve as a potential 
liquid biopsy for diagnostic and prognostic indicators in various malignancies 
(Nilsson et al., 2009; Corcoran et al., 2011; Melo et al., 2015). Therefore, it is 
conceivable that EV transmission in malignancy could be a potential target to 
enhance and monitor therapy response. Pitt et al. (2014) established 
immunotherapeutic anticancer agents using dendritic cell EV (dexosomes), which 
have gone through clinical trials for melanoma, lung and colorectal malignancy 
(Tan et al., 2010).	
A novel strategy for treatment of advanced malignancies, is by the depletion of 
EV (Marleau et al., 2012). Amiloride, a drug used to treat hypertension, has been 
reported to halt EV biogenesis and limit colorectal cancer progression (Chalmin 
et al., 2010). However, advanced investigations are needed to assess the clinical 
safety of EV elimination.	
Due to their various genomic contents along with their extensive distribution and 
biocompatibility, the utilisation of EV as diagnostic biomarkers and therapeutics 
delivering anticancer drugs has been gaining attention (Van den Boorn et al., 
2010; Hu et al., 2012; Pascucci et al., 2014). Improving the current strategies to 
isolate a substantial amount of EV from donor cells, introduction of 
nanotechnologies to pack EV with targeted therapies, will enable the use of EV 
as natural cargo for anti-cancer drugs.	
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1.6 Bone Invasion in OSCC 
Oral cancer involving the lateral tongue, alveolar ridge and floor of mouth, due to 
its anatomical proximity, frequently invades the maxilla or mandible, significantly 
worsening patient outcomes. A few studies have demonstrated the function of 
osteoclasts in bone invasive OSCC but it still remains speculative whether this is 
an osteoclastic or tumour/associated microenvironment driven mechanism. 	
1.6.1 Cytokines  
OSCC secrete cytokines that have been reported to contribute to the process of 
osteoclastogenesis. Bone tissue is considered a reservoir for numerous 
cytokines and growth factors. This allows cell proliferation by maintaining 
malignant cellular division, inhibition of apoptosis, leading to progression of 
tumour growth and invasion of adjacent osseous tissue. Earlier research has 
claimed that osteoclast led bone destruction is the main element in tumour 
progression, invasion and metastasis. 	
Many factors are involved in tumourigenesis and progression. Interleukin-6 (IL6) 
has been shown to significantly intensify ECM degradation by prompting MMP 
expression stimulating bone resorption by enhancing ostoclastogenesis and 
hindering osteocyte and osteoblastic activation (Li et al., 2010). O’Brien et al. 
(1999) demonstrated how osteoblasts expressing RANKL can induce 
osteoclastic bone resorption via IL6. In addition, it has been suggested that 
osteoclasts and not tumour cells predominate in the process of bone invasion in 
mandibular resections of OSCC patients (Shibahara et al., 2005). The findings 
from this study revealed IL6, PTHrP and TNF-α expression in osteoclasts as well 
as tumour keratinocytes and associated tumour fibrous stroma in both bone 
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invasive and non-invasive groups. This study concluded that osteoclasts play an 
important role in OSCC bone invasion.	
Furthermore, Kayamori et al. (2010), validated the expression of PTHrP and IL6 
by conducting immunohistochemistry (IHC) on OSCC patient tissue samples. 
They noticed expression of PTHrP in neoplastic cells in comparison to IL6. 
However, similar IL6 expression was noted in both cancer and stromal cells. They 
further examined RANKL relevance by treating fibroblastic stromal cell lines with 
conditioned media collected from cultured OSCC cells and showed a relation 
between RANKL dependent osteoclast led bone destruction, and up regulation 
of IL6 and PTHrP. Recently, another study group showed both in vitro and in situ, 
that IL6 expression is more pronounced in stromal CAF than in tumour cells 
(Nagasaki et al., 2013). This evidence further validates the significant role of CAF, 
in addition to cancer cells, in bone invasive OSCC.	
1.6.2 Role of TGFβ dependent pathways in cancer progression 
Osseous tissue, precisely the bone matrix, is a reservoir of TGFβ. Pfeilschifter 
and Mundy (1987) showed presence of TGFβ in bone microenvironment, 
following osteoclast mediated bone destruction. In tumourigenesis and 
progression, TGFβ has a fundamental role in modulating cancer cell proliferation, 
differentiation and metastasis (Pickup et al., 2013). Throughout the preliminary 
course of tumour development, TGFβ exhibits tumour suppressive activity 
through growth inhibition, activation of cellular apoptosis (Massagué et al., 2000; 
Siegel and Massagué, 2003), and proteases inhibition (Ito et al., 2004). However, 
during advanced stages, this anti-tumourigenic effect subsides, and is replaced 
by a more aggressive EMT cancer progressive phase, through the stimulation of 
TGFβ expression, ligand activation for tumour growth promotion and pro-
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oncogenic functionality including neoangiogenesis and invasion (Pickup et al., 
2013).	
The recognised TGFβ signalling pathway is involved in a broad superfamily, 
comprising bone morphogenic proteins (BMP), activins, and growth and 
differentiation factors (GDF) which are principal elements in differentiation, 
development, and cellular and humoral homeostasis (Weiss and Attisano, 2013). 
TGFβ1, β2, and β3 are the three main TGFβ ligands, which are encoded by 
distinct genes, but are activated through similar receptor signalling pathways 
(Massagué, 1998). Amongst these, TGFβ1 has been the focus in most 
tumourigenesis studies. 	
The release of TGFβ as a latent protein necessitates the presence of regulatory 
activation mechanisms, including metalloprotease cleavage by MMP9 and MMP2 
(Yu and Stamenkovic, 2000), ECM protein thrombospodin (Schultz-Cherry and 
Murphy-Ullrich, 1993; Crawford et al., 1998), αvβ6 surface integrin (Munger et al., 
1999), or by myofibroblastic contraction (Wipff et al., 2007). In carcinogenesis, 
TGFβ signalling process is mediated through two types of heteromeric cell 
surface transmembrane serine-threonine kinase receptors TGFβ receptor type I 
(TGFβ RI), and receptor type II (TGFβ RII). Following TGFβ1 ligand binding to 
the receptor II complex, TGFβ RII initiates and mediates phosphorylation of TGFβ 
RI, which sequentially phosphorylates Smad2 and Smad3 and co-joins Smad4, 
facilitating nuclear translocation and transcription regulation (Derynck and Feng, 
1997; Piek et al., 1999; Itoh et al., 2000; Massagué et al., 2000; Derynck et al., 
2001)	
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During the process of EMT, cell surface adhesion molecule transition occurs; this 
phenomenon is widely known as “cadherin switching”. In this transition epithelial 
surface antigen E-cadherin expression is replaced with N-cadherin, a 
mesenchymal marker, followed by an acquired tumour cellular expression of 
αSMA and vimentin cytoskeletal proteins (Wan et al., 2013) (Figure 1.4).	
 
 
Figure 1.4: Epithelial-mesenchymal transdifferentiation. On cancer progression, 
several cytokines, and growth factors stimulate keratinocytes to differentiate to a 
mesenchymal phenotype. Promoting loss of cell adhesion, alteration in morphology and 
invasion. (Illustration generated using Photoshop software). 
 
A considerable number of studies have shown the key role of TGFβ in modulating 
EMT, and consequential OSCC bone involvement (Quan et al., 2012; Quan et 
al., 2013; Hwang et al., 2014). A previous study reported morphological changes 
of neoplastic keratinocytes on transfection of V69 (a murine OSCC cell line) with 
TGFβ. This transformation was noted as changing from angular to an extended 
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spindle shape. In vivo transplantation of these cells into the floor of the mouth of 
murine models resulted in highly aggressive tumours (Davies et al., 2000). An in 
vitro study involved transfection of three alternative human head and neck cancer 
cell lines (SCC25, HN5 and TCA8113) with TGFβ1. In contrast to Davis et al. 
(2000), following the predetermined time span of three days, the TGFβ 
dependent amplification of MMP2 and MMP9 was noted to promote bone 
invasion through EMT initiation and sustaining osteoclast activity. Despite these 
findings, no morphological changes were detected in these studies (Qiao et al., 
2010; Quan et al., 2013).	
These opposing findings raise the possibility that morphological transformation 
may not be a prerequisite to obtain EMT features. The precise role of TGFβ on 
osteoclast activity and regulation, therefore, remains to be determined.	
TGFβ has been reported to play a pro-tumourigenic role by inducing 
transdifferentiation of stromal fibroblasts to more stimulated/aggressive αSMA 
expressing myofibroblasts (Pickup et al., 2013). Treatment of normal human 
gingival fibroblasts (NOF) with TGFβ (0.5 to 10ng/ml) leads to αSMA surface 
antigen expression evident through immunofluorescence (Lewis et al., 2004). 
Moreover, when OSCC cell lines CA1, VB6 and 5PT were co-cultured with these 
fibroblasts, a significant up regulation in TGFβ protein expression was detected 
through an ELISA. This data demonstrates the important interaction between 
CAF and TGFβ in cancer progression.	
1.6.3 RANK, RANK ligand and OPG mechanisms. 
As mentioned earlier, the vital factors accountable for bone sustainability and 
structure are RANK, RANKL and its antagonist OPG. Alterations in functional 
equilibrium of these cytokines will either result in osteogenesis (higher OPG 
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expression) or osteolysis (higher RANKL levels). RANK/RANKL signalling 
cascade facilitates differentiation of bone lining cells, osteocytes and osteoblasts 
to osteoclasts, along with macrophage colony-stimulating factor (M-CSF) while 
OPG suppresses these signals.	
OPG acts as a signal for osseous tissue deposition and preservation, alongside  
its bone resorption obstruction functionality (Simonet et al., 1997). OPG belongs 
to the TNK receptor family; it is an actively secreted protein, due to absence of a 
transmembrane element. Experimental studies conducted on murine specimens 
in vivo have shown that OPG administration can arrest tumour growth; prevent 
bone invasion and distant spread of prostate cancer (Armstrong et al., 2008). 
These findings reinforce the role of RANK/RANKL in promoting OSCC bone 
involvement. OSCC cells are known to secrete RANKL. Chuang et al. (2009) 
claimed that there was no significant difference in RANKL expression between 
bone invasive and non-bone invasive OSCC suggesting that oral cancer cells 
may have the capacity to stimulate osteoclastogenesis when in proximity to 
adjacent bone. However, on reviewing this study, noticeable limitations are noted 
as in some of the images the IHC staining does not appear to be specific. OPG 
expression was reported as absent in bone invasive lesions, however this 
expression was also negative in osteoblasts on bone surface, further making the 
data somewhat questionable. In addition, the tumour-bone proximity of the tested 
cohort was not acknowledged.	
It is still uncertain whether all OSCC cells express RANKL or can induce 
osteoclastogenesis on their own. Tada et al. (2005) co-cultured aggressive 
human OSCC (BHY) cell lines derived from the lower alveolus with murine bone 
marrow cells (BMC). In vitro osteoclastic differentiation was weak, although 
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RANKL surface antigen was detected in BHY cells following flow cytometry. 
Following co-culture of BHY cancer cells with primary bone cells and BMC, 
significant numbers of osteoclasts were generated (TRAP stained and counted 
under light microscope). On administration of OPG, this process was significantly, 
but not absolutely inhibited. Inconsistent findings were reported for head and neck 
squamous cell carcinoma HSC-2 cell line. Osteoclastogenesis was profound 
when co-cultured with BMC murine marrow cells, however, these cells lacked 
RANKL expression. This highlights the importance of phenotypic characterisation 
in cancers and the diverse mechanisms involved in the complex milieu of OSCC 
bone invasion. In the former study, the expression of RANKL and failure of 
osteoclastogenesis suggested that the TME ceased to induce RANKL activation, 
while in the second study RANKL expression was suggested to be non-essential 
for bone resorption to occur. Furthermore, IHC analysis of bone invasive OSCC 
revealed lower OPG expression in fibrous stromal cells compared to normal 
mucosa. This raises the possibility that a decline in OSCC OPG expression in the 
presence of osteoblasts, rather than an amplified RANKL expression, may be 
more important in induction of osteoclastogenesis.	
OSCC regulation of osteoclastic differentiation has also been investigated. 
Osteoclasts have relatively brief life spans and are subjected to prompt cellular 
apoptotic death in the absence of RANKL, IL6 and M-CSF. Prolonged osteoclast 
survival has been shown to be related to suppression of Bcl-2 pro apoptotic 
protein (Bim) in BHY cancer cells. These OSCC cells have also been 
demonstrated to induce osteoclastic pit-formation (Tada et al., 2009). Another 
research group injected human OSCC cells (B88) into nude mice and following 
tumour formation OPG treatment was administered. Obvious reductions in 
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tumour growth and osteoclast count were noticed, in addition to increased OSCC 
cell apoptosis. However, the in vitro approach showed no change in proliferation, 
suggesting that tumour and bone microenvironment plays an important role in 
OPG functionality (Shin et al., 2011).	
1.6.4 “Vicious cycle” a cascade regulating bone integrity 
The cascade involved in OSCC bone invasion, is considered a “vicious cycle” 
(Figure 1.5). 
 
Figure 1.5: Vicious cycle of bone invasion. Bone integrity is maintained through TNF 
triad proteins. On binding of RANKL to its receptor RANK, osteoclastogenesis is initiated. 
However, if RANKL binds to its antagonist and decoy receptor OPG osteoclast 
generation is reduced, decreasing bone destruction. (Illustration generated using 
Photoshop software). 
 
The cross talk between tumour and bone through intervening fibrous stroma or 
by direct contact regulates the dynamic advancement of bone destruction. 
Neoplastic keratinocytes secrete humoral factors. Amongst these growth factors, 
cytokines and hormones as PTHrP, which promotes osteoclast differentiation 
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through assembly of RANKL expressed osteoblasts and fibrous stromal cells 
(Chikatsu et al., 2000).	
Both CAF and cancerous tumour cells have been shown to express RANKL (Mao 
et al., 2013) through the joining of the ligand to its receptor RANK located on 
progenitor bone cells, leading to induction of osteoclastogenesis. Consequently, 
the generated osteoclasts resorb osseous tissue. During this process growth 
factors IGF, TGFβ, and BMP are disseminated into the microenvironment, 
promoting further progression of cancer growth. This “vicious cycle” facilitates 
tumour cell proliferation promoting advanced bone invasion. 
1.7 Adjuvant therapeutic implications in cancer 
Cancer associated fibroblasts have been suggested to be good therapeutic 
targets due to their genetic stability and non-proliferative characteristics 
(Johansson et al., 2012; Kinugasa et al., 2014). In reference to OSCC, multiple 
studies support the evidence that CAF secreted hepatocyte growth factor (HGF) 
disrupts EGF expression (Wang et al., 2009; Yamada et al., 2010) conferring 
resistance to an antagonistic EGFR antibody; cetuximab, via CAF induced MMP 
(Johansson et al., 2012). However, normal resting oral fibroblasts were not 
included in this study which would have been useful for comparison with CAF.	
1.7.1 Senotherapeutics 
Senescent cells accumulate with ageing, as well as in pathologies of chronic 
disease. In vitro studies on these ageing cells have shown to impede or prevent 
age related diseases including osteoporosis, pulmonary fibrosis, cardiovascular 
disease, diabetes, and cancer (Zhu et al., 2014; Roos et al., 2016). Zhu et al. 
(2015) first identified senotherapeutics through the contradicting fact that 
senescent cells despite expressing SASP factors that should trigger cell death, 
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are resistant to apoptosis. In addition, proapoptotic pathways are amplified in 
senescence, yet these cells withstand apoptosis (Wang et al., 1995). Therefore, 
senescent cells depend on their pro-survival mechanisms to protect themselves 
from the pro-apoptotic SASP expression. Following this hypothesis, and thorough 
RNA bioinformatics evaluation, senescent cell anti apoptotic pathways (SCAP) 
were proposed (Table 1.1). Through this approach the survival proteins were 
described and targeting of these proteins led to selective apoptosis of senescent 
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Table 1.1: Senolytic drugs and SCAP (Adapted from James et al., 2017) 
SCAP Senolytic agent Effective In vivo 
































The first senolytic drug adapted using this hypothesis were quercetin and 
dasatinib (Zhu et al., 2015), followed by a B-cell lymphoma 2 (BCL-2) family 
inhibitor navitoclax (Chang et al., 2016; Zhu et al., 2016). More recently the use 
of heat shock protein (HSP-90) has also been reported (Fuhrmann-Stroissnigg et 
al., 2017).	
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Targeting a single pro-apoptotic pathway cannot eliminate senescence in all cell 
types. However, combination of different senotherapeutics can have synergistic 
properties, increasing the range of senescent cells that can be eliminated (Zhu et 
al., 2015).	
In age related bone loss, Farr et al. (2017) recently eliminated senescent cells in 
bone by stimulating apoptosis through targeted activation of caspase (INK-ATTC 
transgene), and administration of pharmacological senotherapeutic agents in 
mouse models. They further reported that on exposure to senescent cell 
conditioned media, osteoclast survival was significantly enhanced. Collectively, 
this data can be further used to understand the role of senescence in cancer 
related bone invasion, with potential therapeutic application to limit tumour spread 
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1.8 Summary 
The majority of head and neck cancers are diagnosed as OSCC. Although it is not one 
of the most common cancers, in the United Kingdom, more than 11,900 new cases of 
head and neck cancers were reported in 2016, with an increase in incidence of 
over 33% for new patients diagnosed with oral cancer in the last decade, and 
over 4000 oral cancer-related deaths reported annually (Cancer Research UK, 
2019).  
Bone invasion is a common feature of OSCC and is associated with a poor prognosis. A 
number of previous studies have attempted to explore the mechanism of OSCC 
associated bone invasion, however, the exact molecular mechanism in which OSCC 
invades bone still remains unclear. There is increasing evidence that the tumour 
microenvironment, predominantly composed of CAF, play a key role in tumour 
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1.9 Project hypothesis, aims and objectives 
1.9.1 Hypothesis 
Cancer associated fibroblasts (CAF) play a functional role in OSCC bone 
invasion through a RANKL dependent pathway. 
1.9.2 Aims 
The aim of this study is to investigate whether CAF play a role in bone invasion 
and to identify underlying mechanisms of interactions between CAF and bone 
cells. 
1. Investigate the role of fibroblasts in bone remodelling. 
2. Examine the contribution to different subsets of CAF.  
3. Understand the mechanism by which different subsets of CAF influence 
bone invasion in OSCC. 
4. Assess the possibility of targeting CAF pharmacologically as an 
intervention for bone invasive OSCC. 
1.9.3 Objectives 
1. To investigate the abundance and role of myofibroblastic CAF in bone 
invasion and remodelling in OSCC. 
2. To examine the different subsets of CAF, in particular those with a 
senescent phenotype, in the tumour microenvironment of bone invasive 
OSCC. 
3. To examine whether EV influence bone invasion in oral cancer. 
Data from this project will present novel information concerning the role of CAF 
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2.1 Clinicopathological analysis of OSCC bone 
resections  
The local pathology database was used to identify OSCC cases with bone 
removal. OSCC bone resections diagnosed from 1994 to 2017 (407 cases) were 
identified from the Unit of Oral and Maxillofacial Pathology, School of Clinical 
Dentistry, University of Sheffield archive and the following information retrieved 
from pathology reports: 
• Site (maxilla or mandible) 
• Age 
• Gender 
• Grade of tumour differentiation (well, moderate, and poor) 
• Bone invasion (Superficial cortical resorption or deep cancellous 
invasion) 
• Regional metastasis 
 
2.2 Immunohistochemical (IHC) analysis of OSCC 
incisional biopsies away from bone 
10 OSCC cases that had undergone initial diagnostic incisional biopsies (1996 to 
2016) were selected from the archive detailed in section 2.1.	
Immunohistochemical staining was performed on 4 μm tissue sections to study 
ex vivo expression of a marker of myofibroblastic differentiation (αSMA), bone 
turnover markers (OPG and RANKL), and senescence markers dipeptidyl 
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peptidase-4 (DPP4/CD26) and p16INK4a (ethical approval ref.# 
07/H1309/150).   	
Numerous pilot assays were carried out to optimise primary antibody dilutions to 
detect specific expression and reduce non-specific background staining, 
including determining the optimal antibody concentration, incubation time, 
blocking method and antigen retrieval technique (Table 2.1).	
Table 2.1: Details of primary antibodies used for IHC. 
Primary antibody Dilution Description Details 



























2.2.1 IHC procedure 
OSCC formalin fixed paraffin embedded (FFPE) tissue sections were submerged 
in 100% xylene for 10 min at room temperature (RT) to deparaffinise the tissue 
samples. Sections were dehydrated by immersion in absolute alcohol for a further 
10 min. Incubation in 3% (v/v) hydrogen peroxide in methanol (100%) for 20 min 
was used to block endogenous peroxidase at RT, followed by a wash in PBS, 
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ready for antigen retrieval (Table 2.2). Heat-induced epitope retrieval (HIER) was 
performed by microwaving sections in 0.01 M tri-sodium citrate buffer (pH 6) for 
8 min on high power (Table 2.2). Slides were briefly allowed to cool, prior to 
blocking in serum corresponding to the species in which the primary antibodies 
were raised (100% horse serum for mouse (αSMA) antibody, and goat serum for 
rabbit (RANKL, OPG, DPP4/CD26 & p16INK4a antibody), at RT. After 30 min, 
the blocking serum was removed and 200 μl of primary antibody diluted in 
appropriate 100% serum was applied in a humidified chamber overnight at 4°C 
(Table 2.1). Exclusion of primary antibody served as a negative control.	
	
On the subsequent day, sections were washed twice in PBS for 5 min at RT to 
remove unbound antibody. VECTASTAIN ELITE ABC Kits (Vector Laboratories) 
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Table 2.2: IHC solutions and reagents. 
Chemical reagents Formulation 
3% (v/v) Hydrogen Peroxide 
70 ml Hydrogen Peroxide (H2O2) 
230 ml Absolute Methanol 
0.01 M Sodium Citrate Buffer 11.8 g/ml Sodium Citrate Tribasic 
Phosphate Buffer Saline (PBS) 
425 g/ml Sodium Chloride 
58 g/ml Sodium Phosphate Dibasic 
12.5 g/ml Potassium Phosphate 
5 L Distilled Water 
Secondary Biotinylated Antibody 
Biotinylated Antibody Stock (1 drop) 
Blocking Serum (3 drops) 
10 mL PBS 
VECTASTAIN ELITE ABC 
Reagent A (2 drops) 
Reagent B (2 drops) 
5 ml PBS 
Vector Nova Red Peroxidase 
 
Reagent 1 (1 drop) 
Reagent 2 and 3 (2drops) 
H2O2 (2 drops) 
5 ml distilled water 
DAB Substrate Kit 
Buffer stock solution (2 drops) 
DAB stock solution (4 drops) 
Hydrogen peroxide solution (2 drops) 
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Table 2.3: Details of secondary antibodies used for IHC. 
Secondary antibody VECTASTAIN ELITE ABC Kit 
Anti-human αSMA monoclonal 
antibody 
Horse anti-Mouse IgG 
Catalogue number PK-6102 
Anti-human RANKL polyclonal 
antibody 
Goat anti-Rabbit IgG 
Catalogue number PK-6101 
Anti-human OPG polyclonal 
antibody 
Goat anti-Rabbit IgG 
Catalogue number PK-6101 
Anti-human DPP4 polyclonal 
antibody 
Goat anti-Rabbit IgG 
Catalogue number PK-6101 
Anti-human p16INK4a polyclonal 
antibody 
Goat anti-Rabbit IgG 
Catalogue number PK-6101 
 
The secondary biotinylated antibody was applied to all sections, 1 drop diluted in 
10 ml PBS, and incubated for 30 min at RT. The ABC solution was prepared at 
the same time and left to stand for 30 min prior to application (Table 2.2). After 
30 min, the slides were washed in PBS and ABC solution was applied for a further 
30 min, followed by two more washes in PBS.	
Colour development was performed using the Nova RedTM Peroxidase 
Substrate Kit (Vector Laboratories) for the antibodies detecting αSMA, RANKL, 
and OPG and the reaction was stopped after 5 min by immersing slides in distilled 
water (Table 2.2). DAB Substrate Kit (Vector Laboratories), a chromogenic 
substrate that oxidises in the presence of peroxidase resulting in a brown colour, 
was used for DPP4 and p16INK4a. Slides were incubated with DAB for 6 min, 
then washed in distilled water for 5 min to stop the colour development. Finally, 
the sections were counterstained using haematoxylin (Thermo Electron, UK), 
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dehydrated in increasing concentrations of alcohol (90% then 100% 
respectively), and immersed in xylene (100%) using a Shandon linear staining 
appliance. Glass coverslips were used to seal the sections using a distyrene 
plasticizer xylene (DPX) mountant.	
2.2.2 IHC evaluation  
The stained slides were scanned using a high definition scanner TissueFAXS 
Slide Loader 120 Histo (Wien, Austria), and HistoQuest analysis software (Tissue 
Gnostics Imaging Solution, Austria) was utilised for IHC quantification. Three 
random regions of interest (ROI) per slide were selected covering an area of 0.5 
mm2 in tumour and stroma at the tumour invasive front and bone interface. The 
percentage positivity and staining intensity were measured and calculated by the 
software based on the recommended settings (Table 2.4 and 2.5).	
Table 2.4: HistoQuest settings for haematoxylin measurement. 
Nuclei size 15 
Remove weakly stained objects 1 
Remove small sized objects 1 
Threshold  13 
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Table 2.5: HistoQuest settings for DAB and NovaRed measurement. 
Ring mask Yes 
Use nuclei mask  No 
Use identification cell mask Outside 
Internal radius -0.28 µM 
External radius +0.28 µM 
Maximum growing steps 2.2 µM 
 
2.2.3 Double IHC analysis of senescence in myofibroblasts 
Matched cases of OSCC bone resections were examined, using double IHC, for 
expression of αSMA (monoclonal anti-actin, α-smooth muscle antibody A5228; 
Sigma-Aldrich, Poole, UK, 1:100) and p16INK4a (monoclonal anti-p16INK4a 
antibody ab108349; Abcam, Cambridge) or RANKL (polyclonal anti-RANKL 
antibody ab9957; Abcam, Cambridge, UK; 1:50) (Table 2.1). Staining was 
conducted using the DoubleStain IHC Kit: mouse and rabbit on human tissue 
(Abcam ab210061, Cambridge, UK). Two distinct antigens expressed in human 
tissue were evaluated using HRP-Polymer anti-mouse IgG (Emerald green 
chromogen), and AP-Polymer anti-rabbit IgG (Permanent red chromogen), which 
also gives the benefit of co-localisation. 
OSCC bone resections were deparaffinized as previously described in section 
(2.2.2). Sections were blocked in peroxidase blocking buffer (3% H2O2) for 10 
min, then rinsed twice in distilled water. Antigen retrieval was conducted by HIER 
in citrate buffer (0.01 M sodium citrate buffer) for 8 min in a microwave at high 
power, and allowed to cool in the hot buffer for another 5 min before washing in 
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TBS-T wash buffer (50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.6). 
Slides were incubated in 300 μl of diluted mouse and rabbit primary antibodies 
(anti-αSMA, 1:100, anti-RANKL, 1:50 or anti-p16INK4a, 1:100) in TBS-T. 
Following a 60 min incubation, sections were washed in TBS-T wash buffer (3 
times, 2 min per wash). A fresh mixture of rabbit AP polymer and mouse HRP 
polymer was prepared at a ratio of 1:1 and used promptly. 100 μl of the mixture 
was carefully added to the slides, to cover the sections, and incubated for 30 min 
in a humidifier. Slides were washed in TBS-T (3 times, 2 min per wash). 
Permanent Red staining was performed in accordance to manufacturer’s 
instructions (10 μl Permanent Red Chromogen, 200 μl Permanent Red Activator, 
in 1 ml Permanent Red Substrate).  Permanent red staining solution (100 μl) was 
applied to each slide. After 10 min, the sections were immersed in distilled water 
to stop the reaction. 
Sections were counterstained by briefly dipping slides in haematoxylin for 30 sec, 
rinsed in water (1 min), dipped in PBS (10 sec) for colour development, and rinsed 
in TBS-T before proceeding to the anti-mouse Ig detection using Emerald green 
staining. 100 μl of Emerald chromogen was applied, and sections incubated in a 
humidifier (5 min). Following this, slides were rinsed with distilled water, 
dehydrated in graded ethanol (85%, 95%, 100% absolute ethanol), and xylene 
(20 sec). Sections were mounted using 50 μl limonene mounting medium 
(catalogue ab104141, abcam) supplied and covered with a glass coverslip. 
(catalogue ab104141, abcam) supplied and covered with a glass coverslip. 
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2.3 Cell culture and propagation 
2.3.1 Cell lines and culture conditions 
2.3.1.1 HOB 
Human primary osteoblasts, a gift from Dr Keyvan Moharamzadeh, were isolated 
from bone chips collected following dental implant surgery (Sheffield Research 
Ethics Committee (15/LO/0116, STH Research Department: STH18551), and 
used at passage 2. 
2.3.1.2 NOF 
Primary normal oral fibroblasts were isolated from human gingival tissue, as 
previously described (Hearnden et al., 2009) (Sheffield Research Ethics 
Committee reference number 13/NS/0120, STH17021). NOF 803, 804 and 822 
(from three different donors) were used at passage 3-7 to exclude the possibility 
of senescence (based on previous data obtained in the laboratory). 
2.3.1.3 DENF 316 
Primary normal oral fibroblasts were retrieved from the department archive bio-
repository. These human fibroblasts were isolated from healthy gingival tissue, 
which was collected during molar tooth extraction at Charles Clifford Dental 
Hospital, University of Sheffield (Sheffield Research Ethics Committee reference 
number 04/Q2305/78). Fibroblasts were used between passages 5-7. 
2.3.1.4 CAF 
Primary human cancer associated fibroblasts (CAF 002, 003 and 004- from three 
different donors) were isolated from OSCC resection specimens (Elmusrati et al., 
2017) from Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield 
Research Ethics Committee reference number 13/NS/0120, STH17021) and 
used between passage 3-7. 
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2.3.1.5 H357 
The human OSCC-derived cell line H357 was retrieved from the department bio-
repository. The H357 cell line was originally established from a well-differentiated 
OSCC of the tongue excised from a 74-year-old Caucasian male patient (Prime 
et al., 1990). The primary tumour dimension was 20 mm in diameter with no 
regional lymph node spread or distant metastases.  
2.3.1.6 RAW 264.7 
The murine monocyte cell line RAW 264.6 was acquired from ATCC (ATCC, TIB-
71) and used below passage 5. 
The cells were cultured and propagated in Table 2.6. 
Table 2.6: Media used to propagate the specific cell strains. 




Dulbecco’s Modified Eagle’s Medium 
(DMEM) 
10% (v/v) Foetal Bovine Serum (FBS) 
1% (v/v) Penicillin/ Streptomycin 
1% (v/v) Amphotericin B (250 μg/ml) 
1% (v/v) L-Glutamine 
DENF 316 
NOF 803, 804 and 822 
CAF 002, 003 and 004 
DMEM 
10% (v/v) FBS 
1% (v/v) L-Glutamine 
 
Cells were grown in 12 ml of their corresponding culture media in T75 cm2 tissue 
culture treated surface flasks (Greiner Bio-one, Germany). Cells were incubated 
in 99% humidity, 5% carbon dioxide (CO2), at 37°C until confluent and ready for 
use. 
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2.3.2 Cell subculture and propagation 
After reaching near confluence (70-80%), all cells were trypsinised, reseeded, 
and allowed to further propagate. To achieve this, spent media was discarded, 
and attached cells were irrigated twice in 5 ml of sterile modified Dulbecco’s PBS, 
without calcium or magnesium chloride (catalogue number D8537, Sigma-
Aldrich). Following rinsing (2 x), PBS was removed from the culture flask, 3 ml of 
trypsin (catalogue number T3924, Sigma-Aldrich) was applied, and the cells 
allowed to detach in the incubator at 37°C for 5 min. Following trypsin 
neutralisation with 3 ml 10% FBS DMEM nutrient media, cells were re-suspended 
and centrifuged at 1000 xg for 5 min to obtain a cell pellet. The supernatant was 
discarded carefully to avoid dislodgment of pellet. Cells were re-suspended by 
adding 3 ml of nutrient media, gently agitated by pipetting up and down to 
disperse cells throughout fresh media, and 1 ml was added to new T75 cm2 flasks 
containing 11 ml of the respective media. Cells were allowed to grow in humidified 
incubators as mentioned previously. 
2.3.3 Collection of conditioned media from cultured cells 
Cells were grown to 70-80% confluence,  rinsed twice in PBS and incubated in 
2.5 ml serum free media (1% L-glutamine in low-medium glucose DMEM) in T75 
flask for 24 h. Collected media was centrifuged at 1000 xg for 5 min, filter 
sterilized, and stored at -80°C ready for use in functional assays. 
2.3.4 Indirect co-culture of human primary osteoblasts with H357 
or CAF. 
HOB were cultured to 70-80% confluence in T75 flasks. Spent media was 
discarded, and 3 ml of trypsin was added, following a double rinse with PBS. 
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Flasks were returned to a humidified incubator (3-5 min), until cells could be 
dislodged from the attached surface by gentle agitation. Following neutralization 
(3 ml media) and centrifugation, a haemocytometer was used for cell counting, 
and the cell pellet was resuspended at the required density. HOB (300,000-
500,000 cells) were seeded into 6-well plates (catalogue number 657/60, Greiner 
bio one), making sure the final volume was kept consistent (2 ml/well). Plates 
were left in humidified incubator overnight to allow cellular attachment. 
On the next day, nutrient media was dispensed, osteoblasts were irrigated with 
PBS, and serum free media (2 ml/well) was added for 24 h. Allowing cells to 
culture in serum free media brings all cells into an arrest phase (G0 cell cycle) for 
consistency. Simultaneously, confluent OSCC cells (H357) or CAF (002, 003, 
004) were rinsed in PBS and further serum starved in 5 ml media for 24 h. Serum 
free media (5 ml) in a T75 flask, served as a negative control. 
The following day, serum free media from osteoblasts grown in 6 well plates was 
removed and replaced by 1 ml of conditioned filtered serum free media collected 
from OSCC cells and CAF in the bottom wells. In the upper wells, 1 ml/ well serum 
free media was added; these wells acted as negative controls (Figure 2.1). All 
plates (n=3) were incubated in 99% humidity, 5% CO2 incubator at 37°C for 24 h. 
Chapter 2 Material and Methods  
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 59 
 
 
Figure 2.1: Indirect co-culture of human primary osteoblasts (300,000-500,000 HOB 
cells) treated with serum free conditioned media collected from (A) OSCC cells (H357) 
and (B) CAF (002, 003 and 004). Osteoblasts (HOB) treated in serum free media served 
as the negative control. 
 
Finally, conditioned media was discarded, lysis buffer (350 μl, containing 1% β-
mercaptoethanol) (RNeasy Mini Kit, Qiagen, UK) applied directly to wells and 
cells scraped (30 s) with small scrapers (Fisher Scientific, catalogue number 08-
100-241). Following lysis, osteoblasts were collected in 1.5 ml eppendorf tubes, 
and RNA extraction was commenced promptly for optimal RNA yield. 
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2.3.5 Treatment of fibroblasts with TGFβ1 
Normal oral fibroblasts were cultured in T75 flasks to 70-80% confluence. Media 
was discarded, and cells harvested by adding 3 ml of trypsin for 3 min (flasks 
were returned to humidified incubators to facilitate cell dislodgement). Following 
trypsin inactivation with DMEM nutrient media (3 ml), and centrifugation (1000 xg 
for 5 min), cells were quantified using a haemocytometer, and 250,000 cells 
seeded on sterile coverslips (VWR) (2 ml / well) in a 6 well plate for subsequent 
determination of αSMA expression and localisation using immunofluorescence 
(section 2.7).  
For αSMA mRNA expression evaluation (section 2.5.1), DENF 316 and NOF (803, 
804) were seeded at the 250,000 cells/well in 6 well plates. The cells were 
allowed to adhere to the 6 well plates for 24 h. On the following day, spent media 
was aspirated, fibroblasts were washed in PBS, and serum starved in serum free 
media (2 ml/ well) for 24 h. The next day, serum free media was aspirated, and 
three wells of fibroblasts were treated with 5 ng/ml (Bhowmick et al., 2004) 
recombinant human TGFβ1 (Catalogue number 240B, R&D Systems, UK) diluted 
in fresh serum free media (1 ml/ well). Fibroblasts in serum free media served as 
a negative control (Figure 2.2). 
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Figure 2.2: NOF treatment with TGFβ1. NOF 803, 804 and DENF 316 (250,000 cells / 
well) fibroblasts were seeded on coverslips in 6-well cell culture plates and treated with 
recombinant human TGFβ1 (5ng/ml). Fibroblast in serum-free media served as the 
negative control. 
2.3.6 Induction of senescence in NOF   
Hydrogen peroxide (H2O2), cisplatin, DNA damaging reagents, and replicative 
exhaustion techniques were selected to trigger senescence in fibroblast cell 
cultures (Kabir et al., 2016). Initially, primary human oral fibroblasts (NOF 803, 
804, 822 & DENF 316) were seeded into T75 flasks with a cellular density of 
500,000 cells/flask, when fibroblasts reached 70% to 80% confluence. Cells were 
next exposed to 500 μM H2O2 (catalogue number H/1750/15, Fisher Scientific) 
for 2 h, or 10 μM cisplatin (catalogue number BP809, Sigma Aldrich) for 24 h and 
allowed to incubate in a 99% humidified incubator in 5% CO2 at 37°C. Following 
treatment, fibroblasts were rinsed twice with sterile PBS, 10 ml of fresh growth 
media was added, and the cells were allowed to grow in an incubator for 5 days. 
Senescence induction by replicative exhaustion was conducted by allowing 
primary oral fibroblasts to grow and propagate until passage 25, where cell count 
doubling time decelerated, and the number of cells of the former passage 
(passage 24, 3.5 million cells/flask) was similar to the latter (passage 25, 3.52 
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million cells/flask) after 10 days in culture . NOF cultured in growth media and not 
exposed to H2O2 served as the negative control. 
2.4 Assessment of senescence 
2.4.1 Senescence-associated β-galactosidase assay 
It has been reported that senescent cells exhibit an accumulation and 
overexpression of endogenous lysosomal β-galactosidase, referred to a 
senescence-associated β-galactosidase (SA-β-gal), and regarded as a 
biomarker of cellular senescence. At pH 6, β galactosidase cleaves lysosomal X-
Gal, which precipitates as a blue chromogen in senescent fibroblasts (Dimri et al., 
1995). 
To determine the extent of fibroblast senescence after H2O2, cisplatin treatment, 
and replicative exhaustion, senescence associated β galactosidase (catalogue 
number ab65351, Abcam) activity analysis was performed on low passage 
normal oral fibroblasts (Kabir et al., 2016). 
Following senescence induction, fibroblasts were seeded (10,000 cells/well) into 
12 well plates. NOF (10,000 cells/well) at a low passage (passage 4 or 5) seeded 
in a 12 well plate were also investigated for senescence, and served as a 
negative control. Fibroblasts were left overnight in a humidified incubator for cell 
attachment. On the next day, fibroblasts were rinsed with PBS, and 500 μl of 
fixative was applied for 15 min.  
X-gal staining solution was prepared to a concentration of 20 mg/ml, and a 
mixture of 25 μl X-gal and 5μl 100X staining supplement was added to 470 μl of 
1X staining reagent. Plates were placed in a dark hood, and 500 μl of the mixture 
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was added to each well. Plates were wrapped with aluminium foil and kept in a 
humidified incubator overnight. 
Accumulation of β galactosidase in fibroblasts was analysed, and fibroblasts 
exposed to oxidative, genotoxic and replicative mitotic stress and NOF were 
evaluated at x20 magnification using Olympus CKX41 inverted microscope. 
 
2.4.2 Evaluation of accumulating lipofuscin in senescence, using 
Sudan B Black staining  
Sudan B Black (SBB) histochemical staining was conducted to examine 
lipofuscin accumulation, a recently described biomarker for cellular senescence 
(Georgakopoulou et al., 2013). SBB staining solution was prepared by dissolving 
0.7 g Sudan B Black (Catalogue number 190160250, Arcos Organics) in 70% 
ethanol, covered with parafilm and thoroughly stirred overnight at RT. On the next 
day, the staining solution was filtered three times using filter paper (Catalogue 
number FB59031, Fisherbrand). Primary oral fibroblasts left untreated or 
exposed to H2O2, cisplatin, or replicative exhaustion were seeded onto 12 mm 
sterile glass coverslips (10,000 cells) and allowed to adhere overnight in a 
humidified incubator at 37°C and 20% O2 saturation. On the following day, 
fibroblasts were rinsed twice in PBS followed by fixation in 3.7% formaldehyde 
for 5 min, washed in PBS and stained with SBB for 2 h. After incubation, 
coverslips were rinsed briefly with two changes of 70 % ethanol and washed with 
distilled water. Staining was visualised using a light microscope (Nikon Eclipse 
TS-100, Kingston-upon-Thames). 
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2.5 mRNA expression analysis from cultured cells 
2.5.1 Total RNA extraction and purification 
The cells were collected by adding 350 µl lysis buffer (RLY) to 3.5 µl beta-
mercaptoethanol to cell pellet. Cell lysate was then promptly loaded into the 
provided ISOLATE II Filter (ISOLATE II RNA Mini Kit, BIOLINE, UK) placed into 
2 ml collection tubes, and centrifuged for 1 min at 11,000 x g. Following filtration 
of lysate, 350 μl of 70% (v/v) ethanol was applied to the homogenized lysate and 
pipetted up and down (5-6 times). The lysate was then loaded into ISOLATE II 
RNA Mini Column, fitted into a 2 ml collection tube, and centrifuged for 30 s at 
11,000 x g. After centrifugation, the flow-through was disposed, the column was 
fitted into a new 2 ml collection tube, and membrane-desalting buffer (350 μl) was 
applied to each sample column. Following centrifugation (11,000 x g for 1 min), 
the flow through was disposed of and the samples were subjected to three 
washes, 200 μl RW1 wash buffer (centrifuge 30 s at 11,000 x g), and 600 μl RW2 
wash buffer (centrifuge 30 s at 11,00 x g). Finally, the samples were washed in 
250 μl RW2 wash buffer (centrifuged 2 min at 11,000 x g), flow through was 
discarded, and ISOLATE II RNA Mini column was fitted into a 1.5 ml nuclease 
free collection tube ready for RNA elution. To obtain optimal RNA yield, 60 μl of 
nuclease free water was added to each column, and centrifuged 11,000 x g for 1 
min. The eluted RNA was immediately placed on ice, ready for RNA quantification. 
2.5.2 Quantification of RNA concentration and purity 
The extracted RNA was measured using a Nanodrop (ND-1000) 
spectrophotometer (Thermo Scientific, VWR International; Illinois), and the 
concentration and purity of samples were observed at wavelength 260nm/280nm, 
with an optimal ratio of 2.0. 
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2.5.3 Reverse Transcription (RT) of RNA to complementary DNA 
(cDNA) 
RNA (100μg) was reverse transcribed using High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, USA), according to the manufacturer’s 
instructions. 
Reverse transcription master mix reaction (total volume 20 μl) was prepared 
(Table 2.7). 
Table 2.7: RT master mix components. 
Master mix reagents Volume (total volume 5.8 μl) 
Random primers 2 μl 




Deoxynucleotides (dNTPs) 0.8 μl 
 
A total volume of 14.2 μl diluted mRNA was pipetted into each PCR tube (VWR 
International, USA), and 5.8 μl of the prepared master mix added to each sample 
respectively. To ensure all samples collected at the base of the tubes, samples 
were centrifuged for 15 s at 10,000 xg. Following this, the samples were placed 
in a DNA Engine DYAD (Bio-Rad Laboratories, USA) thermo-cycler, programmed 
at a selected setting of 25°C for 10 min, followed by an increase in temperature 
to 37°C for 2 h, and for 85°C for 5 min, prior to the samples being held at 4°C, 
ready for use or stored at -80°C for cDNA preservation. 
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2.6 Quantitative Real-Time Polymerase Chain 
Reaction (qPCR) 
2.6.1 qPCR protocol 
Following reverse transcription to cDNA, all samples were exposed to real time 
qPCR evaluation using Rotor-Gene Q PCR system (Qiagen, Germany). TaqMan 
primers (Life Technologies, Thermo Fisher Scientific, USA) or primers for SYBR 
quantification (Sigma) were utilized for DNA amplification (Table 2.8 and 2.10). 




RANKL Reference code TNFSF11, Catalogue number PHP0034 
OPG Reference code TNFRSF1, Catalogue number PHC1684 
IL6 part no. Hs00985639_ml 
 
Table 2.9: Real time qPCR TaqMan master mix components. 
Real time qPCR master mix Volume (total volume 9.5 μl) 
Primer/probe 0.5 μl 
B2M reference gene 0.5 μl 
Nuclease free water 3.5 μl 
TaqMan Gene Expression Master Mix 
(Applied Biosystems, Catalogue number 
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Table 2.10: SYBR green primers. 
SYBR primer Details 
p16INK4a Forward 5’ AATAACCTTCGGCTGACTGGCTG 3’, Sigma-Aldrich 
p16INK4a Reverse 5’ TTATTCGCCTCCAGCAGCGCCCG 3’, Sigma-Aldrich 
αSMA Forward 5’ GAAGAAGAGGACAGCACTG 3’, Sigma-Aldrich 
αSMA Reverse 5’ TCCCATTCCCACCATCAC 3’, Sigma-Aldrich 
U6 Forward  5’ CTCGCTTCGGCAGCACA 3’, Sigma-Aldrich 
U6 Reverse 5’ AACGTTCACGAATTTGCGT 3’, Sigma-Aldrich 
 
Table 2.11: Real time qPCR SYBR green master mix components. 
Real time qPCR master mix Volume (total volume 9.5 μl) 
Forward primer  0.5 μl 
Reverse primer 0.5 μl 
Nuclease free water 3.5 μl 
qPCRBIO SyGreen Mix (Catalogue 
number PB20.1501, PCRBIOSYSTEMS) 
5 μl 
 
Human beta-2 microglobulin B2M (Catalogue number Hs00187842_m1, Life 
Technologies, Thermo Fisher Scientific, USA) was chosen as a reference gene 
for TaqMan primers (Kabir et al., 2016), while SYBR green amplifications were 
normalised using the U6 gene due to their low variation across samples, in 
accordance to Livak method (Livak and Schmittgen, 2001). A volume of 0.5 μl of 
cDNA was added to the qPCR master mix (9.5 μl) (Table 2.9  and Table 2.11). 
To exclude the possibility that signals were obtained from amplification of 
contaminating genomic DNA, 0.5 μl RNA (instead of DNA) was used as a 
negative control for all samples. 
Samples were loaded into 0.2 ml PCR tubes (catalogue number 14230225, 
Fisherbrand) in triplicates, centrifuged briefly, to ensure collection of samples at 
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bottom of tube. A two-step setting was used for TaqMan primers, where the 
thermal profile commenced with a denaturation stage at 95°C for 10 s, followed 
by a decrease in temperature to 60°C for 45 s annealing and extension stage, 
this was repeated for 40 cycles. Gene expression of each sample was normalized 
to the corresponding endogenous gene B2M or U6 to obtain ΔCt. For SYBR 
green primer, three steps with melt setting, to generate a melt-curve, was used, 
where the thermal profile commenced with a denaturation stage at 95°C for 10 s, 
then a decrease in temperature to 60°C for 15 s, followed by 72°C for 20 s 
annealing stage, this was repeated for 40 cycles. 
Finally, 2-ΔΔCt method was used to measure fold-change of gene of interest to 
relevant untreated samples (Livak, 2001). 
2.7 Immunofluorescence (IF) 
Following a 24 h stimulation of fibroblasts with TGFβ1, conditioned media was 
discarded, and 1 ml methanol used to wash the coverslips. Methanol was 
aspirated and 1 ml of fresh absolute methanol was added for cellular fixation for 
15 min. The fixed fibroblasts were permeabilised in 1 ml 4 mM sodium 
deoxycholate (catalogue number 89905, ThermoFisher) for 15 min. Blocking 
buffer (2.5% bovine serum albumin (BSA) in PBS) (catalogue number A4503, 
Sigma-Aldrich) was prepared and applied at RT on a shaker to allow equal 
distribution of blocking solution for 15 min. The blocking reagent was discarded 
and monoclonal alpha smooth muscle actin FITC murine antibody (catalogue 
number A2547, Clone 1A4, Sigma-Aldrich), dissolved in 1:100 v/v in blocking 
buffer was applied for 1 h at 37°C. 
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Following antibody incubation, samples were washed in PBS (three times). 
Coverslips were carefully removed from wells, and mounted on glass slides 
(catalogue number 631-0108, VWR International) using a drop of Prolong gold 
DAPI containing mountant (catalogue number P36931, Thermo Fisher Scientific). 
Coverslips were placed in a slide box and allowed to attach to slides at 4°C for 
24 h to ensure uniform staining of DAPI. 
Images were taken at x40 magnification using an Axioplan 2 fluorescent 
microscope.  
2.8 Enzyme-linked immunosorbent assay (ELISA)  
NOF (803, 804, 822) and DENF 316 normal oral fibroblasts, NOF (803, 804, 822) 
exposed to senescence induction (at passage 25 or 5, 10 and 15 days after H2O2 
or cisplatin exposure) and CAF 002, 003 and 004 were cultured in T75 flasks to 
70-80% confluence and seeded in 6 well plates as previously mentioned. The 
plates were incubated for 24 h, to allow cell attachment. 
On the following day, spent media was aspirated, fibroblasts were irrigated in 
PBS, and serum starved in serum free media (2 ml/ well) for 24 h. The next day, 
serum free media was aspirated and stored at -80°C in preparation for an enzyme 
linked immunosorbent assay (ELISA). 
A sandwich duoSet ELISA kit (catalogue number DY626, R&D Systems) was 
conducted to demonstrate and evaluate soluble RANKL expression from CAF in 
comparison to NOF secretion in vitro. Required reagents were composed in 
accordance to manufacturer’s instructions (Table 2.11). 
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Table 2.12: ELISA reagents preparations. 
Reagents Composition 
PBS 1.5 mM KH2PO4 
8.1 mM Na2HPO4 
137 mM KCL 
Wash Buffer 0.05% (v/v) Tween 20 in PBS 
Reagent Diluent 1% (v/v) BSA in PBS 
Substrate Solution 1:1 mixture of colour reagent A (H2O2) and colour reagent B (Tetramethylbenzidine) 
Stop Solution 2 N H2SO4 
 
2.8.1 ELISA detection of soluble RANK ligand 
The capture antibody (murine anti-human RANK ligand) was diluted in PBS (180 
μg/ml of antibody reconstituted in 1 ml PBS), and 100 μl of the working 
concentration was applied to the 96-well microplate (Greiner bio-one), to coat the 
bottom of each well. The plate was sealed (catalogue number 676001, Greiner 
bio-one) to prevent evaporation of diluent, and allowed to incubate overnight at 
RT. 
On the next day, capture antibody was discarded, and each well was washed 
using 400 μl wash buffer (Table 2.12) twice. Extra care was taken following 
washing, and remnant wash buffer was removed by repetitive blotting of 
microplate on clean paper towels. Plates were blocked using 300 μl / well reagent 
diluent and left to stand for 1h at RT. Blocking reagent was aspirated, and the 
wells were washed as previously described.  
Collected conditioned media from samples was diluted in Reagent Diluent and 
added to each well. Plates were sealed and allowed to stand for 2 h at RT. 
Sample supernatant was aspirated, and the wells were washed using the 
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washing buffer and blotted dry. Biotinylated Goat Anti-Human RANKL Detection 
antibody (9 μg/ml of antibody reconstituted in 1 ml in Reagent Diluent), and 100 
μl per well was added, and incubated for 2 h at RT. Following aspiration, irrigation, 
and blotting, 100 μl streptavidin-HRP was applied to each well for 20 min, washed 
and blotted dry followed by addition of substrate solution (100 μl per well) for 
another 20 min at RT. Colour development was terminated by adding 100 μl of 
stop solution. Absorbance was instantly measured using TECAN (Magellan V7.2 
software, Infinite M200) plate reader set at 450 nm with a correction wavelength 
of 570 nm. 
2.8.2 ELISA quantification 
Quantification was carried out using a standard curve in which the optical 
densities of the standards were plotted against standards’ concentration. 
Subtraction of average standard (zero) from the average triplicate readings for 
each standard and sample was performed, and the equation (standard curve and 
the R2 values) was used to quantify RANKL (pg/ml) expression for all samples. 
The experiment was performed in triplicate. 
2.9 Osteoclastogenesis assay 
Murine monocyte/macrophage cells (RAW 264.7) were seeded in a 24 well Osteo 
Assay Surface plate (Catalogue number 3987, Corning, USA) (for 
osteoclastogenesis and pit forming assay), and on coverslips in 24 well plates 
(400 μl, approximately 20,000 cells/well). The cells were placed in a humidified 
incubator for 24 h, to allow cell attachment. On the following day, normal oral 
fibroblasts cultured in T75 flasks to 60-80% confluence, were treated with TGFβ1 
(5 ng/ml). NOF, CAF, S-NOF, and H357 were rinsed twice with sterile PBS, and 
serum starved in 3 ml alpha MEM media (1% Pen/Strep. And 1% anti-fungal, 
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Amphotericin) for 24 h.  
On day three, conditioned media was collected from serum-starved cells, and 
TGFβ1 treated oral fibroblasts, filtered, centrifuged (1000 xg for 5 min), and 400 
μl per well added to RAW 264.7 cells (Figure 2.3). RAW 264.7 treated with 
recombinant RANKL (50 ng/ml) in serum free alpha MEM media served as a 




Figure 2.3: Osteoclastogenesis assay. Corning osteo surface 24 well plate seeded 
with 20,000 RAW 264.7 monocyte/macrophage cells (passage 5). Cells were subjected 
to a daily alpha MEM conditioned media change for 7 days. Samples included 1. 
Conditioned media from serum starved NOF. 2. Conditioned media from serum starved 
NOF. 3. Conditioned media from serum starved CAF. 4. Conditioned media from serum 
starved OSCC (H357). 5. Conditioned media from serum starved NOF treated with 
TGFβ1. 6. Conditioned media from serum starved NOF treated with TGFβ1. 7. Positive 
control, RAW 264.7 treated with 50 ng/ml recombinant RANKL. 8. Negative control, 
monocytes in serum free alpha MEM media. Two wells were designated for TRAP 
staining, and the third well was left to dry after day 7 to observe pit formation. The 
experiment was performed in triplicate. 
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Treatment of monocytes was continued for 7 days, with a daily change of 
conditioned media (collected from NOF, CAF and cancer cell lines). After 7 days, 
TRAP staining (2.9.1), pit forming (2.9.2), and nucleation staining (2.9.3) was 
performed to assess osteoclastogenesis (Figure 2.4). 
 
Figure 2.4: Osteoclastogenesis assay protocol. Conditioned media was collected for 
serum starved cells, and monocytes (20,000 per well) were seeded on a Corning osteo 
surface 24 well plate. Following seven days of daily media change, osteoclast generation 
was evaluated by TRAP staining, and for further verification, the ability to resorb bone 
and multinucleation was assessed. 
 
2.9.1 TRAP staining  
Tartrate-resistant acid phosphatase (TRAP) activity was assessed using the B-
Bridge International (USA) assay kit (catalogue number AK04).  Culture media 
was aspirated, and wells were irrigated with 400 μl of PBS. Following the wash, 
cells were fixed in 200 μl per well of Reagent 1, after 5 min, all wells were washed 
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with 1000 μl of distilled water, this was repeated three times. One vial of 
Chromogenic Substrate (Reagent 3) was diluted in 5 mL of Reagent 2 (Tartrate-
containing Buffer). Following a brief vortex, to ensure all substrate has dissolved 
in buffer, 200 μl of Chromogenic Substrate was added to each well and incubated 
37°C for 1 h (excess incubation was avoided to prevent precipitation of 
chromogenic substrate). When optimal staining was evident, wells were washed 
with distilled water to stop the reaction. Cells were evaluated and positive staining 
quantified under a light microscope (Nikon Eclipse TS-100), in three randomly 
selected high-power fields (magnification x 40). 
 
	2.9.2 Pit formation 
Different wells of the 24 Osteo Surface plate were observed for active osteoclast 
resorptive pit formation assay (Figure 2.3). Initially, culture media was removed 
from wells, and 400μl of 10% (v/v) bleach (hypochloric acid) solution was added 
to each well. Plates were incubated at RT for 5min. Following incubation, wells 
were washed twice with distilled water, and allowed to dry in RT for 3-5 h. Single 
pits or pit clusters were analysed under a light microscope (Nikon Eclipse TS-100) 
in three randomly selected high-power fields (magnification x 40). 
2.9.3 Nucleation staining for osteoclast verification  
RAW 264.7 cells were seeded on coverslips in 24 well plates, at an approximate 
density of 20,000 cells/well, and allowed to propagate as described above 
(section 2.8). Medium was removed and the plates were washed with PBS 
followed by fixation in 3.7% formaldehyde for 5 min. Cells were dehydrated in 
acetone (5 min), and permeabilised with 0.1% TRITON X-100 in PBS. After 
thorough washing, coverslips were mounted on glass slides using SlowFade® 
Diamond Antifade Mountant with DAPI (catalogue number S36968, 
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ThermoFisher) for nuclear staining. Images were obtained using a fluorescent 
microscope. 
2.10 Evaluation of senotherapeutics 
2.10.1 Optimisation of senolytic drugs 
Heat shock protein 90 (HSP90) inhibitor Alvespimycin (17-DMAG) (Catalogue 
number HY-12024, MedChem Express, USA), and B-cell lymphoma -2 (BCL-2) 
inhibitor Navitoclax (ABT263) (Catalogue number A3007, APExBIO Technology, 
USA) were used to target senescence. These drugs were selected due to their 
reported ability to promote apoptosis of senescent cells (Fuhrmann-Stroissnigg 
et al., 2017; Zhu et al., 2017). The drugs were reconstituted in DMSO (5 mM, and 
10 mM respectively), then diluted in DMEM culture media to obtain a range of 
working solutions with graded concentrations. The concentrations 50 nM, 250 nM, 
500 nM, and 750 nM were prepared for Alvespimycin (Fuhrmann-Stroissnigg et 
al., 2017), and 1μM, 2 μM, 3 μM, 4 μM, 5 μM, and 10 μM for Navitoclax (Zhu et 
al., 2016), aliquoted and stored at -20℃. Functional assessment of 
senotherapeutics was optimized by exposing both proliferating and senescent 
fibroblasts to a range of concentrations for 24 h. 
Senescent oral fibroblasts, and proliferating NOF (passage 6) were seeded 
(5,000 cells/well) into 24 well plates and left overnight in a humidified incubator 
to allow cell adherence. On the next day, senescent fibroblasts as well as the low 
passage primary NOF were exposed to different concentrations of Alvespimycin 
and Navitoclax, and then incubated for 24 h at 37°C, in 99% humidity and 5% 
CO2. Senescent fibroblasts and NOF not exposed to the senolytic drugs served 
as a negative control. Following treatment, the cells were rinsed in PBS and fixed 
in 3.7% formaldehyde for 5 min, and a Sa-β-Gal assay was performed to examine 
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the senescent burden in the cell population. This data was then compared to 
senescent cells not treated with the senolytics. In addition, a PrestoBlue cell 
viability test was conducted on both senescent and NOF exposed to the 
senotherapeutic, and the concentration of the optimized drugs that specifically 
initiated apoptosis in senescent fibroblasts and had no significant effect of NOF 
was used. 
2.10.2 Evaluation of senotherapeutic toxicity on NOF viability 
To investigate the effect of Alvespimycin and Navitoclax on cell survival and 
apoptosis on proliferating non-senescent fibroblasts. an experiment was set up 
similar to the one previously described in the senolytics optimizing assay (section 
2.10). NOF were seeded (10,000 cells/ well) in a 12 well plate. NOF were treated 
with Alvespimycin or Navitoclax diluted in serum free DMEM media at graded 
concentrations (50 nM, 250 nM, 500 nM, and 750 nM and 1μM, 2 μM, 3 μM, 4 
μM, 5 μM, and 10 μM respectively) (Figure 2.5) for 24 h. 
Figure 2.5: NOF viability test. 24 well plate seeded with 5,000 NOF cells (passage 5. 
Cells were subjected to treatment with senolytics Alvespimycin or Navitoclax and 
incubated for 24 h. Samples included NOF treated with Alvespimycin (50 nM, 250 nM, 
500 nM, and 750 nM). NOF treated with Navitoclax (1µM, 2 µM, 3 µM, 4 µM, 5 µM, and 
10 µM), negative control, NOF in DMEM media.  
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Following 24 h, a resazurin-based PrestoBlue cell viability reagent (catalogue 
number A13261, Life Technologies) was used at a dilution of 1:10 to assess NOF 
viability after senolytic treatment. PrestoBlue was applied to each well (40 μl 
PrestoBlue in 360 μl conditioned media / well). The 24 well plate was covered in 
aluminum foil and allowed to incubate in a humidified incubator for 1 h. Cell media 
was then collected and transferred to a 96 well plate (each sample was pipetted 
in duplicate). To correct background fluorescence control wells of media with no 
cells was added. 
Fluorescence was measured using TECAN (Magellan V7.2 software, Infinite 
M200) plate reader set at an excitation wavelength of 560 nm with an emission 
wavelength of 590 nm. The mean of the fluorescent readings of the no cell 
controls was deducted from the values of each sample well. Relative 
fluorescence was plotted against time interval for the different senolytic drug 
concentrations and negative control. 
2.11 Extracellular vesicle (EV) isolation and 
analysis 
2.11.1 Graded concentration centrifugation for EV isolation from 
conditioned media in culture 
To enhance the purity of the EV samples and reduce any contaminants, 
conditioned media collected from serum starved cells were exposed to graded 
concentration centrifugations and size exclusion chromatography (SEC) (Théry 
et al., 2018; Peacock et al., 2018) was conducted to isolate EV from cancer cells 
(H357), NOF (803, 804, 822), myofibroblasts (NOF treated with TGFB), CAF (002, 
003, 004), and senescent fibroblasts (NOF exposed to H2O2 or cisplatin). Cells 
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were grown in three T175 flasks to confluence, rinsed twice in PBS and serum 
starved for 72 h in 20 ml serum free DMEM media supplemented with L-glutamine.  
A total volume of 60 ml of conditioned media was collected from serum starved 
cells was used for isolation of EV. 
After 3 days, the conditioned media was collected into 50 ml centrifuge tubes and 
centrifuged at 300 xg for 10 min (J-26XP Beckman Coulter high speed centrifuge) 
to pellet cells and exclude large cellular debris. After the first spin, conditioned 
media was aspirated into a new 50 ml centrifuge tube, centrifuged at 2000 xg for 
15 min, to pellet apoptotic bodies. After centrifugation the conditioned media was 
transferred to a new 50 ml tube, balanced and spun at 1000 x g for 45 min, to 
pellet large EV. Following the third centrifuge cycle, the conditioned media was 
filtered through a 0.22 µm filter,15 ml of the filtered media was transferred into 
Vivaspin protein concentrator spin columns (Catalogue number 28932363, GE 
Healthcare Life Sciences), balanced and centrifuged at 6000 xg for 20 min at 
15˚C. After 20 min the media in the lower compartment of the concentrated 
centrifuge tubes were discarded and 15 ml of the filtered media was added to the 
top compartment of the centrifuge, and centrifuged at the same speed of 6000 
xg, however the time was increased by 5 min. This procedure was repeated until 
all the filtered media was passed through concentration tubes and centrifuged at 
6000 x g, while adding 5 min to each cycle. 
SEC column preparation was performed by adding 14 ml sepharose suspended 
in ethanol (Catalogue number 17101404, GE Health Sciences) to each 10 ml flow 
column (Catalogue number 7321010, Bio-Rad) and allowed to settle for 2 h. A 
polystyrene fret was inserted and placed into the columns at a level 2 mm above 
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the top of the sepharose layer. The columns were then rinsed twice with 10 ml 
0.03% Tween 20 in PBS to remove ethanol. 
 2.11.2 Size exclusion chromatography (SEC) for EV separation 
Following the centrifugation, the concentrated sample of EV (0.5 ml – 1 ml) was 
transferred to the SEC columns. Immediately after the concentrated EV was 
allowed to flow through the fret filter, 10 ml of 0.03% Tween 20 in PBS was added 
to the columns. Fractions of EV (0.5 ml) were collected drop wise in 2 ml labelled 
eppendorf tubes (fractions 1-11) and stored at -20˚C (Figure 2.6). 
 
Figure 2.6: EV isolation by size exclusion chromatography. Conditioned media was 
collected centrifuged at graded speeds (300 xg, 2000 xg, and 10000 xg respectively). 
Following centrifugation, media was filtered, transferred to Vivaspin protein concentrator 
spin columns and centrifuged at 6000 xg for 25 min, adding 5 min to each spin until all 
the sample has been processed. Concentrated media was collected from the top 
chamber of the concentrator spin columns and loaded on to flow columns filled with 
sepharose beads. EV were collected in 2 ml eppendorf tubes (0.5 ml) in fractions (1-11). 
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2.11.3 Quantification of protein content in EV fractions to 
determine highest EV content 
To identify the fraction of isolated EV with highest EV count, a BCA assay was 
carried out using the Pierce BCA Protein Assay Kit (catalogue number 23225, 
Thermo Fisher Scientific, UK). In accordance with the manufacturers’ instructions, 
10 μl of each fraction of EV for each sample or the diluted albumin standard (BSA) 
supplied (0, 0.0025, 0.25, 0.5, 0.75, 1, 1.5, 2 mg/ml of BSA) were pipetted into a 
96 well plate, and 200 μl of the BCA working solution (reagent B to reagent A 
1:50) was added to each well. All standards and samples were run in triplicate. 
The plate was covered and incubated for 30 min at 37 ̊C. Following incubation, 
the plate was cooled to RT, and the optical density of the standards and samples 
were evaluated at 562 nm using a spectrophotometer plate reader TECAN 
(Magellan V7.2 software, Infinite M200). Quantification of protein concentration 
was carried out using a standard curve in which the optical densities of the 
standards were plotted against standards’ concentration. 
2.11.4 EV quantification by nano particle tracking 
ZetaView (ZetaView® BASIC NTA – Nanoparticle Tracking Video Microscope 
PMX-120, Particle Matrix) was used to analyse the size and concentration of EV 
sub-populations. The ZetaView detects particles via light scattering and uses 
Brownian motion to quantify the size of the EV sample. The microscope was 
calibrated using a bead dilution in Milli-Q water (1:250,000). Video was acquired 
with a sensitivity of 85% and shutter value of 70 sec. Sample (1 ml diluted EV in 
PBS) was scanned at 11 positions (in triplicate), and particles were tracked using 
Brownian motion to obtain a mean value. Concentration as a mean percentage 
of the population was further calculated. 
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2.11.5 EV characterisation  
Following quantification, an Exoview R100 (Nanoview Biosciences) – which uses 
antibody affinity-based technology for EV characterisation was used. EV markers 
CD9, CD63, and CD81 were selected, and antibodies against the specific 
tetraspanin antigen were labelled with fluorophores to detect the presence of EV.  
Samples were diluted in ExoView Incubation Solution (EV-TC-INC). 35 ul of 
sample was incubated on ExoView Tetraspanin Chips (EV-TETRA-C) placed in 
a 24 well plate for 16h at room temperature. Chips were washed three times in 1 
ml of Incubation Solution for 3 mins on an orbital shaker. After washing chips 
were incubated with ExoView Tetraspanin Labelling Abs (EV-TC-AB-01) 
consisting of anti-CD81 Alexa-555, anti-CD63 Alexa-647 and anti-CD9 Alexa-488. 
All antibodies were diluted 1:600 in ExoView Blocking Solution (EV-TC-BSA-01). 
Chips were incubated in 250 ul of the antibody solution and 250 ul of Incubation 
Solution for 1 h at room temperature. All chips were then washed as before, once 
in Incubation Solution, three times in ExoView Wash Solution (EV-TC-WSH) and 
once in ExoView Rinse Solution (EV-TC-RNS) prior to drying. Samples were 
imaged on the ExoView R100 using the nScan 2.7 acquisition software. Data was 
analysed using ExoViewer 2.6.9 with the sizing thresholds set at 50 nm and 200 
nm. Mouse IgG served as the negative control. 
2.11.6 Investigation of RANKL expression in EV  
Following EV isolation, quantification and characterisation, an ELISA was carried 
out as previously mentioned (section 2.8) to determine bone resorptive protein 
RANKL expression in EV. 
2.11.7 Osteoclastogenesis assay to examine EV functionality 
Functionality of EV was examined by carrying out an osteoclastogenesis assay. 
This assay was conducted as previously described (section 2.9). However, 
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instead of exposing monocytes to conditioned media collected from serum 
starved cells, these cells were exposed to EV isolated from the conditioned media 
resuspended in serum free alpha MEM media. Pit forming and nucleation assays 
were also performed to further verify osteoclast generation. 
 
2.12 Osteoprotegerin, a RANKL antagonist and 
regulator of osteoclast differentiation and 
activation 
2.12.1 Optimisation of OPG  
Human recombinant OPG (Catalogue number SRP3132, Sigma Aldrich) was 
reconstituted in 5 mM Tris (pH 7.5) to a concentration of 1 mg/ml, and stored at -
80°C. Following OPG preparation an osteoclastogenesis assay was conducted 
as described in section (section 2.9), however prior to exposing the monocytes 
to the conditioned media collected from the serum starved cells (NOF, CAF and 
S-NOF), recombinant OPG was added to the media samples at graded 
concentrations (1 ng/ml, 10 ng/ml, 50 ng/ml, 100 ng/ml and 200 ng/ml) to evaluate 
the optimal dose needed for optimal blockade of osteoclast generation. 
Conditioned media from serum starved cells (NOF, CAF, S-NOF) was the positive 
control, while monocytes in alpha MEM media served as a negative control. 
After 7 days of repeated change of media with or without OPG, TRAP staining 
was performed as previously described (section 2.9.1-2.9.3). The number of 
positive cells were counted and compared to the equivalent positive control. The 
dose of OPG showing the highest reduction in monocyte differentiation to 
osteoclasts was utilised. Optimal human recombinant OPG dose was determined 
to be 100 ng/ml. 
Chapter 2 Material and Methods  
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 83 
 
2.12.2 Investigating the role of OPG in antagonising RANKL 
expression  
To confirm the significance of RANKL in OSCC bone invasion, OPG, RANKL 
decoy receptor and antagonist was studied. An osteoclastogenesis assay was 
conducted (section 2.9), monocytes were exposed to EV or conditioned media 
collected from serum starved NOF, experimentally induced CAF (NOF treated 
with 5 ng/ml recombinant human TGFβ1), CAF (isolated from human OSCC 
tissue), and senescent fibroblasts (exposed to 500 μM H2O2). Samples were 
treated with OPG (100 ng/ml) prior to exposure to monocytes. Monocytes 
exposed to CAF conditioned, and monocytes in alpha MEM media supplemented 
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Figure 2.7: The effect of OPG on osteoclastogenesis. Corning osteo surface 24 well 
plate seeded with 20,000 RAW 264.7 monocyte/macrophage cells (passage 5). Cells 
were subjected to a daily alpha MEM conditioned media change for 7 days. Samples 
included 1. Conditioned media from serum starved NOF (NOF803). 2. Conditioned 
media from serum starved NOF (NOF803) treated with TGFβ1. 3. Conditioned media 
from serum starved CAF (CAF003). 4. Conditioned media from serum starved senescent 
fibroblasts (NOF803 exposed to H2O2). 5. EV isolated from conditioned media from 
serum starved NOF (NOF803).6. EV isolated from conditioned media from serum 
starved NOF (NOF803) treated with TGFβ1. 7. EV isolated from conditioned media from 
serum starved CAF (CAF003). 8. EV isolated from conditioned media from serum 
starved senescent fibroblasts (NOF803 exposed to H2O2). Negative control, monocytes 
in serum free alpha MEM media. Two wells were designated for TRAP staining, and the 
third well was left to dry after day 7 to observe pit formation. The experiment was 
performed in triplicate. 
 
Following 7 days of media change, TRAP staining, pit formation, and cell 
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2.13 Statistical analyses 
Data was reported as mean ± standard deviation (mean ± STDV). ANOVA and 
Student’s t-test was utilised to verify the statistical significance of findings as 
indicated in individual figure legends. A p-value of less than 0.05 was considered 
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3.1 Introduction  
The tumour microenvironment, also termed the tumour stroma, is composed of 
diverse non-malignant cells such as inflammatory cells, mesenchymal stem cells, 
pericytes, bone marrow derived cells, haematopoietic and vascular endothelial 
cells, nerves and lipocytes, and fibroblasts, integrated in a complex extracellular 
matrix (Joyce and Pollard, 2009). The cross talk between neoplastic cells and 
surrounding stroma is constantly maintained, enabling tumour cell stimulation of 
the microenvironment, which as a result actively transmits paracrine signals 
increasing tumour cell proliferation and invasion. Historically bone invasive 
OSCC was thought to be related to tumour size as a result of direct pressure 
related resorption. However, due to the close proximity of these tumours to bone, 
there is increasing evidence that the surrounding tumour stroma including bone 
cells play a key role in tumour progression. In current literature, the TME has 
become a major focus of cancer and in particular OSCC research. ɑSMA, a 
myofibroblastic marker has been frequently reported to be expressed by CAF in 
the tumour stroma in several solid tumours (Radisky et a., 2007; Xing et al., 2010; 
Shiga et al., 2015). The myofibroblastic differentiation of CAF from resting 
fibroblasts, circulating fibrocytes, pericytes, and mesenchymal cells has been 
described to be mainly triggered by TGFβ1 signalling (Bierie and Moses, 2006; 
Xu et al., 2009). CAF have also been reported to be involved in regional lymph 
node metastasis, local recurrence and poor patient outcome in OSCC 
(Kellermann et al., 2007; Vered et al., 2010; Lin et al., 2017). In addition, in vitro 
experiments have shown that CAF can significantly prompt tumour cell 
proliferation and dissemination (Kellermann et al., 2008; Daly et al., 2008), 
however, little is known of the role of CAF in bone invasion in OSCC.  
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Several reports have suggested that CAF may be a potential target in treating 
cancer, due to their genetic stability, and phenotypic similarities of stromal 
fibroblasts across various cancers (Kalluri et al., 2006; Santos et al. 2009; Shiga 
et al., 2015; LeBleu and Kalluri, 2018), suggesting that depletion of CAF could be 
a potentially effective therapeutic approach. This chapter investigates the 
expression and role of myofibroblastic CAF in OSCC progression and bone 
invasion. 
3.1.1 Aim 
To investigate the expression and role of myofibroblastic CAF in bone invasion 
and remodelling in OSCC. 
3.1.2 Experimental approach 
1. OSCC cases with bone involvement (from 1994 to 2017) were retrieved 
from the unit archive and reports reviewed for clinicopathological 
parameters. 
2. IHC was performed on a smaller cohort to investigate αSMA, RANKL and 
OPG expression in incisional OSCC biopsies of cases undergoing bone 
resection at a later date to compare expression of myofibroblastic marker 
αSMA and bone turnover markers RANKL and OPG. 
3. Double IHC on tissue from OSCC bone resection specimens were 
conducted to investigate the co-expression of αSMA and RANKL in CAF. 
4. Human primary osteoblasts (HOB) were indirectly co cultured with 
conditioned media from OSCC cells and CAF, and changes in RANKL and 
OPG mRNA was assessed using qPCR. 
5. Primary normal fibroblasts (NOF) were exposed to TGFβ1 to induce a 
myofibroblastic phenotype and αSMA expression determined through 
Chapter 3 The role of myofibroblastic CAF in the tumour microenvironment of bone invasive 
OSCC 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 89 
immunofluorescence and further quantified on a transcript level by qPCR. 
6. Soluble RANKL protein secretion was also examined in both NOF and 
CAF using an ELISA. 
7. An osteoclastogenesis assay was performed by culturing murine 
monocytes (RAW 264.7) with OSCC, NOF, NOF exposed to TGFβ1 and 
CAF conditioned media. TRAP staining, pit formation and nucleation 
assays will be conducted to confirm osteoclastic differentiation. 
 
3.2 Clinicopathological data 
To study the clinical parameters involved in bone invasive OSCC, reports of 407 
diagnosed OSCC cases (1994 to 2017) with maxillary or mandibular bone 
resections were reviewed using the pathology database of the unit of Oral and 
Maxillofacial Pathology, University of Sheffield  and different clinicopathological 
parameters such as  gender, age, site, tumour grade, bone invasion, and 
metastasis were analysed. 
 
3.2.1 Gender and Site 
The bone resection cases included a broad age range (38 to 91 years), with an 
average age of 67 years, the average age in males and females was 64.8 and 
72.6 years with an age range of 38 to 91, and 48 to 87 years respectively.  Sixty-
three per cent (n=260) of the cases were from male patients while 36.11% 
(n=147) were from females, with a male to female ratio (1.76:1) (Figure 3.1).	
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Figure 3.1: Gender distribution in 407 bone invasive OSCC cases, 63.88% (n=260) 
were male, while 36.11% (n=147) were female patients. 
 
The majority of the cohort (71.49%, n=291) involved mandible resections 
whereas 28.5% (n=116) were maxillary bone resections (Figure 3.2). 
 
Figure 3.2: Site distribution of 407 bone invasive OSCC cases. 71.49% (n=291) 
were mandibular, while 28.50% (n=116) were maxillary resections. 
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3.2.2 OSCC histological grade 
A predominance of moderately differentiated tumours were observed in the 
cohort (54.79%, n=223), while 27.27% (n=111), and 17.93% (n=73) were well 
and poorly differentiated SCCs (Figure 3.3). 
 
Figure 3.3: Grade of primary OSCC tumour. Out of the 407 OSCC cases with bone 
resection reviewed, the majority of tumours were moderately differentiated (54.79%, 
n=223). 27.27% (n=111) of tumours were well differentiated and 17.93% (n=73) poorly 
differentiated SCCs. 
 
3.2.3 Bone involvement 
The involvement and extent of OSCC bone invasion was also examined. OSCC 
bone involvement was defined in accordance to pathology report to superficial 
cortical bone resorption and cancellous bone involvement, the latter categorised 
as true bone invasion (Frederick et al., 2002). Approximately half of the cohort 
(50.98%, n=207) exhibited some degree of bone involvement. 22.24% (n=90) of 
the cases presented with superficial cortical bone resorption (not true bone 
invasion), while 28.74% (n=117) displayed frank cancellous bone invasion 
(Figure 3.4 and 3.5). 
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Figure 3.4: Representative photomicrograph showing bone involvement 
distribution in OSCC cases with bone resection. (A) Superficial cortical resorption. 
(B) Cancellous bone invasion. (magnification x20) 
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Figure 3.5: Bone involvement distribution in 407 OSCC cases with bone resection. 
28.74% (n=117) showed true cancellous bone invasion, while 22.24% (n=90) superficial 
cortical bone resorption, and 49.02% (n=200) showed no evidence of tumour in close 
proximity of bone. 
 
3.2.4 Metastasis 
The OSCC cohort was further investigated for the presence or absence of 
metastasis using the archived pathology reports. Metastasis was evident in 
36.6% (n=149) (Figure 3.6). 30.7% (n=36/117) of SCCs with cancellous bone 
invasion, and 8.8% (n=8/90) with superficial cortical resorption showed regional 
metastasis.  
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Figure 3.6: Distribution of metastasis in 407 OSCC samples with bone resection. 
63.39% (n=258) had no metastasis, while 36.60% (n=149) showed neck lymph node 
metastases. 
 
3.3 Evaluation of stromal marker αSMA and bone 
turnover markers RANKL and OPG expression in 
OSCC tissue away from bone  
Ten incisional biopsies of patients with OSSC (5 cases cortical/superficial, and 5 
cases cancellous bone involvement) matched with bone resections previously 
examined (Elmusrati et al., 2017, data from masters thesis) were selected 
for  analysis, to investigate the expression of αSMA, RANKL and  OPG in 
OSCC CAF, and to correlate whether the intensity of expression of these markers 
could be used to predict bone invasion. IHC was conducted to examine the 
abundance of the CAF marker αSMA, as well as the expression of bone turnover 
markers RANKL and OPG in tumour and surrounding stroma. Following staining, 
the samples were scanned, and staining intensity was evaluated using 
HistoQuest software.	
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3.3.1 Expression of αSMA in tumour microenvironment away 
from bone 
In our previous data (Elmusrati et al., 2017) in over 90% of our cohort (n=10, 5 
deep bone invasion, 5 superficial bone resorption), αSMA positive fibrous stroma 
was seen invading bone ahead of the invasive front of the tumour. In an attempt 
to investigate whether tumour stroma away from bone expressed αSMA, and to 
assess whether αSMA abundance can be used to predict bone invasion on 
resections, incisional biopsies from cases with OSCC bone invasion were 
assessed. Although the expression of αSMA was evident, it was weakly detected 
in fibroblasts in 60% of cases, surrounding the main tumour mass, and in smooth 
muscle cells of blood vessels (Figure 3.7). The average expression of αSMA 
positive cells in incisional biopsy cases that later demonstrated superficial cortical 
resorption was 30.71 ± 10.56 (mean ± STDV), while the average αSMA 
expression intensity was 37.47 ± 3.19. In cases with cancellous bone 
involvement, the average expression of αSMA positive cells in incisional biopsies 
was 42.82 ± 5.04, while the average expression intensity was 41.57 ± 1.58, The 
highest expression of  αSMA positive cells was 48.82% detected in the TME of 
OSCC cancellous bone invasion, however there was no significant difference in 
αSMA expression (p=0.67) in incisional biopsy of superficial cortical bone 
resorption or cancellous bone invasive OSCC (Figure 3.8).	
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A  
B  
Figure 3.7: Representative photomicrographs showing IHC localisation of αSMA 
in incisional biopsies away from bone. (A) Strong αSMA (antibody dilution 1:100) 
expression in myofibroblastic stroma at the invasive tumour front. (B) Negative control 
(magnification x 20). 
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Figure 3.8: Quantification of αSMA expression in OSCC biopsy sections away from 
bone interface in selected cohort (n=10, 5 superficial cortical resorption and 5 
cancellous bone involvement). The average expression of αSMA positive cells in cases 
that presented with superficial cortical bone resorption was 30.71 ± 10.56 (mean ± 
STDV), while the average αSMA expression intensity was 37.47 ± 3.19. In cases with 
cancellous bone involvement the average expression of αSMA positive cells was 42.82 
± 5.04, while the average expression intensity was 41.57 ± 1.58. Error bar = STDV. 
 
3.3.2 RANKL and OPG expression  
Bone turnover markers RANKL and OPG were also evaluated in biopsies of 
tumour away from the bone interface. Our previous results showed readily 
detectable expression in tumour cells and fibroblasts adjacent to bone (Elmusrati 
et al., 2017). In the incisional biopsies, RANKL expression varied, as in cases 
with cancellous bone invasion the expression of RANKL positive cells 43.42 ± 
21.60 (mean ± STDV), and RANKL expression intensity (15.98 ± 4.07) was 
evident in tumour and stroma. This expression was weaker in comparison to 
cases with superficial cortical resorption 54.76 ± 12.30, 17.95 ± 1.17 respectively 
(p=1.01) (Figure 3.9). Moreover, OPG was also weakly detected or absent in 75% 
(n=8) of the samples (Figure 3.10). In cases with cancellous bone invasion the 





















Chapter 3 The role of myofibroblastic CAF in the tumour microenvironment of bone invasive 
OSCC 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 98 
compared to cases with superficial cortical resorption (42.33 ± 5.3), however, 
these differences were not significant (p=0.98) (Figure 3.11 to 3.14).	
A  
B  
Figure 3.9: Representative photomicrographs showing IHC localisation of RANKL 
in incisional biopsies away from bone. (A) RANKL staining evident in OSCC and 
surrounding fibrous stroma. (B) Negative control (magnification x 20). 
Figure 3.9: Representative photomicrographs showing IHC localisation of RANKL 
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Figure 3.10: Representative photomicrographs showing IHC localisation of OPG 
in incisional biopsies away from bone. (A) Weak OPG staining in tumour and stroma. 
(B) Negative control (magnification x 20). 
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Figure 3.11: Expression of RANKL and OPG in biopsies of tumour (away from bone 
interface) with superficial cortical bone resorption (n=5). The average expression of 
RANKL positive cells in biopsies of tumours with superficial cortical resorption was 58.76 
± 12.30 (mean ± STDV), while the average RANKL expression intensity was 17.95 ± 
1.17. Average expression of OPG positive tumour cells was 42.33 ± 5.38, while the 
average expression intensity was 14.74 ± 1.97. Error bar = STDV. 
 
Figure 3.12: Expression of RANKL and OPG in tumour biopsies (away from bone 
interface) with cancellous bone involvement (n=5). The average expression of 
RANKL positive tumour cells in biopsies of tumours with definite cancellous bone 
involvement was 37.42 ± 21.60 (mean ± STDV) while the average RANKL expression 
intensity was 15.98 ± 4.07. Average expression of OPG positive tumour cells was 58.67 
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Figure 3.13: Expression of RANKL and OPG in stroma of OSCC (biopsies-away 
from bone interface) with superficial cortical bone resorption(n=5). The average 
expression of RANKL positive stromal cells in biopsies of cases with superficial cortical 
bone resorption was 26.70 ± 16.27 (mean ± STDV), while the average RANKL 
expression intensity was 12.23 ± 3.62. Average expression of OPG positive cells was 
42.91 ± 3.68, while the average OPG expression intensity was 11.35 ± 3.68. Error bar = 
STDV.	
 
Figure 3.14: Expression of RANKL and OPG in stroma of OSCC biopsies (away 
from bone interface) with cancellous bone invasion (n=5). The average expression 
of RANKL positive stromal cells in initial biopsies of cases with cancellous bone 
involvement was 32.85 ± 12.77 (mean ± STDV), while the average RANKL expression 
intensity was 13.00 ± 4.08. Average expression of OPG positive stromal cells was 39.77 
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3.4 Double αSMA and RANKL expression in OSCC 
microenvironment 
We have previously shown that OSCC stroma expresses the myofibroblastic 
marker (aSMA) and bone turnover marker RANKL in bone resections (Elmusrati 
et al., 2017). To further confirm the co-localisation of both markers in fibroblastic 
tumour stroma, a double immunohistochemical analysis of αSMA and RANKL 
was performed. Matching cases (n=10, 5 cortical/superficial bone resorption, and 
5 cancellous bone invasion) of OSCC with bone were selected and investigated. 
Our data shows that OSCC cells express RANKL, and co-localisation of αSMA 
and RANKL was expressed in fibroblastic stroma surrounding OSCC cells, 
confirming that αSMA positive CAF express RANKL (Figure 3.15). 
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Figure 3.15: Representative photomicrographs showing IHC co-localisation of 
αSMA and RANKL.  αSMA (antibody dilution 1:100) expression (green stain) in 
myofibroblastic stroma. RANKL expression (red) in tumour as well as SMA positive cells 
in OSCC stroma. Co-localization of αSMA and RANKL was evident in fibrous tumour 
stroma (blue). (A) Magnification x 10. (B) Higher magnification (x 20). 
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3.5 Experimentally induced CAF and primary CAF 
isolated from OSCC express stromal marker 
αSMA  
We have previously shown abundant expression of αSMA in stroma ahead of 
OSCC invasive front in tissue from bone resections (Elmusrati et a., 2017). To 
begin to explore the mechanisms underlying this observation, αSMA expression 
was examined in an in vitro model of CAF formation from normal fibroblasts and 
in OSCC-derived CAF. 	
To generate an in vitro model of CAF development, primary oral fibroblasts 
(NOF003, NOF804, and NOF822) were seeded on coverslips, serum starved (24 
h), and treated with recombinant TGFβ1 (5 ng/ml), as previously described 
(Elmusrati et al., 2017; Mellone et al., 2017; Melling et al.,  2018). After 24 h, 
fibroblasts were fixed, and αSMA expression and localisation examined by 
immunocytochemistry. Primary CAF isolated from fresh human OSCC tissue 
were also examined for αSMA. Primary normal oral fibroblasts, in serum free 
media, served as the negative control (Figure 3.16).	
The myofibroblastic marker αSMA was readily detected in NOF following TGFβ1 
exposure. Staining was observed as discrete fibres spanning the cell cytoplasm 
(Figure 3.16). αSMA staining was also evident, in a similar pattern to TGFβ1-
treated NOF in CAF isolated from OSSC tissue and its localisation is in keeping 
with previous reports showing αSMA association with contractile stress fibres in 
myofibroblasts (Serini and Gabbiani, 1999; Lewis et al., 2004; Hinsley et al., 
2012). However, minimal αSMA expression was seen in NOF not exposed to 
TGFβ1 (Figure 3.16). 
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Figure 3.16: Representative photomicrographs showing cytoplasmic αSMA 
expression in fibroblasts using immunofluorescence (A) Negative control, oral fibroblasts 
in serum free media. (B) Normal human oral fibroblasts following TGF-β1 (5 ng/ml) 
treatment (24 h) in serum free media. (C) CAF isolated from human OSCC tissue. 
Myofibroblastic differentiation is evident by αSMA staining in contractile stress fibres 
(magnification x40). 
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To assess αSMA mRNA expression, RNA extracted from NOF exposed to 
TGFβ1, CAF isolated from human OSCC tissue, and untreated NOF (negative 
control) were subjected to qPCR analysis. αSMA transcript expression was 
significantly higher in CAF, and in NOF following TGFβ1 treatment (by 44.21 ± 
2.91, and 39.13 ± 1.60 (mean fold change ± STDV) respectively) while the 




Figure 3.17: Relative expression of αSMA mRNA in normal oral fibroblasts 
following TGFβ1 treatment and CAF isolated from OSCC. NOF (250,000 cells/ well) 
were seeded in 6 well plates, serum starved (24 h), then treated with TGFβ1 (5 ng/ml) 
for 24 h. CAF isolated from human OSCC tissue (250,000 cells/ well) were seeded in 6 
well plates, serum starved (24 h). A significant increase in αSMA mRNA was expressed 
with an average of 39.13 ± 1.60 (mean fold change ± STDV) following TGFβ1 exposure. 
αSMA expression in CAF was 44.21 ± 2.91. NOF in serum free media served as the 
negative control. Error bars= STDV. ** p≤0.01 and **p≤0.001, following a Student’s t-test. 
The graph represents combined results of multiple assays. Experiment performed three 
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3.6 OSCC derived CAF express soluble RANKL 
protein 
We have previously shown that myofibroblasts and NOF exposed to TGFβ1 show 
significantly higher RANKL expression on a transcript and protein level (Elmusrati 
et al., 2017). To further investigate whether OSCC-derived CAF express soluble 
RANKL protein, CAF and NOF were serum starved (24 h), conditioned media 
was collected and RANKL detected by ELISA. RANKL protein expression (mean 
rg/ml ± STDV) was significantly up regulated in conditioned media collected from 
CAF and myofibroblasts (NOF exposed to TGFb1)  (430.90 ± 13.6, p=0.004 and 
323.33 ± 34.9, p=0.0008 respectively) when compared to NOF (161.04 ± 9.9) 
(Figure 3.18). 
 
Figure 3.18: Soluble RANKL protein expression in CAF and NOF. CAF isolated from 
human tissue express significantly higher RANKL than NOF. 250,000 cell/ well of NOF 
(803, 804, and 822), and (CAF 002, 003, and 004) were seeded into 6 well plates, 
allowed to settle overnight, and serum starved (24 h). Conditioned media was collected 
and subjected to an ELISA. Error bar=STDV. The experiment was performed three times 
in triplicate. The increased concentration of RANKL was significantly expressed (mean 
rg/ml ± STDV) in CAF (430.90 ± 13.6), myofibroblasts (323.33 ± 34.9) when compared 
to NOF (161.04 ± 9.9). The graph represents combined results of multiple assays. Error 
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3.7 Expression of RANKL and OPG mRNA in 
primary human osteoblasts 
Bone remodelling is regulated by RANKL, its receptor RANK found on osteoclast 
precursors and the antagonist receptor OPG expressed by osteoblast. RANKL is 
the main marker of osteoclast activation, and only in the presence of RANKL in 
the tumour and surrounding microenvironment will bone destruction commence. 
We have previously demonstrated (Elmusrati et al., 2017) that human primary 
osteoblasts show significantly amplified RANKL and reduced OPG mRNA when 
exposed to conditioned media isolated from CAF compared to NOF.  	
3.7.1 CAF increase RANKL and reduce OPG expression in 
human primary osteoblasts on a transcript level 
To evaluate the influence of human OSCC cells and CAF on RANKL and OPG 
expression in human primary osteoblasts, OSCC cell line H357 and primary CAF 
were serum starved for 24 h, followed by conditioned media treatment (24 h) of 
serum-starved primary osteoblasts (HOB) for 24 h. RANKL and OPG expression 
was quantified using a TaqMan real time qPCR assay.  Media collected from 
primary osteoblasts in serum free DMEM, served as the negative control (Figure 
3.19).	
As exhibited in Figure 3.19, exposure of HOB to OSCC and CAF-derived 
conditioned media significantly amplified RANKL mRNA expression in primary 
osteoblasts. Conversely, OPG expression was significantly reduced in 
comparison with control. The greatest increase in RANKL (4.35 ± 1.02) (mean 
fold change ± STDV) (p< 0.009) and decrease in OPG expression (-0.21 ± 0.13) 
(p<0.004) in HOB was seen following exposure to primary CAF (conditioned 
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media. H357 conditioned media also increased RANKL expression (3.18 ± 0.77, 
p< 0.008), and reduced OPG expression (-0.37 ± 0.39, p< 0.006) in HOB 
 
Figure 3.19: Relative expression of RANKL and OPG mRNA in HOB when cultured 
with CAF, and OSCC conditioned media. HOB (5 X 105) were indirectly co-cultured with 
conditioned media collected from serum starved (24 h) CAF (CAF 002, CAF 003 and 
CAF 004) and H357 cells. A significant increase in RANKL mRNA expression was seen 
when HOB were indirectly co-cultured with conditioned media from CAF (4.35 ± 1.02) 
(mean ± STDV) compared to control (HOB in serum free media). A significant increase 
was also seen following exposure of HOB to H357 conditioned media (3.18 ± 0.77) OPG 
mRNA expression was significantly reduced in CAF (-0.21 ± 0.13), and H357 conditioned 
media (-0.37 ± 0.39). Values= mean ± SD. Error bar = STDV. The graph represents 
combined results of multiple assays. The experiments were performed thrice in 
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3.8 OSCC cells, experimentally induced CAF, and 
CAF isolated from human OSCC tissue induce 
osteoclastogenesis 
Osteoclasts develop from the fusion of monocytic haematopoietic cells. For the 
differentiation of haematopoietic cells to osteoclasts the cytokines RANKL and 
M-CSF1 are essential. M-CSF1 promotes osteoclastogenesis by stimulating the 
proliferation of osteoclast precursors, while RANKL is vital for promoting 
differentiation of osteoclast precursors to functional osteoclasts (Teitelbaum 
2000). In the presence of macrophage survival and proliferation cytokine M-
CSF1, monocytes fuse to form a pre-osteoclast and in the presence of RANKL 
results the quiescent pre-osteoclast becoming an active osteoclast that exhibits 
TRAP activity and the ability to form pits in bone substrates. In this study, 
osteoclasts were generated from the murine macrophage cell line RAW 264.7. 
The advantage of using RAW 264.7 cell is that they express both M-CSF1 and 
its receptor c-fms, and no treatment with M-CSF1 is required (Marino et al., 2014)	
After demonstrating that myofibroblastic CAF express RANKL ex vivo and in vitro, 
an experiment was conducted to investigate whether this expression was 
sufficient to initiate osteoclastogenesis. 	
Monocytes were seeded in Corning Osseo plates, which contain a synthetic bone 
substrate, serum starved, then treated with conditioned media collected from 
serum starved H357 cells, NOF, experimentally induced CAF (NOF treated with 
TGFβ1 (5 ng/ml), and primary CAF isolated from OSCC tissue, in separate wells. 
Media was changed daily. After 7 days, TRAP staining, pit formation assay, and 
nucleation, was studied (Figure 3.20).	
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As previously reported (Elmusrati et al., 2017), H357 cells induced 
osteoclastogenesis (mean number of TRAP positive cells/well ± STDV) (22.61 ± 
2.30), CAF showed a significantly higher increase on osteoclast generation 
(51.16 ± 4.5)  compared to NOF exposed to TGFβ1 (21 ± 1.35).These results 
were also reflected in pit forming assays (mean number of pits/ 3 high power 
fields ± STDV)  (13 ± 3), (24 ± 3), and (14 ± 2) (Table 3.1). Multi-nucleation was 
also indicative of osteoclastogenesis (Figure 3.21). 
Table 3.1: Osteoclastogenesis assay: quantification of TRAP positive cells and 
pits formed. 
Sample Total no. of TRAP 
positive cells  
(mean ± STDV, p value) 
No. of pits per 3 high 
power fields  
(mean ± STDV, p value) 
Negative control 0.0 ± 0.0 0.0 ± 0.0 
NOF  0.0 ± 0.0 0.0 ± 0.0 
NOF + TGFβ1 21 ± 1.35, p=0.0008 14 ± 3, p=0.00006 
Primary CAF 51.16 ± 4.5, p=0.0001 24 ± 3, p=0.00003 
H357 22.61 ± 2.30, p=0.00003 13 ± 2, p=0.00002 
RANKL 33.05 ± 1.8, p=0.00007 18.2 ± 4.0, p=0.00004 
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Figure 3.20: Osteoclastogenesis assay. Monocytes (RAW 264.7) were seeded in 
Osteo Assay surface 24 well plates at a density of 20,000 per well. (A) Negative control; 
cells were grown in serum free alpha MEM media. TRAP staining was negative, pit 
formation was not evident, and DAPI staining showed no multinucleated cells (B) NOF; 
cells were treated with conditioned media collected from serum starved NOF cells in 
alpha MEM media. TRAP staining was negative, pit formation was not evident, and DAPI 
staining showed no multinucleated cells. (C) Experimentally induced CAF; cells were 
treated with conditioned media collected from serum starved NOF treated with TGFβ1 
(5 ng/ml) in serum free alpha MEM media. TRAP staining was observed positively 
staining osteoclasts, pit formation was evident, and DAPI staining showed 
multinucleated cells. (D) CAF isolated from human tissue; cells were treated with 
conditioned media collected from serum starved CAF cells in alpha MEM media. TRAP 
staining was observed positively staining osteoclasts, pit formation was evident, and 
DAPI staining showed multinucleated cells. (E) H357; Cells were treated with conditioned 
media collected from serum starved H357 cells in alpha MEM media. TRAP staining was 
observed positively staining osteoclasts, pit formation was evident, and DAPI staining 
showed multinucleated cells. (F) Positive control; Cells were treated with rRANKL (50 
ng/ml) in serum free alpha MEM media. TRAP staining was observed positively staining 
osteoclasts, pit formation was evident, and DAPI nucleation showed multi-nucleated 
cells. Media was changed daily for 7 days. The experiment was performed three times 
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A  
B  
Figure 3.21: Osteoclast and pit formation quantification. The number of TRAP 
positive cells was counted, and the average number of osteoclasts generated were 
plotted. The number of pits formed due to osteoclasts in three high power fields were 
counted, and the average number of pits was plotted. The highest number of osteoclast 
(mean ± STDV) (51.16 ± 4.5) and resorption pits (24 ± 3), was noticed when conditioned 
media from CAF were exposed to monocytes. H357 cells induced osteoclastogenesis 
(22.61 ± 2.30), as well as NOF exposed to TGFβ1 (21 ± 1.35). These results were also 
reflected in pit forming assays (mean pits ± STDV) (14 ± 3), and (13 ± 2). Error bar = 
STDV. Graphs represent combined results of multiple assays. *p<0.05 was considered 
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3.9 Discussion  
In this chapter, the mechanism of OSCC bone invasion was investigated, with 
particular focus on whether stromal fibroblasts cross talk with proximal bone. 
OSCC is heterogeneous in nature and has a tendency to invade regional 
anatomical structures. Due to proximity of maxillofacial bones to oral mucosa, 
OSCC has a high tendency to invade these structures (Nomara et al., 2005).	
Marsh et al. (2011) highlighted that the presence of a myofibroblastic αSMA 
positive stroma in OSCC is a more sensitive predictor of disease progression and 
prognosis than other long standing and well-known parameters such as TNM 
stage (including tumour size, regional and distant metastasis), perineural or 
lymphovascular invasion and depth/pattern of invasion. Despite these recent 
findings showing the importance of stroma in OSCC, its role in bone invasive 
OSCC remains largely unexplored. We have previously reported that over 90% 
of bone invasive OSCC cases do not demonstrate direct contact between tumour 
cells and bone, and that αSMA positive myofibroblastic CAF are seen intervening, 
and infiltrating bone ahead of the tumour invasive front (Elmusrati et al., 
2017).  The expression of bone turnover markers (RANKL and OPG) in bone 
invasive OSCC and associated stroma was further investigated. Interestingly, 
these markers were highly expressed in both tumour and stroma in close 
proximity to bone suggesting a potential role of CAF in OSCC bone invasion and 
bone turnover.	
In the current study, we aimed to determine whether there is a difference in αSMA 
expression, indicative of the presence of CAF, in OSCC stroma, and 
RANKL/OPG expression adjacent to and away from bone and whether initial 
diagnostic biopsies from these cases can be used to predict bone invasion. In the 
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cohort, αSMA expression was consistently evident in all OSCC cases, in 
agreement with other studies showing high prevalence of αSMA-positive CAF 
(Kellermann et al., 2007; Rao et al., 2014; Bussard et al., 2016). RANKL was 
expressed was evident in tumour cells and surrounding stroma whereas OPG 
staining was either weak or absent. There was no significant difference in αSMA, 
RANKL or OPG expression between incisional diagnostic biopsies taken from 
tumours with cortical resorption or cancellous bone invasion. However, this may 
be due to the small cohort size. Expanding the sample size to include variations 
in histological pattern, tumour site (maxilla / mandible), size, and overall OSCC 
stage, and to examine whether the intensity of expression or the location of 
expression whether adjacent or away from bone is of more importance, is worth 
exploring further. 
Double IHC for bone destruction marker RANKL and myofibroblastic marker 
αSMA was further conducted on OSCC bone resections, to investigate whether 
αSMA-positive CAF express RANKL. RANKL staining was seen in fibrous stroma 
as well as in tumour cells in vicinity of bone. RANKL expression in OSCC stroma 
(Ishikuro et al., 2018) and OSCC cells (Tada et al., 2005; Kayamori et al., 2010) 
have been reported. These findings suggest that RANKL expression in tumour 
cells is related to proximity of invasive front, and the possibility that CAF adjacent 
to OSCC cells may be facilitating this expression.	
Osteoblast regulation of osteoclastogenesis by RANKL expression is a key 
modulator of bone remodelling (Simonet et al., 1997). In the current study, OSCC 
cells were shown to upregulate RANKL and down regulate OPG in HOB 
(Elmusrati et al., 2017), and these results are in agreement with previous reports 
(Ishikuro et al., 2008). However, following identification of αSMA positive CAF 
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express of bone turnover markers OPG and RANKL in OSCC stroma in bone 
resection tissue samples, the influence of CAF on mRNA expression of bone 
turnover markers RANKL and OPG in primary human osteoblasts after indirect 
co-culture was further investigated. CAF-derived factors induced significant 
RANKL amplification and OPG downregulation in primary human osteoblasts. 
These findings show for the first time that primary CAF isolated from human 
OSCC, and experimentally induced myofibroblasts influence similar responses to 
osteoblasts, playing a functional role, promoting a more aggressive TME 
susceptible to bone invasion (Elmusrati et al., 2017).	
Bone destruction and OSCC invasion requires complex interactions with diverse 
cell types, including osteoclasts, multinucleated bone resorbing cell, originating 
from monocyte/macrophage lineage haematopoietic precursors. It has been 
previously reported that the murine macrophage cell line RAW 264.7, upon 
exposure to RANKL, readily triggers osteoclastogenesis (Vincent et al., 
2009).  After demonstrating that CAF express RANKL in vitro and ex vivo, a 
functional assay was conducted to evaluate whether this expression was 
sufficient to induce osteoclastogenesis in the absence of OSCC cell or osteoblast 
derived RANKL. In the current study, highest osteoclast generation was noted 
when RAW 264.7 cells were exposed to CAF-derived conditioned media, further 
highlighting a possible role CAF play in OSCC bone invasion. These results were 
also reflected in the pit forming assay	
In conclusion, this data provides novel evidence that myofibroblastic CAF play a 
role in bone invasion in OSCC through a RANKL-dependent pathway. The 
mechanistic evidence presented here provides support to the ex vivo 
observations that myofibroblastic CAF may play a role in bone invasion of OSCC, 
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4.1 Introduction 
Cellular senescence is a consequence of an accumulation in DNA damage 
whether due to replicative stress caused my telomeres shortening, or 
independent of telomeres length induced by exposure to elevated levels of 
oxidative or genotoxic stress. In spite of these cells being vital and metabolically 
functional, they are non-dividing cells that fail to proliferate following considerable 
cell division. The irreversible state of growth arrest (at G1 phase) is termed 
senescence, characterised by distinctive chromatin and secretome alterations, 
and distinctive to myofibroblasts, as senescent fibroblasts express up-regulated 
levels of tumour suppressor gene p16INK4a and p21 (Prime et al., 2016).	
Various stimulants are responsible for fibroblasts to undergo permanent DNA 
damage induced as a result of oxidative stress from mitochondrial malfunction, 
chemo and radiotherapy as well as exhaustive mitotic activity (Di Micco et al., 
2006). Senescence can be induced in vitro through treatment with hydrogen 
peroxide, anticancer therapeutics such as cisplatin, exposure to irradiation and 
replicative exhaustion (Rodier and Campisi, 2011; Kabir et al., 2016).	
In normal physiology, senescent cells and their SASP have recently been 
indicated to have beneficial roles in tissue remodeling and wound healing (Storer 
et al., 2013; Demaria et al., 2014). However, in carcinomas, irreversible damage 
in cell recovery, or over exhausted DNA, results in senescence, which acts as an 
effective tumour suppressor. Counter-intuitively, when senescent cells 
accumulate in cancer, they are considered as tumour promoters, through their 
enhancement of neoplastic proliferation, invasion, metastasis and therapeutic 
resistance (Prime et al., 2016). Senescent fibroblasts express a vast range of 
pro-tumorigenic secretory proteins, which are jointly termed SASP (Kuilman and 
Chapter 4 Exploring the role of fibroblast senescence in bone invasion in OSCC  
 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 121 
Peeper, 2009; Pazolli et al., 2009). Senescence has been reported in CAF, 
having the ability to promote dysplastic and neoplastic cell proliferation and 
tumorigenesis in carcinomas (Krtolica et al., 2011; Cirri and Chiarugia, 2011; 
Kabir et al., 2016)  	
Recently, a number of senotherapeutics have emerged specifically targeting pro-
apoptotic pathways eliminating senescent cell burden, these agents are called 
senolytics or senomorphics, which suppress SASP expression. Several recent 
studies have used senolytics, not to target senescent cells but due to their pro 
apoptotic capabilities (Zhu et al., 2015; Mertens et al., 2017)  Senolytics, which 
target pro-survival pathways as p53/p21, Bcl-2/Bcl-XL, and PI3K/AKT or ROS-
protective anti-apoptotic pathways, HSP90, when blocked result in senescent cell 
apoptosis. However, the inhibition of senescent cell SASP secretome can be 
targeted by using IɣB Kinase or JAK inhibitors as metformin and rapamycin 
(Niedernhofer and Robbins, 2018). Prospective concerns about the side effects 
and long-term consequences of senolytics must be raised. However, due to the 
intermittent delivery of drug, as senescent cells take a considerable amount of 
time to re-accumulation following clearance these concerns are diminished. In 
contrast, this argument cannot be made for senomorphics, which are 
administered in continuous levels to maintain SASP suppression.	
CAF are heterogenous population of cells comprising different phenotypes 
(LeBleu and Kallurri, 2018; Liu et al., 2019). Previous findings in our lab have 
shown that a subgroup αSMA positive OSCC derived CAF show senescent 
characteristics (Mellone et al., 2017). In this study we sought to identify 
senescence in OSCC microenvironment, understand the possible contribution of 
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senescent CAF to bone invasion. This is of particular interest due to the number 
of emerging drugs targeting senescent cells. 	
4.1.1 Aims  
To examine the different subsets of CAF, in particular the impact of senescence 
in tumour microenvironment of bone invasive OSCC. 
4.1.2 Experimental approach 
1. IHC was performed to investigate the expression of senescence markers 
p16INK4a, and DPP4 (CD26) in OSCC bone resections. 
2. Double IHC in OSCC bone resections was conducted to investigate the 
co-expression of αSMA and p16INK4a. 
3. Senescence was induced in vitro, by exposing low passage NOF to 
oxidative stress H2O2 (S-NOFH2O2), chemotherapeutic drug cisplatin (S-
NOFCis), and replicative stress (S-NOFRep). SA-β-Gal assays was 
conducted to monitor senescence. 
4. Lipofuscin has been reported to accumulate in senescence cells. 
Histochemical stain SBB, known to react towards lipofuscin was utilised to 
confirm senescence induction in NOF. 
5. Expression of myofibroblastic marker αSMA was determined in vitro using 
immunofluorescence. 
6. CAF isolated from human OSCC tissue, and S-NOFH2O2, S-NOFCis, S-
NOFRep was assessed on a transcript level for senescence marker 
p16INK4a, SASP factor IL6, and bone turnover markers RANKL and OPG. 
7. Soluble RANKL protein was examined in CAF, NOF, S-NOFH2O2, S-NOFCis, 
and S-NOFRep using an ELISA. 
8.  An osteoclastogenesis assay was performed by culturing murine 
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monocytes (RAW 264.7) with OSCC, NOF, S-NOFH2O2, S-NOFCis, S-
NOFRep, and CAF conditioned media. TRAP staining, pit formation and 
nucleation assays was conducted to confirm osteoclastic differentiation. 
9. Senescent fibroblasts were targeted by using senotherapeutics, and the 
impact of senolytics drugs (Alvespimycin (17-DMAG) and Navitoclax 
(ABT263)) on osteoclast generation was also studied.  
 
4.2 Evaluation of senescence marker p16INK4a 
and DPP4 expression in ex vivo OSCC bone 
resections at tumour bone interface  
Ten bone resection samples of patients with bone invasive OSSC (5 cases 
cortical/superficial bone resorption, and 5 cases cancellous bone involvement) 
were selected from the Unit archive and analysed using IHC to examine 
expression of senescence markers p16INK4a, and the recently described DPP4 
(CD26). Following staining, the samples were scanned, and staining intensity 
was evaluated using HistoQuest software. 
4.2.1 Expression of tumour suppressor gene p16INK4a in tumour 
microenvironment proximal to bone 
We have previously reported that αSMA expressing cells are seen invading bone 
ahead of OSCC islands in over 90% of cases (Elmusrati et al., 2017). Given the 
recent findings from our lab that ɑSMA positive fibroblasts frequently show 
characteristics of senescence (Mellone et al., 2017), we sought to determine 
whether a subpopulation of the fibrous stroma was senescent. 	
Expression of the well-characterised senescence marker p16INK4a was first 
investigated. Readily detectable p16INK4a was noticed in OSCC cells, stromal 
cells adjacent to bone, and surrounding osteoclasts in bone resorptive areas, and 
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osteoblasts. The percentage of expression of positive cells ranged from 26.8% to 
71.3% (Figure 4.1 and 4.2).	
A  
B  
Figure 4.1: Representative photomicrographs showing IHC localisation of 
p16INK4a. (A) Strong p16INK4a (antibody dilution 1:100) expression in myofibroblastic 
stroma at the invasive tumour front (magnification x40). (B) Negative control. 
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(magnification x 20). 
 
Figure 4.2: Quantification of p16INK4a expression in stromal cells of OSCC bone 
resections. (n=10, 5 superficial cortical resorption and 5 cancellous bone involvement).  
The average percentage of p16INK4a positive cells in cases with superficial bone 
resorption was (45.22 ± 18.96) and (60.48 ± 26.21) in cancellous invasion (mean ± 
STDV). Error bar = STDV. 
4.2.2 Expression of senescence marker DPP4 (CD26) in tumour 
microenvironment proximal to bone 
To further confirm the presence of senescent cells in the microenvironment of 
tumour bone interface an additional cell surface senescent marker, DPP4, was 
also examined. Recently, following mass spectrometry analysis of senescent 
fibroblasts, DPP4 was reported to be expressed by senescent but not proliferating 
fibroblasts (Kim et al., 2017). 	
DPP4 expression was observed in OSCC cells and fibroblasts near bone 
resorptive sites. The percentage of cells expressing DPP4 ranged from 21.7%, 
with the highest percentage of positive expressing cells being 64.05%, and a 
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Figure 4.3: Representative photomicrographs showing IHC localisation of DPP4. 
(A) Strong DPP4 (antibody dilution 1:100) expression in myofibroblastic stroma at the 
invasive tumour front (magnification x 40). (B) Negative control. 
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Figure 4.4: Quantification of DPP4 expression in stromal cells in OSCC bone 
resections (n=10, 5 superficial cortical resorption and 5 cancellous bone involvement). 
The average percentage DPP4 positive cells in cases with superficial cortical bone 
resorption was (33.22 ± 18.96) and (57.48 ± 26.21) in cancellous invasion (mean ± 
STDV). Error bar = STDV. 
 
4.3 Senescent fibroblasts exhibit contractility 
features through the expression of aSMA in 
tumour microenvironment proximal to bone 
Following identification that CAF in OSCC fibrous stroma express myofibroblastic 
marker aSMA and senescence by p16INK4a expression through single staining 
IHC, double immunohistochemical analyses of aSMA and senescent marker 
p16INK4a was carried out to assess whether myofibroblastic CAF are also 
senescent. Matching cases of OSCC with bone involvement were selected as 
described previously. Our data shows that a large proportion of myofibroblastic 
CAF also show senescent characteristics. Senescence was also evident in 
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Figure 4.5: Representative photomicrographs showing IHC co-localisation of 
αSMA (Green) and p16INK4a (Red).  αSMA (antibody dilution 1:100) expression (green 
stain) in myofibroblastic stroma at the invasive tumour front. p16INK4a expression (red) 
in tumour as well as SMA positive cells in tumour stroma. Co-localization of αSMA and 
p16INK4a was evident in fibrous tumour stroma (blue).(A) Magnification x 10. (B) ifi(x 
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20) 
4.4 Characterisation of induction of senescence in 
vitro 
Following identification that stromal cells in bone invasive OSCC tissue express 
senescent characteristics ex vivo, senescence induction in NOF was conducted 
in vitro to investigate the potential functionality of senescent CAF in OSCC bone 
invasion. This assay was performed to verify whether senescence could be 
induced in oral fibroblasts (DENF 316, NOF803, NOF804, NOF822) subjected to 
oxidative stress, exposed to chemotherapeutic drugs or replicative mitotic 
exhaustion, by utilising β-galactosidase as a biomarker. The following 
abbreviations will be used (S-NOFH2O2, S-NOFCis, and S-NOFRep) to denote the 
associated conditions (Table 4.1). 
Table 4.1: Abbreviations used for different senescence induction methods	
Types of senescence induction Abbreviation 
Exposure of NOF to oxidative stress  
(500 µM H2O2 for 2 h) 
S-NOFH2O2 
Exposure of NOF to genotoxic stress  
(10 µM cisplatin for 24 h) 
S-NOFCis 




Cells were seeded (10,000/well) in a 12 well plate and stained with X-gal 
solution. A blue precipitate was evident in senescent fibroblasts following the 
overnight incubation (Figure 4.6). The percentage of blue stained cells resulting 
from lysosomal galactosidase cleavage of X-gal chromogenic substrate was 
quantified. The highest percentage of senescent cells was detected in S-
NOFRep (78.04 ± 8.3, p=0.00003), followed by S-NOFH2O2 (64.21 ± 5.6, 
Chapter 4 Exploring the role of fibroblast senescence in bone invasion in OSCC  
 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 130 
p=0.00005), S-NOFCis (57.03 ± 3.8, p=0.00007), and CAF (31.89 ± 7.9, 
p=0.00009) (mean ± STDV) (Figure 4.7). 
 
Figure 4.6: Representative photomicrographs of SA-b-Gal detection in NOF 
following exposure to different senescence inducers. Primary oral fibroblasts 
exposed to H2O2, cisplatin or replicative mitotic exhaustion were seeded into a 12 well 
plate at a density of 10,000 cells/well. On the following day, cells were rinsed in PBS, 
fixated, and stained with X-gal staining solution (24 h). (A) NOF (803, 804 and 822) not 
subjected to oxidative stress served as a negative control (magnification x20). (B) 
Senescent fibroblasts following H2O2 exposure produced a blue/turquoise precipitate. 
(C) Senescent fibroblasts following cisplatin exposure. (D) Senescent fibroblasts 
following replicative exhaustion. (E) Primary CAF (002, 003, and 004) isolated from 
human tumour tissue also showed senescence. This experiment was performed three 
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times iplicate. (magnification x40). 
 
Figure 4.7: Quantification of SA-β-Gal positive cells. The number of stained cells 
(blue precipitate) in 3 high power fields (magnification x40) after SA-β-Gal assay was 
conducted. The highest percentage of senescence was seen when NOF were subjected 
to replicative exhaustion (passage 25) S-NOFRep (78.04 ± 8.3), followed by S-NOFH2O2 
(64.21 ± 5.6), S-NOFCis (57.03 ± 3.8), and CAF (31.89 ± 7.9) (mean ± STDV). Experiment 
conducted three times in triplicate. *p<0.05 was considered significant, following a 
Student’s t-test. Error bar = STDV. 
4.5 Primary oral fibroblasts express Sudan B 
Black in vitro after experimental senescence 
induction 
Sudan B Black has been recently identified as a biomarker of senescence, 
specifically staining lipofuscin, which distinctively accumulates in senescent cells 
(Georgakopoulou et al., 2013). As there is no single specific marker to detect 
senescence, Sudan B Black histochemical staining was performed to further 
support the findings from the SA-β Gal assay (Figure 4.8). The percentage of 
SBB stained (black deposits) cells was quantified. The highest percentage of 
positive cells was noticed in S-NOFH2O2 (61.66 ± 3.4, p=0.00009), followed by S-
NOFCis (54.21 ± 6.0, p=0.00076), and CAF (28.97 ± 8.3, p=0.00083) (mean ± 
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Figure 4.8: Representative photomicrographs showing Sudan B Black 
histochemical staining in response to different senescence inducers. Primary oral 
fibroblasts exposed to H2O2, cisplatin or replicative mitotic exhaustion were seeded into 
a 12 well plate at a density of 10,000 cells/well. On the following day, cells were rinsed 
in PBS, fixated, and stained Sudan B Black stain (2 h). (A) NOF (803, 804, and 822) not 
subjected to oxidative stress served as a negative control (magnification x20). (B) NOF 
following H2O2 exposure produced a black granular precipitate. (C) NOF following 
cisplatin exposure. (D) Primary CAF (002, 003, and 004) isolated from human tumour 
tissue showing evidence of senescence.  This experiment was performed three times in 
triplicate. (magnification x40).  
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Figure 4.9: Quantification of SSB positive cells. The number of stained cells (black 
precipitate) in 3 high power fields (magnification x40) was counted and the percentage 
of stained cells calculated following Sudan B Black staining. The highest percentage of 
positive cells was noticed in S-NOFH2O2 (61.66 ± 3.4, p=0.00009), followed by S-NOFCis 
(54.21 ± 6.0, p=0.00076), and CAF (28.97 ± 8.3, p=0.00083) (mean ± STDV, p value) 
Error bar = STDV. *p<0.05 was considered significant, following a Student’s t-test. 
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4.6 mRNA expression of p16INK4a and SASP 
factor IL6 is significantly higher in senescent 
fibroblasts 
Senescent fibroblasts S-NOFH2O2, S-NOFCis, S-NOFRep and primary CAF were 
tested for their expression of p16INK4a, and IL6. qPCR analysis of p16INK4a 
and IL6 was performed to detect and quantify senescence on a transcript level. 
These results were compared to primary normal oral fibroblasts, which served as 
a negative control. Significant amplification in senescent marker p16INK4a and 
IL6 expression was observed in senescent fibroblasts, and CAF.  The increased 
fold change of p16INK4a was observed as follows, S-NOFH2O2 (4.1 ± 2.04, 
p=0.006), S-NOFCis (6.30 ± 0.13, p=0.0008), S-NOFRep (7.43 ± 1.88, p=0.0004), 
and CAF (3.14 ± 1.7, p=0.005) (mean ± STDV, p value) (Figure 4.10 A). 
Moreover, IL6 expression was S-NOFH2O2 (15.3 ± 2.08, p=0.03), S-NOFCis (24.5 
± 3.52, p=0.002), S-NOFRep (24.43 ± 1.88, p=0.0006), and CAF (22.56 ± 2.7, 




Chapter 4 Exploring the role of fibroblast senescence in bone invasion in OSCC  
 




Figure 4.10: Relative expression of p16INK4a and IL6 mRNA in senescent oral 
fibroblasts. mRNA expression of senescent marker (A) p16INK4a and (B) IL6 in 
senescent NOF (NOF803, NOF804, and NOF822) was significantly amplified, following 
exposure of low passage NOF (passage 5) to H2O2 (500 μM) for 2 h, cisplatin (10 μM) 
for 24 h, or exposure to replicative mitotic exhaustion (passage 25). (A) The increased 
fold change of p16INK4a was observed as follows, S-NOFH2O2 (4.1 ± 2.04, p=0.006), S-
NOFCis (6.30 ± 0.13, p=0.0008), S-NOFRep (7.43 ± 1.88, p=0.0004), and CAF (3.14 ± 1.7, 
p=0.005) (mean ± STDV, p value). (B) IL6 expression, S-NOFH2O2 (15.3 ± 2.08, p=0.03), 
S-NOFCis (24.5 ± 3.52, p=0.002), S-NOFRep (24.43 ± 1.88, p=0.0006), and CAF (22.56 ± 
2.7, p=0.00034) Data represented n=3, ± STDV *p<0.05 was considered significant, 
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4.7 Experimentally induced senescent fibroblasts 
express stromal marker αSMA 
Following SA-β-Gal and SBB staining, and senescent marker p16INK4a 
expression confirming senescent induction, senescent oral fibroblasts S-NOFH2O2, 
and S-NOFCis, were seeded on coverslips and analysed for intracellular αSMA 
(dilution 1:100) expression using a FITC-conjugated antibody. These results 
show that senescent fibroblasts also exhibit myofibroblastic characteristics as 
αSMA expression was evident in contractile stress fibres (Figure 4.11 A and B). 
These findings were further compared to experimentally induced myofibroblasts 
following TGFβ1 stimulation (Figure 4.11 C), and primary oral CAF isolated from 
human tissue (Figure 4.11 D) which showed similar results.  Expression in 
proliferating normal oral fibroblasts was not detectable (Figure 4.11 E).  
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Figure 4.11: Representative photomicrographs showing immunofluorescence 
detection of αSMA (1:100) αSMA evident staining in contractile stress fibres in normal 
human oral fibroblasts following (A) Negative control, oral fibroblasts (NOF 803, 804) in 
serum free media. (B) NOF (803, 804) exposure to H2O2 (500μM, 2 h) (C) NOF (803, 
804) exposure to cisplatin (10 μM, 24 h) (D) TGFβ1 (5 ng/ml) treatment (24 h) in serum 
free media. (E) CAF (003) isolated from human OSCC tissue. (magnification x40). 
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4.8 Senescent oral fibroblasts express RANKL a 
transcript and protein 
We have previously demonstrated that myofibroblasts (NOF exposed to TGFβ1) 
and primary CAF isolated from human tumour tissue express significantly higher 
levels of the bone turnover marker RANKL compared to primary NOF (Elmusrati 
et al., 2017).  
To investigate whether experimentally induced senescent fibroblasts produce 
bone turnover marker RANKL and OPG on a transcript level and soluble RANKL 
protein level in culture, senescent fibroblasts S-NOFH2O2, S-NOFCis, S-NOFRep 
and primary CAF were examined. RANKL mRNA was significantly amplified (S-
NOFH2O2 (5.8 ± 1.14, p=0.01), S-NOFCis (3.70 ± 1.83, p=0.013), S-NOFRep (5.87 
± 1.23, p=0.001), and CAF (8.84 ± 0.97, p=0.00051) (mean ± STDV, p value) 
(Figure 4.12 A), while a significant downregulation of RANKL decoy receptor 
OPG was observed (S-NOFH2O2 (-0.5 ± 0.64, p=0.017), S-NOFCis (-0.30 ± 0.15, 
p=0.0042), S-NOFRep (-0.53 ± 0.48, p=0.0055), and CAF (-0.42 ± 0.7, p=0.0044) 
(Figure 4.12 B).  
For soluble RANKL protein detection, on day 5, 10 and 15 following treatment, S-
NOFH2O2 and S-NOFCis were serum starved (24 h), conditioned media was 
collected and subjected to an ELISA. RANKL expression in S-NOFRep (passage 
25) was also examined. RANKL protein expression was significantly up regulated 
in conditioned media collected from S-NOFH2O2 after 5 days, and this expression 
increased following 10 and 15 days (220 ± 3.10, p=0.05, 311 ± 4.2, p=0.002, and 
356 ± 4.01, p=0.0006 respectively) (mean rg/ml ± STDV, p value). However, for 
S-NOFCis a significant RANKL expression was only noticed following 15 day of 
cisplatin exposure (338 ± 2.02, p=0.002). Moreover, primary CAF and S-NOFRep 
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demonstrated a significant RANKL expression (497 ± 8.03, p=0.0002 and 366 ± 
4.11, p=0.00011 respectively) when compared to NOF media (Figure 4.13). 
A  
B  
Figure 4.12: Expression of mRNA RANKL and OPG in senescent oral fibroblasts. 
mRNA expression of bone turnover markers (A) Significant RANKL and (B) Significant 
OPG downregulation was observed in senescent NOF (NOF803, NOF804, and 
NOF822), which was significantly increased, following exposure of low passage NOF 
(passage 5) to H2O2 (500 μM) for 2 h, cisplatin (10 μM) for 24 h, or exposure to replicative 
mitotic exhaustion (passage 25). Data represented n=3, ±SD *p<0.05 was considered 
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Figure 4.13: Expression of soluble RANKL protein in senescent oral fibroblasts. 
Senescent oral fibroblasts express significantly higher RANKL protein than unstimulated 
NOF. Highest levels of RANKL seen following 15 days of genotoxic exposure, and in 
non-proliferative NOF (passage 25). 500,000 senescent fibroblasts were seeded in T75 
plates and allowed to settle overnight. The fibroblasts were subjected to oxidative stress 
by treating the cells with H2O2 (500 μM) for 2 h or exposure to chemotherapeutic agent 
cisplatin (10 μM) for 24 h. Conditioned media (day 5, 10 and 15 respectively) was 
collected from serum starved fibroblasts (24 h) and subjected to an ELISA. RANKL 
expression in replicative mitotic exhausted oral fibroblasts (passage 25) was also 
examined. Conditioned media from serum starved (24 h) NOF served as a negative 
control. A significant amplification in RANKL expression was noticed after day 10. Data 
represent n=3 ± SD. *p<0.05 was considered significant, following a Student’s t-test. 
Error bar = STDV. Experiment conducted three times in triplicate. The graph represents 
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4.9 Senescent oral fibroblasts induce 
osteoclastogenesis 
Following induction and assessment of senescence and demonstrating that 
senescent fibroblasts secrete elevated levels of RANKL protein compared to 
proliferating cells, an osteoclastogenesis assay was performed to study whether 
these cells had the ability to initiate osteoclast generation. RAW 264.7 cells were 
seeded on Corning Osseo plates, serum starved, then treated with conditioned 
media collected from serum starved S-NOFH2O2, S-NOFCis, S-NOFRep, OSCC-
derived CAF, and NOF, in separate wells. Media was changed daily. After 7 days, 
TRAP staining, pit formation, and nucleation was studied (Figure 4.14). 
 Following exposure of monocytes to conditioned media collected from senescent 
oral fibroblasts and primary CAF isolated from human OSCC tissue, TRAP 
staining was positive S-NOFH2O2 (32 ± 2, p=0.0002), S-NOFCis (26 ± 3, p=0.004), 
S-NOFRep (34 ± 5, p=0001) and CAF (37 ± 2, p=0.00006) (mean ± STDV, p value), 
the ability of the cells to form resorptive pits S-NOFH2O2 (18 ± 4, p=0.008), S-
NOFCis (13 ± 3, p=0.0005), S-NOFRep (16 ± 4, p=0.0002) and CAF (21 ± 6, 
p=0.0001) (Table 4.2) in the bone scaffold lining , as well as multinucleation was 
also evident further confirming osteoclast formation. However, when monocytes 
were exposed to conditioned media collected from serum starved NOF, 
osteoclastogenesis was not seen, in keeping with data in Chapter 3 (section 3.8). 
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Table 4.2: Quantification of TRAP positive cells and pits formed. 
Sample Total no. of TRAP 
positive cells  
(mean ± STDV, p value) 
No. of pits per 3 high 
power fields  
(mean ± STDV, p value) 
Negative control 0.0 ± 0.0 0.0 ± 0.0 
NOF  0.0 ± 0.0 0.0 ± 0.0 
S-NOFH2O2 32 ± 2, p=0.0002 18 ± 4, p=0.008 
S-NOFCis 26 ± 3, p=0.004 13 ± 3, p=0.0005 
S-NOFRep 34 ± 5, p=0001 16 ± 4, p=0.0002 
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Figure 4.14: Osteoclastogenesis assay. Monocytes (RAW 264.7) were seeded in 
Osteo Assay surface 24 well plates at a density of 20,000 per well. Cell were serum 
starved in alpha MEM media, media was collected every 24 h and monocytes were 
exposed to a daily change of fresh conditioned media for 7 days (A) Negative control; 
cells were grown in serum free alpha MEM media. TRAP staining was negative, pit 
formation was not evident, and DAPI staining showed no multinucleated cells (B) NOF; 
cells were treated with conditioned media collected from serum starved NOF cells. TRAP 
staining was negative, pit formation was not evident, and DAPI staining showed no 
multinucleated cells. Conditioned media collected from (C) S-NOFH2O2; H2O2 (500 μM for 
2 h), (D) S-NOFCis; cisplatin (10 μM for 24 h), and (E) S-NOFRep; replicative exhaustion 
(passage 25) cells. TRAP staining was observed in osteoclasts, pit formation was evident, 
and DAPI staining showed multinucleated cells. (F) CAF; cells were treated with 
conditioned media collected from primary human CAF isolated from OSCC tissue. TRAP 
staining was observed in osteoclasts, pit formation was evident, and DAPI staining 
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Figure 4.15: Senescent oral fibroblasts induce osteoclastogenesis. 15 days after 
NOF (803, 804, and 822) were exposed to H2O2, cisplatin or replicative exhaustion 
(passage 25), RAW 264.7 monocytes were seeded in a 24 well plate at a density of 
20,000 cells/well. Senescent cells were serum starved in alpha MEM media, and 
monocytes were treated daily with the conditioned media for 7 days. (A) The number of 
TRAP positive cells was counted positive S-NOFH2O2 (32 ± 2, p=0.0002), S-NOFCis (26 ± 
3, p=0.004), and S-NOFRep (34 ± 5, p=0001). The highest stimulation of 
osteoclastogenesis was noticed when monocytes were exposed to conditioned media 
from primary CAF (37 ± 2, p=0.00006). (B) Pit formation quantification. The number of 
pits formed due to osteoclasts actively was counted S-NOFH2O2 (18 ± 4, p=0.008), S-
NOFCis (13 ± 3, p=0.0005), S-NOFRep (16 ± 4, p=0.0002). The highest significant 
differentiation of osteoclasts was seen when monocytes were exposed to conditioned 
media from primary CAF 21 ± 6, p=0.0001. Error bar = STDV. *p<0.05 was considered 
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4.10 Senolytic drugs impede tumour progression 
and bone invasion, giving promising therapeutic 
benefits 
We have identified that senescent CAF are present in the microenvironment of 
bone-invasive OSCC. We have also provided evidence, in vitro, that senescent 
fibroblasts and CAF are able to induce osteoclastogenesis, suggesting that CAF 
senescence may play a functional role in bone invasion, and therefore represent 
a potential novel therapeutic target.	
 Alvespimycin and Navitoclax have recently been described as ‘senolytics’ due to 
their ability to selectively promote apoptosis of senescent cells, decreasing their 
pro-tumourgenic burden (Chen et al., 2016; Saini et al., 2018). These two drugs 
were chosen to examine their influence on senescent fibroblast-induced bone 
invasion as they target different pro-apoptotic pathways. 	
4.10.1 The effect of senolytics Alvespimycin (17-DMAG) and 
Navitoclax (ABT263) on NOF viability 
Normal oral fibroblasts were exposed to a range of concentrations of 
Alvespimycin or Navitoclax, to determine the optimum dose to deplete senescent, 
but not proliferating, fibroblasts. NOF and S-NOFH2O2, and S-NOFCis were 
exposed to senolytic drugs Alvespimycin (17-DMAG), and Navitoclax (ABT263) 
of various doses, and the dose with minimal effect on proliferative cells was 
selected 500 nM for Alvespimycin (17-DMAG), and 3 μM Navitoclax (ABT263) 
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Figure 4.16: Effect of senolytics on NOF viability. NOF (803, 804 and 822), S-
NOFH2O2 , and S-NOFCis were subjected to different concentrations of (A) Alvespimycin 
(50 nM, 250 nM, 500 nM and 750 nM), or (B) Navitoclax (1 μM, 2 μM, 3 μM, 4 μM, 5 μM 
and 10 μM) in separate wells of a 24 well plate seeded with 20,000 NOF (803, 804 and 
822). Cell viability was measured at 24 h. Cell viability (%) was plotted against different 
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4.10.2 Senotherapeutics Alvespimycin (17-DMAG) and 
Navitoclax (ABT263) target senescence.   
SA-b-Gal assays were conducted to investigate the effect of senolytic drugs 
Alvespimycin and Navitoclax on senescent fibroblasts (Figure 4.17 and 4.18). A 
significant decrease in senescent cell number was noted. Navitoclax (3 μM) 
reduced senescence by a range of 58-63% (p=0.0005), while Alvespimycin’s 
(500 nM) effect was more potent reducing the senescence by 66-75% 
(p=0.00021) (Figure 4.19). 
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Figure 4.17: Representative photomicrographs showing the effect of senolytics on 
S-NOFH2O2. Oral fibroblasts (NOF803, NOF804and NOF822) exposed to H2O2 (500 μM) 
were seeded into a 12 well plate at a density of 10,000 cells/well. On the following day, 
these cells were exposed to senolytic drugs Alvespimycin (500 nM) or Navitoclax (3 μM). 
After 24 h, cells were rinsed in PBS, fixed, and stained with X-gal staining solution (24 
h). (A) Senescent fibroblasts induced by exposure to H2O2 produced a blue/turquoise 
precipitate. (B) Senescent fibroblasts following exposure to Alevspimycin (500 nM). (C) 
Senescent fibroblasts following exposure to Navitoclax (3 μM).  (magnification x20). The 
experiment was performed three times in triplicate. 
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Figure 4.18: Representative photomicrographs showing the effect of senolytics on 
S-NOFCis. NOF (803, 804 and 822) exposed to cisplatin (10 μM) were seeded into a 12 
well plate at a density of 10,000 cell/well. On the following day, these cells were exposed 
to Alvespimycin (500 nM) or Navitoclax (3 μM). After 24 h, cells were rinsed in PBS, fixed, 
and stained with X-gal staining solution (24 h). (A) Senescent NOF induced by exposure 
to chemotherapeutic cisplatin produced a blue/turquoise precipitate, and a reduction in 
positive cells was seen following treatment with senolytics. (B) Senescent fibroblasts 
following exposure to Alespimycin (500 nM). (C) Senescent fibroblasts following 
exposure to Navitoclax (3 μM).  (magnification x20). The experiment was performed 
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Figure 4.19: Evaluation of senescence following exposure to senolytics. NOF (803, 
822), S-NOFH2O2, and S-NOFCis were exposed to senolytic drugs. The percentage of SA-
b-Gal positive cells following 24 h treatment with (A) Alvespimycin (50 nM, 250 nM, 500 
nM, and 750 nM). (B) Navitoclax (1 µM, 2 µM, 3 µM, 4 µM, 5 µM, 10 µM) was assessed. 
The graph represents combined results of multiple assays. Experiment conducted three 
times in triplicate. *p<0.05 was considered significant, following a Student’s t-test. Error 
bar = STDV. 
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4.10.3 Senolytic drugs limit bone invasion by reducing 
osteoclast generation 
The influence of Alvespimycin, and Navitoclax on osteoclastogenesis was next 
studied. Murine monocytes (RAW 264.7) were seeded in 24 well Osteo assay 
surface plates, and treated with conditioned media from serum starved 
experimentally induced senescent fibroblasts  S-NOFH2O2, S-NOFCis,  S-NOFH2O2 
and S-NOFCis exposed to Alvespimycin (500 nM) or Navitoclax (3 μM), and 
conditioned media from serum starved CAF. After 7 days, TRAP staining, pit 
formation and nucleation was evaluated. RAW 264.7 cells cultured in NOF 
conditioned media served as the negative control. The number of osteoclasts 
generated were significantly less following Alvespimycin and Navitoclax exposure,  
S-NOFH2O2 (33 ± 4, 7 ± 2 after Alvespimycin exposure, and 12 ± 4 Navitoclax), S-
NOFCis  (24 ± 4, 3 ± 1 Alvespimycin, and 5 ± 3 Navitoclax), CAF (38 ± 3, 13 ± 2 
Alvespimycin, and 21 ± 3 Navitoclax) (mean ± STDV). These results were also 
reflected in the pit forming (S-NOFH2O2 (17 ± 2, 4 ± 1 after Alvespimycin treatment, 
and 7 ± 1 Navitoclax), S-NOFCis  (14 ± 3, 2 ± 1 Alvespimycin, and 5 ± 1 Navitoclax), 
CAF (19.1 ± 3.8, 6.9 ± 1.5 Alvespimycin, and 10 ± 2 Navitoclax), and nucleation 
assays (Table 4.3). Throughout the samples Alvespimycin exposure had a more 
potent effect on osteoclastogenesis and pit formation reduction compared to 
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Table 4.3: Quantification of TRAP positive cells and pits formed following 
senolytic drug exposure 
Sample Total no. of TRAP 
positive cells 
(mean ± STDV,  
p value) 
No. of pits per 3 high 
power fields  
(mean ± STDV, p value) 
Negative control 0.0 ± 0.0 0.0 ± 0.0 
NOF  0.0 ± 0.0 0.0 ± 0.0 
S-NOFH2O2 33 ± 4, p=0.001 17 ± 2, p=0.0001 
S-NOFH2O2+ Alvespimycin  7 ± 2, p=0.00006 4 ± 1, p=0.00002 
S-NOFH2O2 + Navitoclax 12 ± 4, p=0.0001 7 ± 1, p=0.001 
S-NOFCis  24 ± 3, p=0.00003 14 ± 3, p=0.0001 
S-NOFCis + Alvespimycin 3 ± 1, p=0.00005 2 ± 1, p=0.00008 
S-NOFCis + Navitoclax 5 ± 3, p=0.001 5 ± 1, p=0.0008 
CAF 38 ± 2, p=0.00002 19.1 ± 3.8, p=0.00002 
CAF + Alvespimycin 13 ± 2, p=0.0005 6.9 ± 1.5, p=0.0007 
CAF + Navitoclax 21 ± 3, p=0.003 10.01 ± 2, p=0.0006 
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Figure 4.20: Osteoclastogenesis assay, the effect of senolytics on osteoclast 
generation. RAW 264.7 monocytes (20,000 cells/well) were seeded in Osteo Assay 
surface 24 well plates. Cell were serum starved in alpha MEM media. Monocytes were 
exposed to the collected media. Media was changed daily for 7 days (A) Negative control; 
cells were grown in serum free alpha MEM media. TRAP staining was negative, pit 
formation was not evident, and DAPI staining showed no multinucleated cells (B) NOF; 
cells were treated with conditioned media collected from serum starved NOF cells. TRAP 
staining was negative, pit formation was not evident, and DAPI staining showed no 
multinucleated cells. (C) S-NOFH2O2; cells were treated with conditioned media collected 
from serum starved NOF treated with H2O2 (500 μM for 2 h). TRAP staining was 
observed was observed in osteoclasts, pit formation was evident, and DAPI staining 
showed multinucleated cells. (D) S-NOFH2O2 treated with Alvespimycin; cells were treated 
with conditioned media collected from serum starved S-NOFH2O2 following exposure to 
Alvespimycin (500 nM for 24 h) and (E) S-NOFH2O2 treated with Navitoclax; S-NOFH2O2 
following exposure to Navitoclax (3 μM for 24 h). A significant reduction of TRAP staining 
osteoclasts, pit formation, and multinucleated cells DAPI staining was observed. (F) S-
NOFCis; cells were treated with conditioned media collected from serum starved NOF 
treated with cisplatin (10 μM for 24 h). TRAP staining was observed positively staining 
osteoclasts, pit formation was evident, and DAPI staining showed multinucleated cells. 
(G) S-NOFCis treated with Alvespimycin; cells were treated with conditioned media 
collected from serum starved S-NOFH2O2 following exposure to Alvespimycin, and (H) S-
NOFCis treated with Navitoclax; S-NOFH2O2 following exposure to Navitoclax. A significant 
reduction of TRAP positive osteoclasts, pit formation, and multinucleated cells with DAPI 
staining were observed. (I) CAF; cells were treated with conditioned media collected from 
primary CAF isolated from OSCC tissue. TRAP staining was observed in osteoclasts, 
the ability for the activated osteoclast to form pits in the bone scaffold was evident, and 
DAPI nucleation showed multi-nucleated cells. (J) CAF treated with Alvespimycin; cells 
were treated with conditioned media collected from serum starved primary CAF following 
exposure to Alvespimycin, and (K) CAF treated with Navitoclax; primary CAF following 
exposure to Navitoclax. The number of TRAP positive osteoclasts, pit formation, and 
multinucleated cell DAPI staining significantly decreased. The experiment was 
performed three times in duplicate. Magnification x40. 
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Figure 4.21: Senolytics reduce osteoclast generation. 15 days after fibroblasts 
(NOF803, NOF804, NOF822) were exposed to H2O2, or cisplatin, senescent fibroblasts 
were treated with Alvespimycin (500 nM) or Navitoclax (3 μM) for 24 h.  RAW 264.7 
monocytes were seeded in a 24 well plate at a density of 20,000 cells/ well. Senescent 
cells before and after exposure with senolytic drugs were serum starved in alpha MEM 
media, and monocytes were treated daily with the conditioned media for 7 days. (A) 
Osteoclast generation quantification. The number of TRAP positive cells was counted. 
The number of osteoclasts generated were significantly less following Alvespimycin and 
Navitoclax exposure,  S-NOFH2O2 (33 ± 4, 7 ± 2 after Alvespimycin exposure, and 12 ± 4 
Navitoclax), S-NOFCis  (24 ± 4, 3 ± 1 Alvespimycin, and 5 ± 3 Navitoclax), CAF (38 ± 3, 
13 ± 2 Alvespimycin, and 21 ± 3 Navitoclax) (mean ± STDV). (B) Pit formation 
quantification. These results were also reflected in the pit forming (S-NOFH2O2 (17 ± 2, 4 
± 1 after Alvespimycin treatment, and 7 ± 1 Navitoclax), S-NOFCis  (14 ± 3, 2 ± 1 
Alvespimycin, and 5 ± 1 Navitoclax), CAF (19.1 ± 3.8, 6.9 ± 1.5 Alvespimycin, and 10 ± 
2 Navitoclax), The experiment was performed three times in duplicate. Error bar = STDV. 
**p<0.01was considered significant, following a Student’s t-test. 
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4.11 Discussion  
The TME plays a critical role in cancer progression and invasion. A considerable 
amount of research has focused on αSMA-expressing myofibroblastic CAF in the 
TME. However, recent reports have provided evidence that CAF represent a 
heterogeneous population, and one sub-population of CAF, which are senescent 
fibroblasts have been described. Senescent fibroblasts are evident in 
premalignant lesions (Costea et al., 2013; Procopio et al., 2015) as well as OSCC 
stroma (Hassona et al., 2013). Campisi et al. (2007), reported that the 
characteristic features of senescent cells including elevated levels of cytokines 
and growth factors which have a pro tumourgenic effect in cancers.  
In oral cancer, senescent cells have been described to be evident through the 
elevated expression of p16INK4a (Parkinson, 2010; Hassona et al., 2013; Kabir 
et al., 2016; Mellone et al., 2017). However, in the current study, cell surface 
protein DPP4 (CD26), reported by Kim et al. (2017), which is specifically 
expressed in senescent cells was investigated for the first time in OSCC to further 
support the expression of the well-recognised senescent marker p16INK4a. 
Tissue from OSCC bone resections was examined for the presence of senescent 
cells in tumour stroma. Senescent markers p16INK4a and DPP4 were analysed 
and the percentage of positive stromal cells at the tumour bone interface ranged 
from 21% to 73%. These findings identify that senescence is evident in OSCC 
cells and surrounding stroma, suggesting an active role in bone invasion. 
To study senescence in vitro, normal oral fibroblasts at a low passage were 
exposed to DNA damaging agents H2O2, cisplatin or replicative exhaustion to 
induce senescence. Following five days of H2O2 or cisplatin treatment, and 
replicative mitotic exhaustion (passage 25) the majority of the fibroblasts were 
Chapter 4 Exploring the role of fibroblast senescence in bone invasion in OSCC  
 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 160 
positive for SA-β-Gal, further confirming senescence transformation of resting 
oral fibroblasts. These results are in agreement with previous studies (Kabir et 
al., 2016). 
Senescent fibroblasts were investigated on a transcript level for senescence 
marker p16INK4a, and SASP factor IL6, and a significant amplification was noted 
when compared to NOF. Bone turnover markers RANKL and antagonist or decoy 
receptor OPG were further examined and a significant up-regulation in RANKL 
was observed, while OPG mRNA expression was down-regulated consistently, 
compared to control NOF. Conditioned media collected at different time intervals 
was also subjected to an ELISA to investigate whether senescent fibroblasts 
secreted RANKL protein. Senescent fibroblasts produced significantly more 
soluble RANKL protein in comparison to untreated NOF. These findings are in 
further agreement that RANKL expression is activated in senescence and may 
be considered a novel SASP factor (Kim et al., 2017) 
To further evaluate these findings, exposure of RAW 264.7 monocytes to 
conditioned media from senescent fibroblasts resulted in osteoclast generation. 
These findings suggest that the TME in OSCC comprises CAF as well as 
senescent fibroblasts and both could potentially contribute to OSCC-mediated 
bone destruction. 
Following confirmation that senescent fibroblasts play a key role in the initiation 
of osteoclastogenesis, senolytics were investigated to assess whether a 
reduction in senescence can reduce the paracrine effects promoting 
osteoclastogenesis. Fuhrmann-Stroissnigg et al. 2017 first introduced 
Alvespimycin as a novel senolytic agent able to promote apoptosis in senescent 
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fibroblasts. In addition, in recent studies, Navitoclax has been reported to promote 
apoptosis in senescent cells as human lung fibroblasts, human umbilical vein 
epithelial cells, and mouse embryonic fibroblasts (Zhu et al., 2015). Moreover, 
navitoclax decreased senescence fibroblast burden in the liver leading to a 
reduction in fibrosis (Moncsek et al., 2018). Furthermore, Chen et al. (2016), 
demonstrated the pro apoptotic functionality of Navitoclax in targeting CAF in 
hepatocellular carcinoma, however senescence was never examined. 
The current study is the first to specifically target senescent CAF with senolytics. 
Drugs were optimised, and dose selected targeting senescent fibroblasts but 
having minimal effect on proliferative cells, 500 nM for Alvespimycin (17-DMAG), 
and 3 µM Navitoclax (ABT263). Significant reduction in osteoclast generation was 
recorded following exposure to both senolytics. These results suggest a potential 
clinical application for senolytic drugs as an adjunct therapy in the treatment of 
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5.1 Introduction 
EV have been gaining interest as a novel mode of cellular communication in 
biomedical research. Increasing evidence shows that cancer-derived EV play 
important roles in tumour progression (Kahlert and Kalluri, 2013). EV transport 
nucleic acids and proteins to recipient cells, influencing tumour growth, 
advancement, metastasis and therapeutic resistance (Vader et al., 2014; 
Minciacchi et al., 2015; Becker et al., 2016). EV derived from malignant cells are 
capable of inducing dysplastic transformation in normal cells. Abd Elmageed et 
al. (2014), found that adipose-derived stem cells became malignant when 
exposed to EV isolated from prostate cancer. Similar results have also been 
reported in breast cancer, where miRNA containing EV silenced mRNA in non-
neoplastic cells, resulting in transcriptome reprogramming and malignant 
transformation (Melo et al., 2014). 
Cancer derived EV have a significant impact on the TME by encouraging tumour 
angiogenesis, immune cell infiltration, and activation of resting fibroblasts to CAF, 
facilitating tumour progression. Webber et al. (2010), reported that prostate 
cancer EV expressed TGFβ, and actively triggered myofibroblastic differentiation 
of normal fibroblasts in tumour microenvironment promoting tumour growth. 
These results are in further agreement where cancer EV stimulated the 
differentiation of mesenchymal cells to CAF in gastric (Gu et al., 2012) and breast 
cancer (Cho et al., 2012). 
In bone, EV have also been reported to regulate osteoclast-osteoblast 
communication, where EV derived from osteoblasts were described to promote 
osteoclastogenesis (Deng et al., 2015). Moreover, Huynh et al. (2016) observed 
that osteoclasts expressed EV inhibited osteoclast generation.  As one of the 
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main objectives of this study, we sought to investigate the role of EV and CAF in 
OSCC microenvironment and examine their influence on bone invasion. 
 
5.1.1 Aims 
To examine OSCC and different subsets of CAF derived EV and assess whether 
these EV influence bone invasion in oral cancer. 
 
5.1.2 Experimental approach 
1. EV were isolated from NOF, OSCC, CAF and senescent fibroblasts by 
graded centrifugation and size exclusion chromatography, quantified using 
nano particle tracking.  
2. Assessment of enrichment of the EV markers CD9, CD63 and CD81 was 
used to confirm EV isolation.  
3. Soluble RANKL protein was also examined in EV isolated from OSCC, 
NOF, CAF, and senescent fibroblasts with an ELISA. 
4. An osteoclastogenesis assay was performed by culturing murine 
monocytes (RAW 264.7) with OSCC, NOF, CAF, and senescent 
fibroblasts conditioned media as well as EV isolated from these samples. 
TRAP staining, pit formation and nucleation assays was conducted to 
confirm osteoclastic differentiation. 
5. The ability of OPG, a RANKL decoy receptor, to influence the functions of 
EV was assessed through an osteoclastogenesis assay, following 
exposing monocytes to conditioned media or EV treated with OPG.  
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5.2 EV isolation from OSCC, NOF, CAF, 
myofibroblasts and senescent oral fibroblasts 
 
5.2.1 Collection of EV from oral cancer and stromal cells 
Cells were grown in culture media (DMEM) in tissue culture treated surface flasks. 
Once 70-80% confluence was reached, cells were rinsed twice with PBS, and 
serum starved in DMEM for 72 h. Conditioned media was collected ready for EV 
isolation by graded centrifugation and SEC. A cell count of 18 million cells was 
sufficient for optimal EV isolation and downstream analyses. 
5.2.2 Quantification and size distribution of EV 
A ZetaView (ZetaView Basic NTA- Nanoparticle Tracking Video Microscope 
PMX-120, Particle Matrix) was used to analyse the concentration and size of EV. 
Following EV isolation, a small quantity (3 ml) of the isolate was used for 
nanoparticle tracking analysis.  
EV from NOF, myofibroblasts (NOF exposed to TGFβ1), CAF, S-NOFH2O2 and S-
NOFCis, and H357 were loaded into the ZetaView. The samples were scanned at 
11 positions (in triplicate), and particles were tracked by Brownian motion to 
obtain an average measurement. The number of EV produced per cell was 
calculated by multiplying the dilution factor of the sample used with the particle 
concentration and divided by the total number of cells at the time of conditioned 
media collection (Figure 5.1 and 5.2). 
The average number of particles (mean ± STDV) and majority of the particle size 
range were observed as follows, NOF (84.12 ± 7.53, and 105 to 165 nm), 
myofibroblasts (NOF + TGFβ1) (127.15 ± 2.2, and 105 to 225 nm). CAF (142.51 
± 6.26, and 75 to 195 nm), S-NOFH2O2 (182.58 ± 5.39, and 105 to 225 nm), S-
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NOFCis (166.34 ± 3.33, and 75 to 165 nm), and H357 (280.5 ± 2.7, and 75 to 255 
nm). The data showed significant differences (p<0.0001) in average particle 
number between samples following a one-way ANOVA statistical test. 
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Figure 5.1:  EV size distribution analysis by nanoparticle tracking using ZetaView 
instrument. Cells were serum starved (72 h), following EV isolation by SEC, EV were 
tracked by Brownian motion to obtain and average measurement. (A) Representative 
distribution of EV size distribution profile in NOF (803, 804, and 822). (B) Representative 
distribution of EV size in myofibroblasts, NOF (803, 804, and 822) treated with TGFβ1 
(5 ng/ml). (C) Representative distribution of EV size in CAF (002, 003, and 004). (D) 
Representative distribution of EV size in senescent oral fibroblasts (NOF803, 804, and 
822) induced by exposure to H2O2 (500 µM). (E) Representative distribution of EV size 
in senescent oral fibroblasts (NOF803, 804, and 822) induced by exposure to cisplatin 
(10 µM). (F) Size distribution of EV in OSCC cell line H357. p value of 0.0001 following 
a one-way ANOVA statistical test. All samples were run in triplicate (3 biological and 
experimental repeats). Histograms plotted using GraphPad Prism 8 software. 
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Figure 5.2: Average number of EV produced by different cell types.  The ZetaView 
instrument was utilised to calculate the mean number of EV produced, NOF (84.12 ± 
7.53), myofibroblasts NOF exposed to TGFβ1 (5 ng/ml) (127.15 ± 2.2), CAF isolated 
from human tissue (142.51 ± 6.26), senescent oral fibroblasts NOF exposed to H2O2 
(500 µM) (182.58 ± 5.39), senescent oral fibroblasts NOF treated with cisplatin (10 µM) 
(166.34 ± 3.33), and OSCC cell line H357 (280.5 ± 2.7). Values are expressed as (mean 
± SD). Error bar = STDV. Experiment was conducted in triplicate. *p<0.05 was 
considered significant, following a Student’s t-test. **p value of 0.0013 following a one-
way ANOVA statistical test. 
 
5.3 Characterisation of EV expressed by oral 
cancer cells and NOF  
 
Following EV isolation and particle profile analysis conducted through ZetaView 
nanoparticle tracking, further investigation was required to confirm the 
enrichment of EV, and exclude the presence of non-EV lipoproteins, salt 
aggregates, or other contaminants as isolation/profile analyses only detect 
nanoparticles but do not provide definitive evidence that these particles are EV.  
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isolated from OSCC cell line H357, and primary NOF from conditioned media of 
serum starved cells (72 h), through graded centrifugation and SEC. EV samples 
were probed with widely reported EV markers tetraspanins CD9, CD63, and CD8 
(Théry et al., 2018). Murine IgG acted as a negative control.  
As previously described (section 2.11.5) samples were diluted in ExoView 
Incubation Solution. 35ul of sample was incubated on ExoView Tetraspanin 
Chips (placed in a 24 well plate for 16h RT) to allow EV marker-specific binding. 
Following incubation, fluorophore secondary antibody labelling with anti-CD81 
Alexa-555, anti-CD63 Alexa-647 and anti-CD9 Alexa-488 was further applied, 
specifically binding to tetraspanins expressed on EV membrane. Both H357 and 
NOF samples were positive for tetraspanin markers CD9, CD63, and CD8, and 
expression of multiple markers was also observed (Figure 5.3 and 5.4). 
Furthermore, in addition to characterisation, EV size distribution profiling was also 
conducted. In both NOF and H357 cells, the largest group of EV was between 
45-70 nm, with slight discrepancy between tetraspanin expression. The average 
size of NOF derived EV in accordance with tetraspanin marker expression was 
as follows CD9 (63.4 nm) (Figure 5.3 A), CD63 (67.7 nm) (Figure 5.3 B), and 
CD81 (63.1 nm) (Figure 5.3 C) , while H357 EV profile was CD9 (65.6 nm) (Figure 
5.4 A), CD63 (65.1 nm) (Figure 5.4 B), and CD81 (65.9 nm) (Figure 5.4 C). The 
particle count however was distinctly different. H357 cells (Figure 5.4 E) produced 
10 times more EV in comparison with NOF derived EV (Figure 5.4 E). These 
results are in agreement with the data generated following EV quantification using 
the ZetaView nanoparticle tracking instrument (section 5.2.2). 
 
Chapter 5 Extracellular vesicles: communicators in OSCC microenvironment 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 170 
 
Figure 5.3. Characterisation of EV derived from primary NOF. Exoview R100 was 
utilised for affinity-based technology for EV characterisation. EV tetraspanin markers (A) 
CD63 (red), (B) CD81 (blue), and (C) CD9 (green) were selected, and antibodies against 
the specific tetraspanin antigen were labelled with fluorophores to detect the presence 
of EV. EV expression of more than one marker exhibited a mixed colour of fluorophore 
probes. SEC isolated NOF samples were diluted (1:600). (D) Murine IgG negative control. 
(E) EV population size distribution showed an amplified expression in EV with a size 
range of 45 to 70 nm, with a specific EV profile of CD9 (63.4 nm), CD63 (67.7 nm), and 
CD81 (63.1 nm). 
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Figure 5.4. Characterisation of EV derived from OSCC cell line H357. Exoview R100 
was utilised for affinity-based technology for EV characterisation. EV tetraspanin 
markers (A) CD63 (red), (B) CD81(blue), and (C) CD9 (green) were selected, and 
antibodies against the specific tetraspanin antigen were labelled with fluorophores to 
detect the presence of EV. EV expression of more than one marker exhibited a mixed 
colour of fluorophore probes. SEC isolated H357 samples were diluted (1:600). (D) 
Murine IgG negative contro. (E) EV population size distribution showed an amplified 
expression in EV with a size range of 45 to 70 nm, with a specific EV profile of CD9 (65.6 
nm), CD63 (65.1 nm), and CD81 (65.9 nm). 
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5.4 EV isolated from OSCC, CAF and senescent 
fibroblasts express bone resorption marker 
RANKL 
EV can carry different cargo as growth factors. RANKL has been reported to be 
carried in osteoblast derived EV playing a functional role in osteoclast formation 
(Deng et al., 2015). After identifying that RANKL expression is significantly 
increased in H357, myofibroblasts, CAF (section 3.6 and 3.7), and S-NOF 
(section 4.8) and had the ability to promote osteoclastogenesis , the presence of 
RANKL in  EV derived from H357, OSCC-derived CAF , NOF, myofibroblasts 
(NOF treated with 5 ng/ml TGFβ1), and  S-NOFH2O2 and S-NOFCis  was 
investigated. Cells were serum starved (72 h), conditioned media was collected 
and EV isolated by SEC were subjected to ELISA for RANKL. Secreted RANKL 
protein was significantly increased in conditioned media collected from H357, 
CAF and senescent oral fibroblasts compared to NOF. Concentration (ρg/ml) of 
soluble RANKL protein was recorded as follows (mean rg/ml ± SD, p value) , 
NOF (102.01 ± 9.04, p=0.012), myofibroblasts (NOF + TGFβ1) (155.6 ± 8.3, 
p=0.0008), senescent EV S-NOFH2O2 (198.76 ± 7.16, p=0.0004), senescent EV 
S-NOFCis (177.37 ± 7.83, p=0.013), CAF EV (183.85 ± 9.11, p=0.011), and  H357 
EV (267.48 ± 2.60, p=0.00077). (Figure 5.5). 
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Figure 5.5: Soluble RANKL protein expression in EV isolated from OSCC, CAF, 
myofibroblasts and senescent oral fibroblast. OSCC cell line H357, primary CAF 
isolated from human tissue (CAF 002, 003, and 004), senescent oral fibroblasts 
senescent oral fibroblasts induced by exposure of NOF (803, 804 and 822) to H2O2 (500 
μM) or cisplatin (10 µM) following 15 days of senescence induction, myofibroblasts (NOF 
803, 804, and 822 treated with 5 ng/ml TGFβ1), and primary normal oral fibroblasts (NOF 
803, 804, and 822) were propagated in T175 flasks (3 flasks) until 80% confluence (8 
million cells/flask). Cells were then serum starved (72 h), conditioned media was 
collected and EV isolated by SEC. EV resuspended in PBS were subjected to an ELISA. 
Error bar=STDV. *p<0.05 was considered significant, following a Student’s t-test. The 
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5.5 EV isolated from OSCC, CAF and senescent 
fibroblasts EV are instrumental in promoting bone 
invasion in OSCC 
 
After demonstrating that EV isolated from H357, CAF, and S-NOFH2O2 or S-
NOFCis express RANKL in vitro, an experiment was conducted to investigate 
whether this expression was sufficient to initiate osteoclastogenesis.  
As previously mentioned (section 2.9) monocytes (RAW 264.7, which express 
MCSF-1) were seeded in Corning Osseo plates, serum starved, then treated with 
EV isolated from conditioned media collected from serum starved (72 h) cells (20 
million cells), H357, NOF, experimentally induced myofibroblasts (NOF treated 
with TGFβ1, primary CAF, and senescent oral fibroblasts in separate wells. EV 
isolated from 18 million cells were resuspended in alpha MEM media, and media 
was changed daily. After 7 days, TRAP staining, pit formation assay, and 
nucleation, was examined as described (section 2.9) (Figure 5.6). 
Osteoclast generation (Figure 5.7 A) and pit formation (Figure 5.7 B) was evident 
following exposure of monocytes to EV derived from NOF +TGFβ1 (25 ± 1.54, 
p=0.0003 and 18 ± 2.9, p=0.0004, respectively),  S-NOFH2O2 (30 ± 2.35, p=0.0005 
and 20 ± 3.77, p=0.0003) , S-NOFCis (25 ± 3.01, p=0.00007 and 15 ± 2.40, 
p=0.0009), CAF (34 ± 1.06, p=0.0001 and 20 ± 1.73, p=0.00008), and H357 (36 
± 2.77, p=0.00004 and 22  ± 3.03, p=0.00002) compared to NOF (Table 5.1). 
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Table 5.1: Number of TRAP positive cells and pits formed following EV exposure 
Sample Total no. of TRAP 
positive cells  
(mean ± STDV, p value) 
No. of pits per 3 high 
power fields  
(mean ± STDV, p value) 
 EV NOF 0.0 ± 0.0 0.0 ± 0.0 
EV NOF + TGFβ1 25 ± 1.54, p=0.0003 18 ± 2.9, p=0.0004 
EV S-NOFH2O2 30 ± 2.35, p=0.0005 20 ± 3.77, p=0.0003 
EV S-NOFCis 25 ± 3.01, p=0.00007 15 ± 2.40, p=0.0009 
EV CAF 34 ± 1.06, p=0.0001 20 ± 1.73, p=0.00008 
EV H357 36 ± 2.77, p=0.00004 22 ± 3.03, p=0.00002 
CAF 41.83 ± 2.7, p=0.0001 36.2 ± 2.7, p=0.00001 
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Figure 5.6: Osteoclastogenesis assay with EV isolated from conditioned media. 
Monocytes (RAW 264.7) were seeded in Osteo Assay surface 24 well plates at a density 
of 20,000 per well. RAW 264.7 cells were exposed to EV isolated (graded centrifugation 
and SEC) from conditioned media collected from serum starved (72 h) cells (18, 000,000 
cells) in alpha MEM media. (A) NOF (803, 822) EV; TRAP staining negative, no pit 
formation or multinucleation observed. (B) NOF + TGFβ1 (803, 822) EV (C) S-NOFH2O2 
(803, 822) EV (D) S-NOFCis (803, 822) EV; (E) CAF (003, 004) EV (F) H357 EV TRAP 
positive osteoclasts, pit formation and multinucleated cells observed. (G) CAF (003, 004) 
conditioned media; media was collected from serum starved CAF and monocytes were 
exposed to this media. This sample served as a positive control. Osteoclasts stained 
positive for TRAP, pit formation and multinucleated cells were evident. Error bar=STDV. 
*p<0.05 was considered significant. The graph represents combined results of multiple 
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Figure 5.7: EV produced by OSCC, CAF, and senescent oral fibroblasts induce 
osteoclastogenesis. RAW 264.7 monocytes were seeded in a 24 well plate at a density 
of 20,000 cells/ well. OSCC cell line H357, CAF (003, and 004), senescent oral 
fibroblasts (NOF 803, and 822 exposed to H2O2 (500 μM) or treated with cisplatin (10 
μM) were serum starved in alpha MEM media. EV were isolated by SEC, and monocytes 
were treated daily with EV isolated from conditioned media for 7 days. (A) The number 
of TRAP positive cells was counted. EV derived from NOF +TGFβ1 (25 ± 1.54), S-
NOFH2O2 (30 ± 2.35), S-NOFCis (25 ± 3.01), CAF (34 ± 1.06), and H357 (36 ± 2.77) (B) 
Pit formation quantification. The number of pits formed by EV derived from NOF +TGFβ1 
(18 ± 2.9), S-NOFH2O2 (20 ± 3.77) , S-NOFCis (15 ± 2.40), CAF (20 ± 1.73), and H357 (22  
± 3.03). Error bar=STDV. *p<0.05 was considered significant, following a Student’s t-test. 
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5.6 OPG antagonises RANKL production by EV 
isolated from OSCC, CAF and senescent 
fibroblasts and impedes bone invasion in OSCC  
The major factors responsible for bone homeostasis are RANK, RANKL and its 
antagonist OPG. The RANK/RANKL signalling cascade facilitates differentiation 
of bone lining cells, osteocytes and osteoblasts to osteoclasts, along with M-CSF 
while OPG suppresses these signals. Alterations in functional equilibrium of 
these cytokines will either result in osteogenesis, favoured by elevated OPG 
expression or osteolysis, promoted by elevated RANKL levels. 	
OPG acts as a signal for bone deposition, and limitation of bone resorption. This 
experiment was conducted to study the importance of RANKL in bone invasive 
OSCC and evaluate if blocking RANKL with its decoy receptor OPG, affects 
osteoclast generation.	
5.6.1 Optimisation of RANKL antagonist OPG 
Following OPG preparation (section 2.12.1) an osteoclastogenesis assay was 
conducted as described before (section 2.9). However, unlike the 
osteoclastogenesis assay previously described, NOF, H357, CAF and S-NOF 
were treated with OPG at graded concentrations (1 ng/ml, 10 ng/ml, 50 ng/ml, 
100 ng/ml and 200 ng/ml) in serum free media. Following 24 h for OPG treatment, 
monocytes were exposed to the conditioned media and EV collected from the 
treated cells, and the optimal dose needed for maximum hindering of osteoclast 
generation was analysed. Conditioned media from serum starved cells (H357, 
CAF, senescent fibroblasts) served as the positive control, while monocytes in 
alpha MEM media acted as the negative control. An osteoclastogenesis assay 
was conducted, and the optimal dose of OPG with the highest reduction in 
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monocyte differentiation to osteoclast was analysed. A significant reduction 
(mean ± STDV) in osteoclast numbers was observed following exposure OPG 
(100ng/ml) exposure. S-NOFH2O2 (24.6 ± 2.5, and 3 ± 1.4, p=0.003), CAF (33.92 




Figure 5.8: Optimisation of cell treatments with recombinant human OPG. NOF, 
CAF, H357, and senescent oral fibroblasts were serum starved for 24 h and subjected 
to different concentrations of recombinant human OPG (1ng/ml, 10 ng/ml, 50 ng/ml, 100 
ng/ml, and 200ng/ml), prior to exposure to monocytes RAW 264.7, with a daily media 
change for 7 days. The relative reduction of osteoclast generated following OPG 
treatment was plotted against dose. Monocytes in serum free alpha MEM media served 
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5.6.2 OPG significantly reduces osteoclast generation 
To confirm the significance of RANKL in OSCC bone invasion, an 
osteoclastogenesis assay was conducted (section 2.9), monocytes were 
exposed to conditioned media and EV collected from serum starved NOF, 
experimentally induced myofibroblasts (NOF exposed to TGFβ1), CAF (isolated 
from human OSCC tissue), and S-NOFH2O2 treated with OPG (100 ng/ml) (Figure 
5.9). The number of TRAP positive cells generated (Figure 5.10 A) and pits 
formed (Figure 5.10 B) following OPG exposure to conditioned media and EV 
samples were quantified, and these results were compared to conditioned media 
not supplemented with OPG, and negative controls (RAW 264.7 in serum free 
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Table 5.2: Number of TRAP positive cells and pits formed following OPG 
exposure 
Sample Total no. of TRAP 
positive cells  
(mean ± STDV, p value) 
No. of pits per 3 high 
power fields  
(mean ± STDV, p value) 
Negative control 0.0 ± 0.0 0.0 ± 0.0 
NOF  0.0 ± 0.0 0.0 ± 0.0 
NOF + TGFβ1 27.2 ± 3.6, p=0.001 15.3 ± 2.25, p=0.001 
NOF + TGFβ1 + OPG 5.05 ± 2.1, p=0.00038 4.7 ± 1.5, p=0.04 
EV (NOF + TGFβ1) + OPG 1 ± 1.2, p=0.008 2 ± 1.5, p=0.02 
S-NOFH2O2 24.7 ± 3.4, p=0.0007 30.1 ± 5.4, p=0.00003 
S-NOFH2O2 + OPG 11.83 ± 2.7, p=0.0009 6.8 ± 2.7, p=0.002 
EV (S-NOFH2O2 + OPG) 3.05 ± 1.8, p=0.0079 2.2 ± 1.3, p=0.04 
H357 36.7 ± 4.2, p=0.00004 33.1 ± 4.6, p=0.0002 
H357 + OPG 15.01 ± 3.82, p=0.0005 17.02 ± 2.88, p=0.0031 
EV (H357) + OPG 7.0 ± 2.8, p=0.006 5.1 ± 3.8, p=0.019 
CAF 37.03 ± 3.85, p=0.00003 32.95 ± 7.35, p=0.00007 
CAF + OPG 13.04 ± 1.28, p=0.0002 16.01 ± 2.28, p=0.018 
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Figure 5.9: Osteoclastogenesis assay with OPG treatment. Monocytes (RAW 264.7) 
were seeded in Osteo Assay surface 24 well plates at a density of 20,000 per well. RAW 
264.7 cells were exposed to conditioned media or EV isolated (graded centrifugation and 
SEC) from conditioned media collected from serum starved (72 h) cells (18, 000,000 
cells) in alpha MEM media. Samples were then treated with OPG (100 ng/ml) prior to 
being exposed to monocytes. Media was changed daily for 7 days. (A) Negative control; 
RAW 264.7 exposed to serum free alpha MEM media. TRAP staining negative, no pit 
formations or DAPI multinucleation. In samples (B) NOF, (C) NOF conditioned media 
treated with OPG, and (D) NOF EV treated with OPG, TRAP staining, pit formation and 
multinucleation was not evident. (E) Experimentally induced CAF/myofibroblasts (NOF 
treated with 5 ng/ml TGFβ1) conditioned media. TRAP staining was seen in osteoclasts, 
pit formation was evident, and DAPI staining showed multinucleated cells. (F) 
Experimentally induced myofibroblasts conditioned media and (G) EV treated with OPG. 
TRAP positive cells, pit formation and multinucleated cells reduced in number. (H) S-
NOFH2O2, NOF803 conditioned media exposed to H2O2 (500μM) initiated osteoclast 
generation, pit formation and multinucleation. (I) S-NOFH2O2 media treated with OPG. 
RAW 264.7 cells were exposed to OPG (100 ng/ml) treated conditioned media collected 
from serum starved S-NOFH2O2, reduction of osteoclast generation, pit formation and 
multinucleated cells. (J) S-NOFH2O2 EV treated with OPG. TRAP staining was negative, 
pit formation was absent, and DAPI staining showed no multinucleated cells. (K) H357 
conditioned media, TRAP staining was observed positively staining osteoclasts, pit 
formation was evident, and DAPI staining showed multinucleated cells. (L) H357 
conditioned media and (M) EV treated with OPG. A reduction in TRAP staining, pit 
formation was evident, as well as DAPI stained multinucleated cells. (N) CAF conditioned 
media. TRAP staining was observed in osteoclasts, pit formation was evident, and DAPI 
staining showed multinucleated cells. (O) CAF conditioned media and (P) EV treated 
with OPG. TRAP positive cells, pit formation and multinucleated cells were evident but 
less in number. (Q) OPG diluted in alpha MEM media. Monocytes were exposed to OPG 
(100 ng/ml) in alpha MEM media. TRAP staining was negative, pit formation was absent, 
and DAPI staining showed no multinucleated cells. The experiment was performed three 
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Figure 5.10: OPG significantly reduced osteoclast generation caused by H357, 
CAF, and senescent oral fibroblasts and derived EV. RAW 264.7 monocytes were 
seeded in a 24 well plate at a density of 20,000 cells/ well. Normal oral fibroblasts 
(NOF803), myofibroblast (NOF exposed to TGFβ1, 5 ng/ml), OSCC cell line H357, CAF 
(003), senescent oral fibroblasts (NOF 803 exposed to H2O2 500 μM) or treated with 
cisplatin (10 μM) were serum starved in alpha MEM media. EV were isolated by SEC, 
and monocytes were treated daily with conditioned media or EV isolated from 
conditioned media. A media change was conducted daily, OPG (100 ng/ml) was added 
to the conditioned media/EV for 7 days. Monocytes exposed to CAF conditioned media 
served as a positive control, while monocytes treated with OPG diluted in alpha MEM 
media was a negative (A) The number of TRAP positive cells was counted. A reduction 
in osteoclastogenesis was significantly noticed throughout the samples. NOF + TGFβ1 
(27.2 ± 3.6), NOF + TGFβ1 + OPG (5.05 ± 2.1), EV (NOF + TGFβ1) + OPG (1 ± 1.2), S-
NOFH2O2 (24.7 ± 3.4), S-NOFH2O2 + OPG (11.83 ± 2.7), EV (S-NOFH2O2 + OPG) (3.05 ± 
1.8), H357 (36.7 ± 4.2), H357 + OPG (15.01 ± 3.82), EV (EV (H357) + OPG) (7.0 ± 2.8), 
CAF (37.03 ± 3.85), CAF + OPG (13.04 ± 1.28), and EV (CAF) + OPG (5.01 ± 3.39).  (B) 
Pit formation quantification. The number of pits formed due to osteoclasts was counted. 
NOF + TGFβ1 (15.3 ± 2.25), NOF + TGFβ1 + OPG (4.7 ± 1.5), EV (NOF + TGFβ1) + 
OPG (2 ± 1.5), S-NOFH2O2 (30.1 ± 5.4), S-NOFH2O2 + OPG (6.8 ± 2.7), EV (S-NOFH2O2 + 
OPG) (2.2 ± 1.3), H357 (33.1 ± 4.6), H357 + OPG (17.02 ± 2.88), EV (EV (H357) + OPG) 
(5.1 ± 3.8), CAF (32.95 ± 7.35), CAF + OPG (16.01 ± 2.28), and EV (CAF) + OPG (2.03 
± 1.7). Error bar=STDV.  *p<0.05 was considered significant, following a Student’s t-test. 
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5.7 Discussion. 
In the previous chapters CAF were observed to play a significant role in bone 
remodelling and OSCC bone invasion. To further investigate the role of EV as 
communicators in TME, in this chapter, cancer and CAF derived EV were isolated 
from conditioned media, characterised and examined to determine whether they 
play a role in bone invasion in oral cancer.  
Cancer derived EV have a significant impact on the TME by encouraging tumour 
angiogenesis, immune cell infiltration, and activation of resting fibroblasts to CAF, 
mediating tumour progression. Webber et al. (2010), reported that prostate 
cancer carried TGFβ on the EV surface and actively triggered myofibroblastic 
differentiation of normal fibroblasts in the TME, which promoted tumour growth. 
These results are in agreement with findings subsequently reported in gastric (Gu 
et al., 2012), and breast cancer (Cho et al., 2012). Stromal derived EV have also 
been suggested to promote invasion and metastasis in breast cancer (Luga et 
al., 2012). Hence, EV communication between cancer and surrounding stromal 
fibroblasts may add another dimension to the complexity of TME and contribute 
to tumour progression.  This chapter showed for the first time OSCC 
communication with the surrounding fibroblastic stroma, and the communication 
between non-malignant cell of the TME. In particular, the role of EV released by 
OSCC, CAF, myofibroblasts, and senescent oral fibroblasts in bone remodelling.  
In this study, EV were isolated from OSCC cell line H357, CAF, NOF, 
myofibroblasts (NOF exposed to TGFβ1), and senescent oral fibroblasts (induced 
by H2O2 or cisplatin exposure). Size profiling, and quantification was performed 
by ZetaView nanoparticle tracking analysis. It is important to highlight that 
although nanoparticle analysis is commonly used for EV profiling, this technique 
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has its limitations. The ZetaView lacks specificity in detecting the purity of the 
sample to be examined, as it records any particles that can be tracked (Bachurski 
et al., 2019).  
To further confirm EV isolation, ExoView analysis which employs affinity-based 
system on a multiplex microarray chip was conducted to further supplement the 
data generated by NanoView nanoparticle tracking. In ExoView, tetraspanin 
CD81, CD63, and CD9 are immuno captured on the chip and observed for each 
single EV, and the co-expression of a maximum three EV surface proteins can 
be assessed. Furthermore, EV of a size as small at 50 nM can accurately be 
detected (Bachurski et al., 2019). Our samples demonstrated an EV size 
population ranging between 45-70 nm. Tetraspanin marker CD9, CD63, and 
CD81 were significantly expressed throughout the samples.  
The international Society of Extracellular Vesicles has recommended the 
assessment of EV markers by western blot in EV research (Lötvall et al., 2014). 
However, in this study several attempts were made but unfortunately due to the 
low yield of EV quantities and isolated protein, immunoblotting was unsuccessful.  
To evaluate the role of EV in bone invasion, the presence or absence of bone 
resorptive soluble RANKL protein in EV was analysed. EV isolated from 
conditioned media were subjected to ELISA. RANKL protein expression was 
significantly increased in EV isolated from H357, CAF and senescent oral 
fibroblasts compared to NOF. To further evaluate these findings and assess the 
functionality of RANKL, a functional osteoclastogenesis assay was conducted. 
RAW 264.7 monocytes were exposed to EV isolates extracted from H357, 
primary CAF isolated from human OSCC tissue, experimentally induced CAF 
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(NOF exposed to TGFβ1), S-NOFH2O2. Osteoclast generation was significantly 
amplified when compared primary human NOF. 
Following confirmation that H357, CAF, myofibroblasts, and senescent oral 
fibroblasts, and derived EV carry RANKL, and play a key role in the initiation of 
osteoclastogenesis, the ability of recombinant human OPG to block the observed 
effects was assessed. It has previously been reported that OPG inhibits 
osteoclast differentiation from murine haematopoietic precursors in vitro (Simonet 
et al., 1996; Lacey et al., 1998). Significant reduction in osteoclast generation 
was observed following exposure of OPG to both conditioned media and EV, 
suggesting that bone invasion in OSCC is mainly manipulated through a RANKL 
dependent pathway.  
In conclusion, these results show for the first time that cancer and CAF derived 
EV carry RANKL, and significantly promote osteoclast generation. On blocking 
this signal with OPG, osteoclastogenesis was significantly reduced. These results 
suggest that RANKL expressing EV are involved in cell to cell communication 
between CAF and osteoclast progenitor cells, and OPG decreases osteoclast 
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6.1 Introduction 
Oral squamous cell carcinoma (OSCC) comprises 95% of all neoplasia of the oral 
cavity, and approximately 30% of head and neck malignancies (Haddad and Shin, 
2008). It is the eleventh most common cancer worldwide, with over half a million 
new patients diagnosed annually, and is the 8th most frequent cause of cancer-
related mortality (Warnakulasuriya, 2009). In the United Kingdom alone, more 
than 11,900 new cases of head and neck cancers were reported in 2016, with an 
increase in incidence of over 33% for new patients diagnosed with oral cancer in 
the last decade, and over 4000 oral cancer-related deaths reported annually 
(Cancer Research UK, 2019). 
In the past decade, accumulating evidence has emerged supporting a role for the 
tumour stroma in cancer progression (Radisky et al., 2007; De Wever et al., 2008; 
Xu et al., 2009; Marsh et al., 2011; Dourado et al., 2019). Pietras and Ostman, 
(2010) described the pro-tumourgenic stromal remodelling that occurs due to 
altered paracrine signalling from neoplastic epithelial cells, generating a more 
permissible environment promoting tumour progression and spread. Cancer 
associated fibroblasts (CAF), frequently the predominant cell type in the tumour 
microenvironment, have been shown to regulate various aspects of tumour 
advancement, such as the infiltration of immune cells, angiogenesis, and ECM 
remodelling promoting neoplastic cell migration and metastasis. In addition, the 
presence of CAF is considered a strong predictor of poor prognosis in OSCC 
(Surowiak et al., 2007; Kellermann et al., 2007; Marsh et al., 2011; Dourado et al, 
2019).  
In this study, the contribution of CAF to OSCC bone invasion was investigated. 
Ebrahimi et al. (2011) reported the frequent complication of bone invasive OSCC, 
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significantly increasing recurrence, morbidity and mortality rates. Owing to the 
proximity of maxillofacial bones, OSCC has a high tendency to invade bone 
(Nomara et al., 2005). However, the precise mechanisms by which OSCC 
invades bone remains unclear. Invasion of bone by OSCC has traditionally been 
ascribed to tumour size and a consequence of pressure related resorption 
(Slootweg and Müller, 1989). However, recent studies suggest that the process 
is not as simple as originally thought and small tumours can be highly infiltrative 
with evidence of bone invasion (Fives et al., 2017). This suggests the existence 
of more complex interactions between tumour, and possibly cells of the TME, and 
bone.  
In our previous study, over 90% of our cohort presented with stroma intervening 
between tumour front and proximal bone with absence of direct contact between 
OSCC cells and bone (Elmusrati et al., 2017, masters thesis). These findings 
suggested that the stroma in OSCC, which predominantly comprises CAF, may 
play a role in bone invasion. Therefore, in this current study we set out to further 
investigate interactions between CAF and bone invasion. 
CAF are heterogeneous in nature as they differentiate from various cell types and 
can also be divided into different sub populations (LeBleu and Kallurri, 2018; Liu 
et al., 2019). Of these different CAF phenotypes, a senescent CAF subgroup has 
previously been identified (Kabir et al., 2016; Mellone et al., 2017). 
This current study is the first to report that CAF, whether isolated from human 
OSCC tissue, experimentally induced in vitro by treatment of human primary NOF 
with TGFβ1 (myofibroblastic phenotype) or exposed to oxidative (H2O2), 
genotoxic stress (cisplatin) and replicative exhaustion (senescent phenotype) 
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have a functional role in up regulation of bone turnover markers and promotion 
of osteoclast generation and activation. Furthermore, we demonstrate a role for 
CAF-derived RANKL, a key mediator of bone destruction, in this process and 
provide evidence that extracellular vesicles may act as mediators of these effects. 
Interestingly, our data indicates that the pro-bone invasive effects of CAF may be 
ameliorated by a new class of drugs, senolytics, currently entering clinical trials 
for other indications. 
CAF, unlike cancer cells, are genetically stable, making them unlikely to develop 
resistance, and limiting side effects that are reported with available cancer cell 
targeted treatments, amplifying their therapeutic potential. Targeting these cells 
with senolytics may be a promising therapeutic approach to limit tumour spread 
and bone involvement. 
6.2 Myofibroblastic stroma in OSCC 
A great deal of attention has been focussed in recent years on studying tumour 
cell interaction with ‘myofibroblastic’ CAF in tumour growth and invasion (De 
Wever et al., 2008). Myofibroblasts were first described in healing wounds, and 
due to their contractile characteristics, facilitate healing by increasing proximity of 
wound edges (Majno et al., 1971). These fibroblasts differentiate from multiple 
cell types and can be divided into different subpopulations. Besides their 
contribution to wound healing, myofibroblast-like fibroblasts are present in the 
TME and play a key role in cancer cell proliferation and invasion (Marsh et al., 
2011; Elmusrati et al., 2017). 
Although there is no specific marker for CAF, αSMA, expressed in myofibroblasts, 
is the most reliable and frequently used marker to identify CAF histopathologically 
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(Pietras and Östman, 2010; Dourado et al., 2018). Marsh et al. (2011) highlighted 
that the presence of a myofibroblastic αSMA positive stroma in OSCC is a more 
sensitive predictor of disease progression and prognosis than other long standing 
and well-known parameters such as TNM stage (including tumour size and 
metastasis), perineural or lymphovascular invasion and depth and pattern of 
invasion. Despite these recent findings showing the importance of CAF in OSCC, 
its role in bone invasive OSCC remains largely unexplored. Ishikuro et al. (2008) 
reported the presence of intervening fibrous stroma that expressed RANK and 
RANKL in OSCC mandibular bone resections. Moreover, following co-culture of 
human OSCC cell lines with mouse osteoblasts, an up regulation in RANKL and 
RANK mRNA expression was reported. We have previously shown that over 90% 
of our bone invasive OSCC cases did not demonstrate direct contact between 
tumour cells and bone, and that αSMA positive myofibroblastic CAF were seen 
intervening, and infiltrating bone ahead of the tumour invasive front.  We further 
investigated the expression of bone turnover markers (RANKL and OPG) in bone 
invasive OSCC and associated stroma. Interestingly, the bone destructive marker 
RANKL was highly expressed in both tumour and stroma in close proximity to 
bone suggesting a potential role of CAF in OSCC bone invasion and bone 
turnover (Elmusrati et al., 2017). 
In our current study, we set out to determine whether there is a difference in 
αSMA-expression in OSCC stroma, and RANKL/OPG expression adjacent to and 
away from bone and whether initial staging biopsies from these cases can be 
used to predict bone invasion. RANKL expression was expressed in tumour cells 
and surrounding stroma in a number of our samples. On reviewing the histology 
of resection specimens from these cases, the tumour appeared to be in close 
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proximity to bone.  However, OPG staining was either weak or absent. These 
findings are quite similar to previous studies in the context of tumour and bone 
cells (Kayamori et al., 2010; Ishikuro et al., 2005; Tada et al., 2005) and show 
that RANKL expression is more prominent near bone, suggesting that RANKL 
plays a key role in promoting bone invasion 
Chuang et al. (2009) compared the IHC expression of osteoclastogenesis 
markers RANKL and OPG in OSCC samples with and without bone involvement. 
Amplified RANKL, and reduced OPG staining was evident in OSCC cells in both 
groups. This expression may be due to the proximity of underlying bone to tumour 
front, and the capability of both OSCC groups to initiate bone invasion. This study 
also reported positive RANKL expression in normal oral mucosa (control group), 
which is unusual and highlights the need for further investigations to determine 
the validity of these findings. 
Osteoblasts express RANKL and are necessary in promotion of osteoclast 
generation and activation (Kular et al., 2012). To further investigate the effect of 
H357 and CAF on RANKL and OPG mRNA expression in primary human 
osteoblasts, an indirect co-culture method was employed. A significant 
amplification of RANKL and down regulation of OPG on a transcript level was 
consistently noted in HOB after exposure to H357 and CAF conditioned media 
following 24 h compared to controls (human primary osteoblasts in serum free 
media). Our findings are in agreement with previous research where an indirect 
co-culture of murine osteoblast with OSCC (BHY) conditioned media show an 
upregulation in mRNA RANKL (Ishikuro et al., 2008). This is also in keeping with 
previous studies that have reported mRNA OPG down regulation when BHY 
(human OSCC cell line) cells were cultured with primary murine osteoblasts (Jimi 
Chapter 6 Discussion 
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma 198 
et al., 2011). Interestingly, these RANKL expressing BHY cells, when inoculated 
into mice, developed a highly invasive tumour but were unable to initiate 
osteoclast differentiation from murine haematopoietic cells. However, this study 
did not consider investigating any other tumour microenvironment variables, and 
only focused on the effect of cancer cells on mouse osteoblasts. In our study, we 
demonstrate for the first time the effect of CAF-derived factors on RANKL and 
OPG expression in primary human osteoblasts. 
Previous studies have demonstrated that OSCC cell lines can promote 
myofibroblastic transdifferentiation of oral fibroblasts by conditioned media 
treatments through TGFβ1 signalling (Lewis et al., 2004; Marsh et al., 2011; 
Webber et al., 2018). In culture, exposure of fibroblasts to recombinant TGFβ1 is 
sufficient to induce a myofibroblastic phenotype (Sobral et al., 2011). In the 
current study, primary NOF isolated from human gingival tissue were treated with 
an optimal dose (5 ng/ml) of recombinant TGFβ1 for 24 h to trigger the transition 
of resting NOF to a myofibroblastic, CAF-like phenotype (Elmusrati et al., 2017; 
Melling et al., 2018). Following TGFβ1 stimulation, αSMA is integrated in actin 
stress fibres, increasing the contractility of normal fibroblasts (Serini and Gabbiani, 
1999; Lewis et al., 2004; Hinsley et al., 2011). In keeping with these, αSMA 
expression was observed in contractile stress fibres through 
immunofluorescence and was significantly amplified on a transcript level in 
experimentally induced CAF as well as CAF isolated from human tissue 
compared to controls. CAF isolated from human OSCC tissue and experimentally 
induced CAF share common characteristics, however, it is now known that 
myofibroblastic CAF induced through TGFβ1 signalling pathway represent only a 
subpopulation of CAF (Lewis et al., 2004; Kellermann et al., 2008; Mellone et al., 
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2017). Other subpopulations, such as those displaying a senescent phenotype 
through the expression of both αSMA and senescent marker p16INK4a have 
been reported as a CAF subset (Mellone et al., 2017). 
Bone invasion in OSCC is mainly regulated by the differentiation and activation 
of osteoclasts from hematopoietic precursors (Jimi et al., 2010). It has previously 
been proposed that stromal cells and osteoblasts are required in osteoclast 
generation through a process involving cell-to-cell communication with osteoclast 
precursors. This assumption was further confirmed by the discovery of TNF 
ligand RANKL (Suda et al., 1999; Boyle et al., 2003). Osteoclastogenesis is a 
complex mechanism regulated by three necessary molecules, RANKL expressed 
by osteoblasts, stromal and cancer cells and osteoblasts, its receptor RANK 
found on osteoclasts, and decoy RANKL antagonist OPG regulated by 
osteoblasts. RANKL and M-CSF have been reported to promote 
osteoclastogenesis in the absence of osteoblasts highlighting the importance of 
these markers in osteoclast differentiation and survival (Suda et al., 1999; Ross 
and Teitelbaum, 2005). In the current study, osteoclasts were generated from the 
murine macrophage cell line RAW 264.7. It has been previously reported that the 
murine macrophage cell line RAW 264.7, upon exposure to RANKL readily 
triggers osteoclastogenesis (Vincent et al., 2009). The advantage of using RAW 
264.7 cell is that they express both M-CSF and its receptor c-fms, and no 
treatment with M-CSF is required (Marino et al., 2014). RAW 264.7 monocytes 
were exposed to conditioned media collected from experimentally induced 
myofibroblastic CAF, and CAF isolated from human OSCC tissue. In our study, 
we observed morphological transdifferentiation of RAW 264.7 cells to large 
multinucleated cells after five days, and TRAP positive osteoclasts within seven 
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days of RANKL treatment. In addition, osteoclast functionality was evaluated by 
observing resorption pit formation on osteo-surface wells. Although H357 cells 
induced osteoclastogenesis, CAF showed the highest influence on osteoclast 
generation and these results were also reflected in pit forming assays showing 
multi-nucleation indicative of osteoclastogenesis. This is the first evidence that 
CAF are able to influence osteoclastogenesis, suggesting they may play a role in 
bone invasion. 
6.3 Senescence promotes OSCC bone invasion 
A considerable amount of research has focused on the role of αSMA-expressed 
myofibroblasts or CAF in tumour microenvironment. However, in recent years it 
has become evident that CAF represent a heterogeneous population with 
different fibroblastic phenotypes, suggesting that these distinct activated 
fibroblasts may have discrete roles in cancer progression (Shiga et al., 2015; 
Prime et al., 2017; Puram et al., 2017). A subpopulation of CAF that show 
characteristics of senescence are also evident in premalignant lesions (Costea 
et al., 2013; Procopio et al., 2015) as well as OSCC stroma (Hassona et al., 2013). 
Laberge et al. (2015), reported the characteristic features of senescent cells 
comprising a state of irreversible growth arrest, whilst maintaining metabolic 
activity, and expressing elevated levels of cytokines, growth factors and 
extracellular matrix components. This altered secretome is referred to as 
senescence associated secretory phenotype (SASP). 
Two separate types of CAF have been isolated from genetically stable (GS-
OSCC) and unstable (GU-OSCC) oral cancers. In this study, OSCC 
characterisation was based on the expression of p53 and p16INK4a mutations. 
The research group reported that CAF extracted from GU-OSCC were senescent 
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due to their loss of p53 and p16INK4a, while in contrast CAF isolated from GS-
OSCC exhibited wild type p53 and p16INK4a (Lim et al., 2011). Hassona et al. 
(2013) further contemplated that the development of the senescent CAF 
phenotype was caused by amplified levels of ROS related to TGFβ1, and TGFβ2, 
resulting in oxidative DNA damage. However, not all CAF in this model were 
senescent, further confirming CAF heterogeneity in OSCC.  
In the current study, senescent CAF were identified through 
immunohistochemical analysis of tissue from OSCC bone resections. Staining for 
senescence markers p16INK4a and DPP4/CD26, a recently discovered marker, 
reported to specifically be expressed on senescent cells following mass 
spectrometry analysis (Kim et al., 2017), was seen in stromal CAF proximal to 
invading bone. 
Mellone et al. (2017) analysed the two CAF subtypes, aSMA positive 
myofibroblasts and senescent fibroblasts. They showed that senescent CAF 
predominantly expressed aSMA in vivo, and that following senescence induction 
in vitro (irradiation, exposure to H2O2, cisplatin and replicative exhaustion) 
developed molecular and morphological features similar to myofibroblasts 
induced through the TGFβ1 signalling pathway. Co-expression of p16INK4a and 
aSMA in senescent fibroblasts was also confirmed using dual IF staining. In our 
study, double immunostaining on OSCC bone resections was conducted to 
examine whether a subpopulation of senescent CAF was present within the 
aSMA positive population. Co-localisation of senescence marker p16INK4a in 
αSMA positive CAF was evident in our cohort confirming the presence 
of senescent CAF in bone invasive OSCC stroma. These findings were in 
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agreement with previous studies (Hassona et al., 2013; Mellone et al., 2017; 
Dourado et al., 2019).	
 
 Senescence induction can be induced in vitro by DNA damaging stimulants as 
exposure to H2O2, cisplatin, replicative exhaustion or irradiation (Prime et al., 
2017, Mellone et al., 2017). In this study, to examine mechanistically whether 
senescent oral fibroblasts could influence bone remodelling, senescence was 
induced in normal oral fibroblasts at a low passage. Following five days of H2O2 
or cisplatin treatment, and after being cultured to replicative exhaustion (passage 
25), the majority of the fibroblasts exhibited a flattened and expanded morphology 
(Wagner et al., 2008), and were significantly positive for SA-β-Gal, indicative of 
senescence induction in agreement with previous studies (Kabir et al., 2016). 
 
Due to the lack of one specific marker to identify cellular senescence, and SA-β-
Gal becoming the most reliable and widely used senescence biomarker, a panel 
of indicators was required to confirm senescence induction. Sudan B Black (SBB), 
a histochemical stain for lipofuscin, which accumulates in aging cells, has recently 
been reported to identify senescent cells (Georgakopoulou et al., 2013). 
Therefore, to support the SA-β-Gal and p16INK4a data, SBB abundance was 
analysed in fibroblasts in culture. Black granular deposits of SBB were evident, 
further confirming senescence in primary CAF isolated from human OSCC, and 
experimentally induced senescent CAF (S-NOFH2O2, S-NOFCis, and S-NOFRep).. 
These results are in agreement with the cytological staining reported by 
Georgakopoulou et al. (2013). However, the SBB staining in FFPE tissue sections 
reported by the group was somewhat unreliable and controversial, as staining did 
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not appear specific. In the current study, SBB was also attempted in tissue from 
FFPE OSCC bone reactions however staining appeared variable and not specific 
to senescent cells. The lack of specificity in staining lipofuscin in paraffin 
embedded section may be due to elimination of these lipoproteins in the process 
of tissue preservation and deparaffinisation, making senescence difficult to 
identify in archived, fixed, tissue. The lack of a reliable marker of senescence in 
fixed tissue remains a problem for the field; however, in this thesis we observed 
specific staining of stromal cells for DPP4, a recently described marker of 
senescent cells, suggesting this may be a good senescence indicator in FFPE 
tissue. 
Senescent CAF have been reported to express αSMA (Mellone et al., 2017), and 
αSMA positivity in OSCC stroma has been reported to be linked to poor survival 
(Kellermann et al., 2007). In this study. CAF isolated from human OSCC and 
senescent CAF induced in vitro (S-NOFH2O2, S-NOFCis, and S-NOFRep) exhibited 
apparent αSMA positive stress fibres when compared to unstimulated primary 
NOF, following immunofluorescence. These findings suggest that senescent CAF 
may represent a population of αSMA positive CAF identified in OSCC, and these 
cells must be considered when investigating prognosis and potentially CAF-
targeting therapy. 
In bone, cellular senescence accumulating at pathological sites has a detrimental 
effect on bone mass (Kim et al., 2017; Farr et al., 2019). Chen et al., (2013), 
reported that an increased cellular senescence in bone resulted in an 
upregulation of SASP components such as IL6, TNFα, and NF-kB ligand 
(RANKL), and a decrease in OPG protein, leading to an unbalanced RANKL to 
OPG ratio promoting osteoclastogenesis and favouring bone destruction.  
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In this study, further analysis of senescence marker p16INK4a, IL6 and bone 
turnover RANKL and OPG in senescent CAF revealed a significant increase in 
p16INK4a, IL6 and RANKL, while OPG expression was downregulated on a 
transcript level throughout our cohort when compared to NOF. The prime bone 
destruction marker RANKL is expressed in both membrane bound and secreted 
soluble forms (Ikeda et al., 2001). Based on the evidence that NF-kB signalling 
is activated in senescence (Chen et al., 2013; Kim et al., 2017) and SASP 
develop with time (Kabir et al., 2016; Ohtani, 2019) an ELISA was conducted to 
investigate the expression of soluble RANKL protein at different time intervals 
following senescence induction in vitro. RANKL expression was significantly up-
regulated in S-NOFH2O2, S-NOFCis, and S-NOFRep following 5 days, 15 days of 
senescence induction and at passage 25 respectively. These findings provide 
direct evidence that senescent oral fibroblasts can synthesise and secrete 
elevated levels of RANKL, and the kinetics are similar to those of the well-
established SASP component IL6, indicating that RANKL may be considered a 
novel component of SASP. 
 
Exposure of RAW 264.7 monocytes to conditioned media collected from 
senescent fibroblasts resulted in osteoclast generation. These findings suggest 
that the TME composed of senescent and myofibroblastic CAF could potentially 
contribute to OSCC-mediated bone destruction. 
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6.4 Senolytics, a promising therapeutic 
application in limiting bone invasion in OSCC 
The common modality for treatment of OSCC with bone involvement is surgery 
with bone resection followed by chemo and/or radiotherapy. Unfortunately, the 
available chemotherapeutic drugs are cytotoxic for both normal and cancerous 
cells. In addition, exposure of the tumour and surrounding normal tissue to 
genotoxic stress caused by chemotherapeutic drugs such as cisplatin or high 
doses of radiation may further complicate treatment by triggering senescence 
induction. 
Senolytic drugs have recently been shown to selectively promote apoptosis in 
senescent cells, decreasing their pro-tumourgenic burden (Short et al., 2019). 
Several senolytics have been developed targeting different pro-apoptotic 
pathways. In this study, Navitoclax (ABT263) - an inhibitor of BCL-2 family - was 
used. Navitoclax has been reported to trigger senescent cell death in some but 
not all human and mouse cells (Chang et al., 2016; Zhu et al., 2016; Moncsek et 
al., 2018), however, toxicity has been reported due to weak cell selectivity 
exhibited with BCL-2 senolytics (Garland et al., 2013). Nonetheless, since the 
development of navitoclax as a senolytic it has been substantially used as a tool 
to study senescence (Chang et al., 2016; Kim et al., 2017; Zhu et al., 2017). Kim 
et al., (2017) recently reported an increase in apoptosis of bone marrow stromal 
cells following treatment with navitoclax in aged mouse models. This depletion in 
senescent cell burden in bone microenvironment resulted in a significant 
decrease in RANKL expression, further impeding osteoclast formation.  
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More recently, HSP90 inhibitors (17-DMAG) have been identified as a novel 
group of senolytic drugs (Fuhrmann-Stroissnigg et al., 2017). HSP stabilizing 
proteins have been reported to be associated with tumour cell proliferation in 
several cancers, making it a potential drug target (Taipale et al., 2010). Numerous 
current and previous clinical trials have explored the use of HSP90 solely or in 
adjunction with chemo or radiotherapy (Trepel et al., 2010; Jhaveri et al., 2012; 
Shah et al., 2018). HSP90 inhibitors are not only expressed in pathology,but have 
important physiological roles in cellular processes.It is probably for these reasons 
that there are still no FDA approved HSP90 inhibitors available for cancer 
treatment.  
 
Following demonstration that senescent fibroblasts are able to promote 
osteoclastogenesis, we next assessed whether the removal of senescent 
fibroblasts would reduce the paracrine effects promoting osteoclastogenesis. 
Previous reports have demonstrated the pro apoptotic functionality of senolytics 
in targeting CAF in hepatocellular carcinoma, nonetheless senescence was 
never examined (Chen et al., 2016). However, this current study is the first to 
specifically target senescent CAF with senolytics. Doses were selected targeting 
senescent fibroblasts but having minimal effect on proliferative cells. Significant 
reduction in osteoclast generation was recorded following exposure of senescent 
fibroblasts to both senolytics. Although the reduction in osteoclastogenesis was 
significant when CAF were exposed to Alvespimycin and Navitoclax, this 
reduction was less compared to experimentally induced S-NOF. These findings 
may be due to the heterogeneous nature of primary CAF isolated from OSCC, 
comprising different phenotypes. 
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6.5 Cell to cell communications in the tumour 
microenvironment are mediated by secreted EV 
In the past decade, a role has been established for EV in cell-to-cell 
communication. In the context of cancer, the cross talk between tumour and 
associated microenvironment is crucial to support cancer development and 
invasion. EV are involved in diverse mechanisms that sustain tumour 
advancement including angiogenesis, inflammation, EMT transition, cell 
proliferation as well as migration subsequently leading to invasion and metastasis 
(Becker et al., 2016; Xu et al., 2018).  
Unfortunately, the literature is lacking in research on oral cancer/OSCC derived 
EV. Most of the published studies have focused on investigating oral cancer 
biomarkers in EV isolated from saliva (Tanaka et al., 2013; Winck et al., 2015; 
Iwai et al., 2016; Kawahara et al., 2016) highlighting its diagnostic and prognostic 
potential in oral cancer. More recently, Dourado et al. (2019) reported that CAF-
derived EV secreted in the tumour microenvironment promoted OSCC cell 
proliferation and invasion. This research group highlighted the heterogeneous 
nature of five primary CAF cultures isolated from well differentiated OSCC of the 
lateral border of the tongue or floor of mouth. All the primary CAF exhibited 
myofibroblastic features, and senescent phenotypes were also detected in these 
cultures (approximately 20% of the CAF population). Moreover, CAF-derived EV 
showed an increased proteolytic profile and loss of cell adhesion factors when 
compared to EV isolated from NOF following proteomic analysis, explaining the 
migratory phenotype of CAF, and on further exposure of OSCC cell lines to CAF-
EV, an increase in OSCC cell migration was reported. 
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To date, the role of EV in bone invasion hasn’t been studied. However, recent 
reports have investigated the role of EV in bone remodelling, providing evidence 
that EV play a functional role in the dynamics of bone synthesis and resorption 
(Deng et al., 2015; Yin et al., 2017; Tao and Guo, 2019). These findings provided 
rationale to investigate the role of EV in bone invasive OSCC.  
In the current study, EV were isolated from OSCC cell line (H357), primary NOF 
and CAF, experimentally induced CAF (NOF exposed to TGFβ1) and senescent 
fibroblasts (S-NOFH2O2, S-NOFCis). To enhance purity and decrease 
contaminants, graded centrifugation followed by SEC was chosen as an optimal 
method in isolating EV from cell culture supernatants (Gardiner et al., 2016). 
Following EV extraction, size profiling and quantification, characterisation was 
conducted to confirm EV isolation. Well-established EV ‘markers’ CD9, CD63, 
and CD81 were examined, and were significantly observed throughout our 
samples confirming EV isolation. 
To investigate the potential of EV to communicate with osteoclast precursors 
and initiate osteoclastogenesis, RANKL expression was examined through an 
ELISA and the soluble RANKL protein was significantly increased in EV isolated 
from conditioned media collected from H357, CAF and senescent oral fibroblasts 
compared to NOF.  
To further evaluate these findings and assess the functionality of RANKL, RAW 
264.7 monocytes were exposed to EV isolates extracted from H357, primary CAF 
from human OSCC tissue, experimentally induced CAF (NOF exposed to TGFβ1), 
S-NOFH2O2, S-NOFCis, and  compared to primary human NOF, in an attempt to 
study the influence of EV derived from these cells on osteoclastogenesis, 
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Osteoclast generation and activation was evident throughout the samples, 
suggesting a significant contribution of RANKL expressed EV in bone invasive 
OSCC. Previous reports have implicated EV in bone remodelling (Deng et al., 
2015; Yin et al., 2017; Tao and Guo, 2019). However, this data is the first to show 
the effect of cancer cell and CAF-derived EV, and the first to directly demonstrate 
association of RANKL with EV in OSCC related bone invasion. 
OPG, a decoy receptor of RANKL has been reported to limit bone resorption by 
inhibiting osteoclast formation (Simonet et al., 1997). Several studies have shown 
that following administration of OPG, cancer cell invasion or metastasis to bone 
was inhibited (Canon et al., 2008; Armstrong et al., 2008; Tada et al., 2013). 
These results suggest that RANKL is the key modulator of bone involvement in 
cancer. Tada et al. (2013), demonstrated that by treating a co-culture of OSCC 
cells and murine osteoblasts with OPG, osteoclastogenesis was inhibited. 
Furthermore, in a recent study, RANKL expression in OSCC cells was inhibited 
following OPG exposure, and conditioned media collected from OSCC cells 
following RANKL knockout decreased osteoclast generation and bone resorption 
(Sambandan et al., 2017). 
In this current study, and previously published data (Elmusrati et al., 2017) 
RANKL expression was seen in tissue OSCC bone resections with staining seen 
in carcinoma cells and CAF invading bone ahead of tumour using IHC. Moreover, 
following the observation that OPG expression was down regulated in H357, 
primary CAF, experimentally induced myofibroblasts, and S-NOF, while 
increased levels of RANKL in H357, CAF, myofibroblasts, and senescent oral 
fibroblasts, and EV derived from these cells was observed in vitro. This further 
suggests that RANKL play a key role in bone invasive OSCC. 
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Recombinant human OPG, was used to target RANKL/RANK signalling cascade. 
Significant reduction in osteoclast generation was recorded following exposure of 
both conditioned media and EV to OPG. These findings suggest that obstructing 
RANKL/RANK interaction with OPG can impede osteoclastogenesis and inhibit 
bone invasion in oral cancer. 
6.6 Prospective implications in improvement of 
cancer therapies 
Bone destruction associated with OSCC invasion is a devastating sequel leading 
to a poor prognosis. Numerous studies have focused on understanding the 
pathway by which carcinoma cells invade bone in oral cancer, however, the 
molecular mechanism associated with how CAF promote tumour advancement 
is not fully understood. CAF, unlike cancer cells, are generally thought to be 
genetically stable and therefore make good therapeutic targets as resistance is 
unlikely to develop.  
Amongst the heterogeneous subpopulations of CAF in oral carcinomas, the 
myofibroblastic and senescent phenotypes are the most characterised. The 
introduction of senolytic drugs that target CAF in anti-cancer therapies is an 
expanding and particularly promising specialty of contemporary research for 
modern cancer treatments. However, this study is the first to utilise senolytic 
drugs to target senescent CAF and derived EV. Alvespimycin and Navitoclax 
demonstrated a significant reduction in senescent CAF burden, and further 
reducing OSCC bone destruction by osteoclastogenesis impediment.  
The perspective of EV targeted cancer therapies has also recently emerged. EV 
have low immunogenicity, biocompatible and are naturally capable of 
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communicating with target cells. They can carry cargo of vast oncogenic proteins, 
and also have potential for drug delivery as well (Samanta et al., 2018). The 
growing focus on EV in cancer, however, brings about new challenges as 
isolation and quantification, and whether current technologies are efficient in 
detecting minimal EV levels remains controversial. Regardless of these obstacles, 
unlike protein biomarkers, EV contain RNA which can be promptly amplified and 
profiled, providing advanced opportunities for the development of diagnostic 
biomarkers in cancer. Moreover, EV also have the ability to transmit messages 
raising the possibility that senescent cells may potentially have systemic effects 
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6.7 Conclusions 
I. αSMA-positive CAF intervening between tumour and underlying bone 
appear to play a role in bone invasive OSCC. 
II. RANKL and OPG expression ex vivo correlates to proximity of tumour to 
bone. The expression of both RANKL and OPG is higher in cases with 
frank OSCC bone invasion. 
III. Indirect co-culture of human primary osteoblasts with conditioned media 
from human OSCC and human isolated CAF significantly amplify RANKL 
and reduce OPG mRNA expression in vitro. 
IV. Treatment of normal oral fibroblasts with recombinant TGFβ1 induces 
transdifferentiation of resting fibroblasts to a αSMA positive CAF 
phenotype, significantly increasing RANKL expression on a transcript and 
protein level, and further promoting osteoclastogenesis. 
V. Senescent fibroblasts can be experimentally induced by exposure to 
oxidative (H2O2), genotoxic stress (cisplatin) and replicative exhaustion.  
VI. Conditioned media collected from primary CAF isolated from fresh human 
oral tissue, and experimentally induced senescent fibroblasts (S-NOFH2O2, 
S-NOFCis, and S-NOFRep) and derived EV, show significantly higher 
expression of soluble RANKL protein compared to NOF. 
VII. EV isolated from H357, primary CAF, experimentally induced 
myofibroblasts (NOF exposed to TGFβ1), S-NOFH2O2, S-NOFCis produce 
significantly more RANKL protein compared to NOF derived EV. 
VIII. CAF isolated from human tissue, experimentally induced myofibroblasts 
(NOF exposed to TGFβ1) and experimentally induced senescent 
fibroblasts (S-NOF) all show a significant increase in osteoclast generation. 
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IX. Senolytics Alvespimycin and Navitoclax, significantly promote death in 
senescent fibroblasts, and reduce osteoclast formation. 
X. Recombinant OPG blocks RANKL expression in CAF and senescent 
fibroblasts and derived EV, and reduces osteoclastogenesis 
To summarise, this study shows that CAF play a key role in bone invasive 
OSCC providing an opportunity for therapeutic intervention. 
6.8 Future work 
I. Our restricted ethical approval limited the extent of the clinical data to be 
analysed. We would further like to expand and correlate all the OSCC 
bone invasive clinical reports for 5-year disease free survival rate and 
prognostic evaluation. 
II. Examining a larger histological and IHC bone invasive cohort, and further 
increasing the control group as well. 
III. Further verify the presence of CAF in tumour microenvironment but 
studying other myofibroblastic IHC markers as FAP and FSP. 
IV. Examine other components of the tumour environment as inflammatory 
cells, through IHC staining for lymphocytes, macrophages and endothelial 
cells and correlate with bone invasion. 
V. Further examine the role of CAF and senescent oral fibroblasts on 
osteoclastogenesis in vivo. 
VI. Investigate the efficacy of senolytics or senomorphics on OSCC bone 
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